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Summary
The eukaryotic cell nucleus is a highly organised organelle, with distinct specialised
sub- compartments responsible for specific nuclear functions. Within the context
of this functional framework, the genome is organised, allowing contact between
specific genomic regions and sub-compartments. Previous work has shown that
genes in both cis and trans can make specific contacts with each other. I hypothesise
that such a preferred juxtaposition may impact the propensity for specific cancer-
initiating chromosomal translocations to occur.
In this thesis, I describe how I have extended and developed a ligation based
proximity assay known as enriched 4C. I have coupled this technique with high
throughput sequencing to determine genomic regions that spatially co-associate
with the proto-oncogenes MLL, ABL1 and BCR. In addition to further developing
the laboratory protocol, I have created bioinformatics tools used in the analysis of
the sequencing data. I find that the association profiles of the three genes show
strong correlation to the binding profile of RNA polymerase II and other active
marks, suggesting that transcribed genes have a propensity to associate with other
transcribed regions of the genome. Each gene also exhibits a unique repertoire of
preferred associations with specific regions of the genome. Significantly, I find that
the most frequent trans association of BCR is telomeric chromosome 9, encom-
passing its recurrent translocation partner gene ABL1. Interestingly, ABL1 is not at
the maximum point of interaction. I use DNA-fluorescence in-situ hybridisation to
validate the e4C association.
My data supports a hypothesis that gene transcription has a direct role on gen-
ome organisation. I suggest that preferred co-associations of genes at transcription
factories may promote the occurrence of specific chromosomal translocations.
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Chapter 1
Introduction
The nucleus is a highly complex organelle responsible for the faithful replication
and maintenance of the DNA template and regulation of its transcriptional products.
To achieve this, the contents of the nucleus are organised into compartments spe-
cialising in processes such as transcription and replication. Abnormalities in the
organisation of the nucleus are often associated with diseases such as cancer. In
this chapter I will discuss the current understanding of nuclear structure and or-
ganisation and how it may be involved in the initiation of oncogenic chromosomal
translocations.
1.1 Nuclear compartmentalisation
Because the nuclear interior is devoid of membrane bound structures its organisa-
tion is defined by a dynamic equilibrium - a sum product of the many processes
and requirements involved in nuclear biology. The organisation of DNA within
the nucleus is tied to the organisation of the nuclear proteome and together they
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control all nuclear processes. A number of nuclear proteins are found in aggregates
typically referred to as subnuclear compartments. The clustering of proteins into
compartments increases the efficiency of biochemical processes and is predicted by
the principle of molecular crowding (reviewed in Cook, 2002). It is a key feature in
the organisation of the nucleus.
The largest subcompartment found in the mammalian nucleus is the nucleolus.
The only subcompartment to be visible with light microscopy alone, the nucleolus
is formed by the clustering of ribosomal RNA gene clusters known as Nucleolar
Organising Regions (NORs) and facilitates efficient transcription of these genes by
RNA polymerase I. The colocalisation of the template genes with the transcriptional
machinery allows rapid and efficient cycling of the polymerases as well as the
assembly with ribosomal proteins (reviewed in Pederson, 2011).
A large number of other protein subcompartments exist, some whose function
have not been fully characterised. Many have been associated with nuclear pro-
cesses such as silencing (PcG bodies) and transcription (transcription factories).
The organisation of the genome is directed in part to access these subcompartments
(reviewed in Osborne and Eskiw, 2008). Transcription factories are discussed in
detail in Section 1.5.
1.2 Chromatin
Chromatin is a general term used to describe DNA packaged around histone proteins
to form nucleosomes, and the plethora of additional proteins that bind to them both.
There are two principle forms of chromatin: euchromatin and heterochromatin.
These were first described in the early twentieth century due to their differential
staining with carmine acetic acid within the nucleus (Heitz, 1928). Heterochro-
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matin stains darkly with giemsa stains because it remains highly condensed during
interphase and often associated with the nuclear periphery. Constitutive hetero-
chromatin consists of repetitive elements found in centromeres and telomeres, it
plays a structural role within the genome and is highly compacted during interphase.
Facultative heterochromatin is less compact and consists of inactive chromatin that
can vary between cell types as they differentiate. Heterochromatin is well known
as being a repressive environment for gene expression. An example of this is
the position-effect variegation seen in Drosophila melanogaster - a chromosomal
inversion in the X chromosome characterised in the early 1930s can place the white
gene close to pericentric heterochromatin, leading to the spreading of heterochro-
matin marks which silences the white gene and results in a change in eye colour
(reviewed in Girton and Johansen, 2008). In contrast, euchromatin is the site of
most genic transcription (Chesterton et al., 1974), its looser compaction allowing
cellular machinery access to the DNA, enabling the binding of transcription factors
and the initiation of transcription.
The differences between heterochromatin and euchromatin lie within the pro-
teins that they contain. Chromatin acts as a platform for proteins to bind to. Dif-
ferences in histone modifications, histone variants, nucleosome packing and DNA
modifications affect the accessibility and binding profile of the chromatin and can
control how the sequences within are used.
1.2.1 Histones
To package DNA, the double helix is wrapped around an octamer of core histones:
two H2A, two H2B, two H3 and two H4. 146 base pairs of DNA interact with these
positively charged proteins to form the nucleosome, which is then bound by histone
H1 with linker DNA to make a total of 166 base pairs (Fig 1.2.1, Davey et al., 2002).
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This packing forms the 10 nm fibre, often known as ’beads on a string’ due to its
appearance in electron micrographs. At their most basic level, histones function
to compact DNA by counteracting the negative charge of the phosphorylated back
bone.
Figure 1.2.1 – Structure of the nucleosome. X-ray structure of a nucleosome core
particle at a resolution of 1.9Å. DNA can be seen wrapped around the core histones,
which have flexible tails extending into the nuclear matrix. PDB structure 1KX5 (Davey
et al., 2002).
1.2.2 Histone modifications
Core histones have flexible amino-terminal tails which extend outside of the nuc-
leosome, and are accessible to proteins within the nucleoplasm. These tails can be
post-translationally modified at a large number of residues - lysine (methylation,
acetylation, ubiquitination, sumoylation, ADP-Ribosylation), arginine (methyla-
tion) as well as serine and threonine (phosphorylation). These modifications can
affect the packing of chromatin (Wolffe and Hayes, 1999) as well as which proteins
can bind. The large number of combinatorial possibilities that result from these
modifications have been dubbed the ’Histone Code’ (Strahl and Allis, 2000). Dif-
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ferent modifications are related to different chromatin states. For example, active
promoters are typically enriched for di- and tri-methylation of histone 3 lysine 4
(H3K4) whilst inactive promoters are enriched for trimethylation at lysine residues
27 (H3K27me3) and 9 (H3K9me3) (See table 1.2.1 for a summary. For review, see
Zhou et al., 2011).
Modification Histone Residue Effects on transcription
Acetylation
H2A K5 Activation
H2B K5, K12, K15, K20 Activation
H3
K4, K14, K18, K23, K27 Activation
K9 Histone deposition
H4
K5, K12 Histone deposition
K8, K16 Activation
Methylation
H3
K4, K79 Euchromatin
K9, K27 Silencing
R17 Activation
K36 Elongation
H4
R3 Activation
K20 Silencing
Phosphorylation
H2A S1, T119 Mitosis
H2AX S139 DNA repair
H3 T3, S10, T11, S28 Mitosis
H4 S1 Mitosis
Ubiquitination
H2A K119 Silencing
H2B K120 Activation
Table 1.2.1 – Summary of known mammalian histone modifications. H, histone; K,
lysine; R, arginine; S, serine; T, threonine. Adapted from Sadri-Vakili and Cha, 2006.
As chromatin immunoprecipitation (ChIP) has become a common laboratory
technique, combined with microarray techniques (ChIP on chip) and next genera-
tion sequencing (ChIP-Seq), our understanding of how histone modifications affect
chromatin biology on a genome-wide scale has advanced dramatically. Profiling
chromatin types using multiple datasets covering a large number of histone modific-
ations is sufficient to predict the identity and function of regions in the genome with
a high degree of accuracy, revealing previously unknown enhancers (Heintzman
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et al., 2007; Ernst and Kellis, 2010; Hon et al., 2009). Ernst et al. used the genome-
wide profiles of nine histone modifications in nine different cell types to define
fifteen chromatin states, including promoters, enhancers, insulators and transcribed
regions (Ernst et al., 2011). They integrated data from genome-wide association
studies (GWAS) and found numerous enhancer elements that coincide with dis-
ease associated mutations. Such genome-wide approaches can reveal differences
between cell types and are powerful tools in understanding how the genome is
interpreted in health and disease.
1.2.3 Histone variants
In addition to histone tail modifications, chromatin can be modified by the incorpor-
ation of histone variants. The genes encoding canonical core histones are found in
clustered repeat arrays within the genome, are transcribed during replication and are
highly conserved between species. Histone variants are found as single genes spread
through the genome and are subject to far greater diversity (Talbert and Henikoff,
2010).
CENP-A is a human variant of histone H3 which replaces the canonical his-
tone in centromeric heterochromatin. It is a key factor in the establishment of the
centromeres and kinetochores required for mitosis. The histone variant is incor-
porated with the help of a number of chaperone proteins, including HJURP, after
replication of DNA has finished (Dunleavy et al., 2009; Foltz et al., 2009). CENP-
A is essential for the formation of centromeres.
Another frequent histone variant found in humans is H3.3, which differs from
canonical H3 by just four amino acids (Talbert and Henikoff, 2010). This histone
variant is found within transcribed genes, promoters and regulatory elements, and
is thought to be laid down during transcriptional elongation (Schwartz and Ahmad,
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2005). Nucleosomes containing H3.3 appear to be less stable than canonical nuc-
leosomes, with a high turnover (Schwartz and Ahmad, 2005). It is possible that
this increased turnover of the nucleosomal components helps to keep the chromatin
open and accessible to the transcriptional machinery (Talbert and Henikoff, 2010).
Other core histone proteins also have variants, such as H2A.Z, a histone variant
located on either side of the nucleosome free regions found at the transcriptional
start sites of active genes as well as insulator regions (Zlatanova and Thakar, 2008).
H2A.Z is able to promote the recruitment of RNA polymerase II to certain regions,
such as the yeast GAL1-10 genes, by mediating C-terminal interactions with the
transcriptional machinery (Adam et al., 2001).
1.2.4 Higher order chromatin structure
One of the key functions of histones are to package DNA into a compact form. The
phosphate backbone of DNA carries a strong negative charge, negated by positively
charged residues within the histone core particle. In its least compact configura-
tion, chromatin forms a 10 nm fibre known as “beads on a string”. At the other
extreme chromatin forms mitotic chromosomes, condensing DNA 10- to 20,000
fold (Woodcock and Ghosh, 2010). Despite a great deal of research on forms of
chromatin that exist between these two structures, definitive packing structures have
not been forthcoming, primarily due to problems resolving individual chromatin
strands within the nucleus by microscopy. Some evidence shows that a 30 nm fibre
may exist, though the packing of nucleosomes in this structure is still a topic of
debate (reviewed in Tremethick, 2007). A recent paper by Fussner et al. suggests
that all chromatin within in-vivo mouse nuclei is present as 10 nm fibres and that
the 30 nm is not a common form of chromatin (Fussner et al., 2012).
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Recent investigations of genomic organisation using genome-wide interaction
mapping techniques have investigated the higher order packing of interphase chro-
matin (Lieberman-Aiden et al., 2009; Kalhor et al., 2011). Modelling approaches
using this association data suggests that chromatin behaves like a fractal globule;
unentangled chromatin packed upon itself in series of ever increasing “globules”.
Such a structure satisfies the need for chromatin to pack and unpack for mitosis
without forming knots and is highly space efficient (Lieberman-Aiden et al., 2009).
1.3 Two-dimensional organisation
Since the inception of cytogenetics, it has been known that not all chromosomes
are the same. The development of chromosome banding techniques in the 1970s
allowed detailed human karyotypes to be determined, complete with differential
staining of regions within each chromosome (Caspersson et al., 1970). Banding
assays can show regions of heterochromatin and euchromatin, highlighting the vari-
ation in characteristics across regions of the genome (reviewed in Trask, 2002). In
prokaryotes, genes are often found in cistrons and can be coexpressed in single poly-
cistronic mRNAs. This type of linear organisation is not present in most higher eu-
karyotes, with the notable exception of the nematode worm Caenorhabditis elegans
(Blumenthal et al., 2002), though gene clusters resulting from tandem duplication
are frequently found throughout mammalian genomes. Some specific examples of
two-dimensional clustering have been shown: testes-specific genes in Drosophila
melanogaster have been found in clusters more frequently than would be expected
by chance (Boutanaev et al., 2002) and genes sharing transcription factors can be
found in clusters in the yeast Saccharomyces cerevisiae (Janga et al., 2008).
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The sequencing of the human genome allowed detailed analysis of GC content,
gene density and repetitive sequence content (Lander et al., 2001). Versteeg et
al. integrated a multitude of SAGE tag expression profiles from different cell
types into the genomic map and built on earlier work, defining regions of high
transcriptional activity called ridges (Versteeg et al., 2003; Caron et al., 2001).
They found ridges to be gene-dense, highly transcribed, have a high GC content
and low LINE repeat density. These features are based purely on the underlying
sequence content and so do not vary amongst cell types. The different ridges and
anti-ridges were found to contain different classes of genes, with weakly expressed
genes clustering within anti-ridges and clusters of highly expressed housekeeping
genes found predominantly in ridges (Versteeg et al., 2003).
On a gross scale, chromosomes are formed by two arms denoted p and q,
connected by a centromere and capped by telomeres. Centromeres and telomeres
contain primarily repetitive sequence and are important for the structural mainten-
ance of chromosomes. Chromosomes 13, 14, 15, 21, 22 and Y are “acrocentric”:
the p arms are so short that they are difficult to observe.
Whilst the two-dimensional organisation of the genome cannot completely ex-
plain the degree of complexity found within the transcriptome, these studies demon-
strate that the order of sequence within the genome is not entirely random and can
affect the transcriptional control of genes.
1.4 Chromosome Territories
As chromosomes decondense after metaphase they retain some degree of structure,
forming “chromosome territories” (CTs) (Cremer and Cremer, 2001). Circumstan-
tial evidence for interphase organisation of chromosomes has existed for a long
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time, first suggested by Carl Rabl in 1885 (Rabl, 1885). Oberservations by Stack
et al. using microscopy with giemsa-band staining suggested that chromosomes
retained some degree of organisation during interphase (Stack et al., 1977), and
in 1982 Cremer et al., showed that interphase chromosomes occupy territories by
studying the pattern of DNA damage in metaphase chromosomes after spot irra-
diation during interphase (Cremer et al., 1982). The subsequent development of
chromosome paints, a method to visualise entire or part-chromosomes with fluores-
cence in-situ hybridisation (FISH), confirmed these findings (Schardin et al., 1985;
Manuelidis, 1985; Bolzer et al., 2005).
Figure 1.4.1 – Chromosome Territories. Image of a Human fibroblast cell in G0 with
all chromosomes labelled using multi-colour FISH. Adapted from Bolzer et al. (Bolzer
et al., 2005)
As FISH techniques have developed, so too has the detail with which CT or-
ganisation can be studied. Several groups have shown that chromosome territory
position within the nucleus is not random and correlates with chromosome size (Sun
et al., 2000; Cremer et al., 2001; Bolzer et al., 2005), gene-density (Cremer et al.,
2001; Croft et al., 1999) and replication timing (Ferreira et al., 1997; Visser et al.,
1998) - those near the centre of the nucleus tend to be gene-rich, early replicating
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and small. CT positioning appears to be conserved through evolution (Tanabe et al.,
2002) and is cell type specific (Parada et al., 2004; Kuroda et al., 2004).
1.4.1 CTs and transcription
It is known that for some but not all genes, positioning at the nuclear periphery
correlates with reduced gene expression (Kosak et al., 2002; Dietzel et al., 2004;
Zink et al., 2004). To investigate whether nuclear positioning can cause changes in
transcriptional activity or is simply a consequence, three groups published studies
which artificially tethered genomic regions to the inner nuclear membrane using
lac operators (lacO) (Finlan et al., 2008; Reddy et al., 2008; Kumaran and Spector,
2008). Finlan et al. and Reddy et al. both observed a decrease in the transcriptional
activity of the regions when tethered (Finlan et al., 2008; Reddy et al., 2008), an
effect that was ablated when cells were treated with trichostatin A (TSA) to inhibit
class I and class II histone deacetylases (Finlan et al., 2008). It should be noted
that this effect does not appear to apply to all loci (Kumaran and Spector, 2008).
Whilst these studies suggest that it is nuclear positioning that leads to transcriptional
effects, a study by Croft et al. showed that inhibition of transcription causes a
reversible change in CT position (Croft et al., 1999) and Bridger et al. showed a
difference in CT positioning between proliferating and senescent human fibroblasts
(Bridger et al., 2000). Large scale rearrangements of CTs have also been observed
during cell differentiation (Stadler et al., 2004; Szczerbal et al., 2009), likely due to
changes in transcriptional profiles and chromatin remodelling.
This evidence suggests that there is a dynamic interplay between CT positioning
and transcription - gross transcriptional patterns may drive the position of chromo-
somes within the nucleus, and those positions may in turn affect the transcription of
the genes they contain.
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1.4.2 Chromosome territory dynamics
The movement of chromatin loci within the nucleus is known to be largely due
to local Brownian motion, or “constrained diffusion” and seems to be limited by
attachment to a nuclear cytoskeleton, nucleoli and the inner nuclear membrane
(Marshall et al., 1997; Chubb et al., 2002), though some studies have shown a
mixture of local diffusion and larger, active movements (Vazquez et al., 2001).
Chuang et al. studied Chinese hamster ovary (CHO) cells after stimulation with
a transcriptional activator and analysed the movement of a reporter locus from the
nuclear periphery to the interior of the nucleus (Chuang et al., 2006). They found
that chromosome movements happened in rapid unidirectional bursts, suggesting
an active mechanism. This was supported by a later study in human fibroblast cells
by Mehta et al. who demonstrated chromosome movement only 15 minutes after
serum starvation, a process that was ablated by the inhibition of actin polymerisation
or myosin activity (Mehta et al., 2010). Such rapid movements on such a large scale
come at a large energy cost to the cell and indicate the importance of chromosome
positioning in nuclear function.
1.4.3 Chromatin decondensation and the
inter-chromosomal space
In addition to the study of whole chromosome positioning, there has been a great
deal of research into the positioning of individual sequences relative to their chro-
mosome territory. Early studies suggested that transcribed genes were found at the
surface of chromosome territories (Zirbel et al., 1993) leading to a model whereby
transcriptionally inactive genes are buried within territories and expressed genes
are able to contact transcriptional machinery in an inter-chromosome domain (ICD)
(Cremer et al., 1993). This model gained support due to studies showing genes at
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the periphery of CTs (Kurz et al., 1996) and new techniques to visualise the ICD
using microscopy (Bridger et al., 1998). A number of FISH studies showed genes
moving away from their territories in large loops upon activation (Volpi et al., 2000;
Mahy et al., 2002a; Chambeyron and Bickmore, 2004), suggesting that they may be
recruited to the ICD for transcription.
Despite these case studies, looping is not a prerequisite for transcription; DNA-
FISH studies have shown transcription within the volume of chromosome territories
(Verschure et al., 1999; Mahy et al., 2002b). Osborne et al. showed that the actively
transcribed Uros gene is more frequently outside the CT than the inactive gene
Fgfr2, though this position was not necessary for transcription, suggesting that
actively transcribed genes may preferentially locate to the surface of CTs, but that
this alone is not sufficient to drive transcription (Osborne et al., 2004). As such, it
has been suggested that the inter-chromosomal domain model should be renamed
the inter-chromatin domain model, whereby chromosomes are invaginated with
channels and subdivided into domains of chromatin approximately one megabase
in size (Cremer and Cremer, 2001).
1.4.4 Chromosome territory intermingling
A question that followed immediately from the discovery of loops extending from
chromosome territories was that of chromosome intermingling. Mathematical mod-
elling approaches capable of predicting intermingling volumes correlated with known
rates of irradiation induced DNA damage (Holley et al., 2002; Hlatky et al., 2002).
This was later backed up with a study by Branco and Pombo, who studied thin
cryosections of nuclei with high resolution light and electron microscopy; they
found that there is significant intermingling of chromatin between chromosome ter-
ritories, and that the extent of this intermingling correlated strongly with previously
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recorded irradiation induced translocation frequencies (Branco and Pombo, 2006).
The degree of intermingling changed significantly for three chromosome pairs after
transcription inhibition with α-amanitin, suggesting a role for specific transcription
interactions in the organisation of the nucleus (Branco and Pombo, 2006).
In support of chromosome intermingling, the HoxB extra-chromosomal loops
found to extend from the chromosome territory upon gene activation (Chambeyron
and Bickmore, 2004) were found to make increased trans chromosomal interactions
whilst looping out (Würtele and Chartrand, 2006), suggesting that the loops contact
other chromosomes rather than occupying an empty inter-chromosomal space. A
large number of inter-chromosomal contacts have been detected by recent genome-
wide chromosome conformation studies, supporting the presence of chromosome
intermingling (Lieberman-Aiden et al., 2009).
1.5 Transcription factories
To fully understand the structure and function of the genome, we must see it in the
context of the nuclear proteome. Proteinaceous subcompartments are found within
the nucleus and aid the control of chromatin dynamics and efficient functioning of
related processes.
One class of nuclear subcompartment which has come to light within the past
thirty years is the transcription factory, seen as foci of hyper-phosphorylated RNA
polymerase II scattered throughout the nucleus. The vast majority of genic tran-
scription appears to take place at transcription factories (Jackson et al., 1993; Os-
borne et al., 2004; Ragoczy et al., 2006; Eskiw et al., 2008; Schoenfelder et al.,
2010), challenging the classical model of transcription found in many text books
(discussed below).
15
Chapter 1: Introduction
A CB
rDNA
transcript
pol II
pol I 
B C
Figure 1.5.1 – Nascent RNA and transcription factories. (A) Transcription foci in
HeLa cells, visualised with labelled Br-UTP in 100 nm cryosections. Nascent RNA
(green) is concentrated in punctate foci. (B) Model for a nucleolar factory, showing a
transcript with multiple polymerases generating a crescent shaped focus. (C) Model for
a nucleoplasmic factory. Multiple transcribed regions each with a single polymerase
generate a smaller cloud of nascent transcripts. Adapted from Cook et al., Science
(2009) (Cook, 1999).
The first study to suggest that eukaryotic transcription does not take place with
a processive RNA polymerase moving along a DNA template was by Jackson,
McCreedy and Cook in 1981. They showed that nascent RNA transcripts labelled
with [3H] uridine remained within the nucleus when loops of DNA were removed
using a nuclease (Jackson et al., 1981). They went on to show that RNA polymerase
II and active genes were also resistant to elution after chromatin digestion (Jackson
and Cook, 1985). The term ’transcription factories’ was coined by Jackson et al. in
1993. Fluorescence microscopy was used to label the incorporation of bromouridine
triphosphate (BrUTP) into nascent RNA; discrete foci of nascent transcription could
then be seen within the nucleus which did not form in the presence of the RNA
polymerase II inhibitor α-amanitin (Jackson et al., 1993). Further studies showed
that these foci contained RNA polymerase II along with many other components
required for transcription (Iborra et al., 1996; Grande et al., 1997). An ultrastruc-
tural study by Eskiw et al. used correlative microscopy with both electron spec-
troscopic imaging (ESI) and fluorescence microscopy to study nuclei sections. ESI
16
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can distinguish nitrogen and phosphorous atoms without labelling, and fluorescence
light microscopy can visualise transcription through labelling BrUTP in nascent
transcripts. The authors found that nascent RNA is almost always associated with
the surface of large nitrogen-rich protein structures with a diameter of ~87 nm,
comparable in size to that predicted for a transcription factory (Eskiw et al., 2008).
The discovery of transcription factories has demanded a new model for the
action of RNA polymerase II (Cook, 1999). The revised model proposes that
instead of RNA polymerase II freely diffusing to active genes and tracking along
the gene body, genes are recruited to transcription factories and are pulled through
a stationary polymerase. Such a model provides a better explanation for the mech-
anics of transcription - clustering of transcriptional activity may enable the cell to
conduct transcription in a much more efficient manner; HeLa nuclei have a 1 µM
concentration of active RNA polymerase II, whereas the local concentration within
transcription factories is closer to 1 mM (Cook, 2002). Additionally, a polymerase
enzyme moving along a gene would rotate with the helix of the DNA wrapping the
nascent transcript around the template. Genes pulled through static transcription
factories would extrude their RNA transcripts into the nucleoplasm (Iborra et al.,
1996; Cook, 1999), creating topological loops within the template DNA which may
be removed through the activity of topoisomerases.
Jackson et al. went on to work on a quantitative analysis of transcription factor-
ies in HeLa cells calculating the number of active RNA polymerases, the number of
transcription sites and the number of polymerases associated with each transcrip-
tional unit (Jackson et al., 1998). They showed that each HeLa cell nucleus contain
approximately 2400 transcription factories, each with approximately 30 active RNA
polymerase II complexes (Jackson et al., 1998). Importantly, this study showed that
there are more transcribing units than there are foci of transcription, suggesting that
17
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genes must colocalise to transcribe. The number of transcription factories varies
a great deal amongst cell types, but the observation that genes colocalise within
transcription factories has been confirmed by a number of different techniques.
Osborne et al. showed that greater than 90% of actively transcribed genes are
associated with transcription factories (Osborne et al., 2004). They demonstrated
that transcription is a discontinuous process with the frequency of nascent RNA
transcription foci related to primary transcript RNA concentrations, suggesting that
transcription occurs in bursts. Multiple genes both in cis and in trans were seen to
dynamically colocalise in transcription factories, supporting predictions that genes
must share transcription factories (Osborne et al., 2004; Jackson et al., 1998). A
later paper by Osborne et al. showed that the immediate-early genes Myc and Fos
are dynamically recruited to existing transcription factories within five minutes of
B-cell stimulation, suggesting that the recruitment of genes to pre-existing tran-
scription factories may be a method of transcriptional control (Osborne et al., 2007).
It is worth noting that the concept of genes being recruited to immobile tran-
scription factories is not universally accepted, with some doubt over the resolution
achievable by FISH and 3C studies (reviewed in Sutherland and Bickmore, 2009).
1.5.1 Specialised transcription factories
After the demonstration that genes share transcription factories, a number of groups
postulated that specific genes may colocalise at a subset of transcription factories.
The self-organising principle applied to transcription factories would predict this;
just as the local concentration of active RNA polymerase II is elevated by the
clustering of transcribing units, the local concentration of transcription factors that
bind to those transcribed units will also be elevated (Cook, 2002). It is thought
that genes diffusing to a transcription factory already engaged with other genes that
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share the same factors are more likely to engage and be transcribed themselves
(Bartlett et al., 2006). Indeed, genes regulated by common transcription factors
appear to cluster within specific chromosomes in yeast (Janga et al., 2008) and
testis-specific genes are found clustered in Drosophila (Boutanaev et al., 2002) -
genes clustered in linear sequence are more likely to associate in three dimensions.
Some evidence that such specialised transcription factories may exist within
mammalian cells came from Osborne et al. (2007). Myc and Igh are commonly
translocated in Burkitt’s lymphoma and mouse plasmacytoma. They showed that
approximately one quarter of actively transcribing Myc alleles shared a transcription
factory with Igh, over double the rate of colocalisation found with the control genes
tested. Using DNA-FISH they showed an overall reduction in spacing between
Myc and Igh alleles upon B cell stimulation, suggesting that Myc alleles are being
specifically recruited to transcription factories containing transcribing Igh (Osborne
et al., 2007). Xu and Cook later demonstrated that the transcription of plasmids
transfected into cells clustered together at a handful of transcription factories. The
plasmids were generated with one of four promoter types, one of three genes and
one of three 3’ regions and were found to segregate according to their promoter and
the presence of an intron (Xu and Cook, 2008).
Perhaps the best evidence for the existence of specialised transcription factories
came in a publication by Schoenfelder et al. in 2010 (Schoenfelder et al., 2010).
They used a variety of techniques to investigate the nuclear localisation of erythroid
genes. A genome-wide screen of genes associating with Hba and Hbb at transcrip-
tion factories showed enrichment for genes with CACC motifs capable of binding
the erythroid-specific transcription factor Klf1. Using immunofluorescence they
found that nuclear Klf1 foci overlap with active RNA polymerase II foci, suggesting
that a subset of transcription factories are enriched for Klf1 in erythroid tissues
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(Fig 1.5.2). Co-localising Klf1 dependent genes associated with these Klf1 specific
transcription factories at a high frequency, and a number of these gene associations
were lost in Klf-/- knockout mice. These data suggest that a network of Klf1 specific
transcription factories exist within mouse erythroid tissues, and that Klf1 specific
genes are preferentially recruited to these sites (Schoenfelder et al., 2010). If such
specialised transcription factories are a general feature in mammalian nuclei, they
could be a key driving force in the organisation of the genome.
HbbKlf1Klf1 RNAPII
8080 4040 0
***
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Hbb/Hba
Hbb/Hmbs
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Hbb/Cpox
Hbb/Hist1
Hba/Hist1
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**
Hba/Tubb5
Klf1-associatedNot Klf1-associated
A B C
Figure 1.5.2 – Klf1 specialised transcription factories. (A) Immunofluorescence
showing Klf1 (red) overlapping with a subset of RNA polymerase II transcription
factories (green). (B) RNA immuno-FISH showing transcribing Hbb alleles (green) co-
localising with Klf1 (red). (C) Percentages of co-localising transcript pairs colocalisation
with Klf1 associated transcription factories (right, black bars) and non-Klf1 associated
factories (left, white bars). Expected level of association due to chance shown by green
bar. Scale bars show in (A) and (B) represents 2 µm. Taken from Schoenfelder et al.
(Schoenfelder et al., 2010).
It is important to note that the evidence above does not describe exclusively
specific transcription factories, i.e. factories which are incapable of transcribing
genes not controlled by Klf1. Indeed, although statistically significant, the gene
associations detected suggest a population bias. Specialised transcription factories
are certainly not required for the transcription of the eukaryotic genome, but may
aid efficiency and affect nuclear organisation and function.
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1.6 Chromatin interactions in three dimensions
1.6.1 Promoter and enhancer interactions
The classical model of gene promoter regulation began with the characterisation of
the lac operon in Escherichia coli in 1961 (Jacob and Monod, 1961). Three genes
required for the digestion of lactose are controlled by the binding of a repressor
protein which blocks transcription by RNA polymerase. This repressor can form
a tetramer and bind two region simultaneously, requiring a topological loop in the
chromatin.
A number of eukaryotic genes were later found to require distal enhancer ele-
ments (Banerji et al., 1981), prompting speculation that the looping of chromatin
allowing direct interaction between sequences may be a common mechanism (Dor-
sett, 1999). Direct evidence for in-vivo chromatin interactions was provided in 2002
with two papers studying the mouse beta globin (Hbb) locus (Carter et al., 2002;
Tolhuis et al., 2002). This locus contains four beta-like genes arranged in order of
their expression through development. Approximately 50 kilobases upstream is a
locus control region (LCR), containing multiple DNase hypersensitive sites (HS1-
6) (Bender et al., 2000). Carter et al. used a novel technique called RNA TRAP
(tagging and recovery of associated proteins) which localises horseradish peroxi-
dase (HRP) to the site of nascent RNA production of a specific gene. The HRP
catalyses biotinylation of nearby chromatin which can be purified and quantified
by quantitative real-time PCR (qPCR). They showed a 15-fold enrichment of biotin
over the HS2 region of the LCR when the actively transcribing Hbb-b1 transcript
was used for the HRP localisation, demonstrating that this region of the LCR is in
very close proximity to the Hbb-b1 gene (Carter et al., 2002).
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Tolhuis et al. (Tolhuis et al., 2002) used the chromosome conformation capture
technique (3C) developed by Dekker et al. to study the organisation of chromatin
within yeast (Dekker et al., 2002) (for discussion of this technique see Section
3.1.1). They studied the same globin locus and also found evidence for interaction
between the LCR hypersensitive regions and the Hbb genes. Importantly they
showed that in mouse foetal brain tissue, where the Hbb locus is not expressed,
the chromatin adopted a linear conformation without any looping (Tolhuis et al.,
2002). Palstra et al. went on to show that each gene contacts the LCR as it is
expressed, supporting a system where the developmentally controlled genes must
contact an enhancer within the LCR in order to be expressed (Palstra et al., 2003).
They showed that erythroid progenitor cells dedicated to the lineage but not yet
expressing beta-like globin genes form a ’poised’ structure, contacting the LCR but
not engaging strongly with the HS2 enhancer (Palstra et al., 2003).
1.6.2 Chromatin hubs
The beta globin locus has become a model system for the active chromatin hub
(ACH) model (de Laat and Grosveld, 2003), describing a system where loops of
chromatin containing elements capable of controlling the expression of genes are
found in close three-dimensional space to the genes that they control. Other gene
clusters have also been shown to behave in a similar manner, notably the TH2 locus
and Hox clusters.
The TH2 locus control region is involved in the transcriptional control of cy-
tokine genes IL4, 5 and 13 (Lee et al., 2003). Spilianakis et al. showed that
these genes cluster together in T cells, NK cells, B cells and fibroblasts, despite
not being expressed in the last two cell types. In T cells and NK cells the genes
additionally associate with the TH2 LCR (Spilianakis and Flavell, 2004). The
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authors suggest that this mechanism allows the coordinate expression of the gene
cluster in a controlled manner.
The Hox genes are master regulators of gene transcription and are responsible
for the creation of vertebrate segments during development. Hox gene clusters A to
D are transcribed in sequence as development of the embyro progresses and have
been observed decondensing and looping out from their chromosome territories
upon activation (Chambeyron and Bickmore, 2004). Noordermeer et al. studied the
Hox clusters in three different mouse embryonic day 10.5 tissues: forebrain, anterior
trunk and posterior trunk (Noordermeer et al., 2011). They found that the Hoxd
cluster formed a discrete domain in forebrain, where it is inactive. In anterior and
posterior trunk the Hoxd cluster is active, but different genes are transcribed. In both
tissues they found the cluster to form two distinct compartments correlating with an
inactive and active regions. Using circularised chromosome conformation capture
(4C), a technique based on 3C, they showed that genes move from the inactive
to active compartment as they are activated, correlating with active histone marks
(Noordermeer et al., 2011).
1.6.3 Long range interactions
As the role for distal enhancers has become more established, evidence has been
uncovered for increasingly distant interactions. For example, Sharpe et al. de-
veloped a mouse model for preaxial polydactyly by random insertion of a reporter
cassette (Sharpe et al., 1999) which they found to affect a cis regulatory site over
a megabase upstream of the gene Shh, known to be important in the condition
(Lettice et al., 2002). Lettice et al. went on to characterise this enhancer, which lies
within an intron of the gene Lmbr1 unrelated to the condition, demonstrating that
7q36 abnormalities found in patients with preaxial polydactyly disrupt this enhancer
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(Lettice et al., 2003). In 2005, Velagaleti et al. characterised breakpoints found
in two patients with the skeletal malformation syndrome campomelic dysplasia
(Velagaleti et al., 2005). They found the breakpoints corresponded to two different
regulatory elements, one 1.1 Mb upstream of the target gene SOX9 and one 1.3
Mb downstream. Kleinjan et al. used mouse models carrying yeast artificial chro-
mosomes (YACs) to characterise multiple distal enhancers of the developmental
control gene Pax6 (Kleinjan et al., 2006). They found that as different enhancers
were removed, expression of the gene was abolished in different tissues, suggesting
a complex system of enhancer - promoter interactions driving the pattern of tissue-
specific expression (Kleinjan et al., 2006).
1.6.4 Interactions in trans
Spilianakis et al. went on from characterising the intra-chromosomal interactions of
the TH2 LCR (described above) to show that the same locus forms inter-chromosomal
interactions (Spilianakis et al., 2005). Depending on the stimulus received, naïve
T cells can differentiate into either TH1 or TH2 cells, defined by the expression of
either IFN-γ or IL-4. Spiliankis et al. showed that the Ifng gene on chromosome 10
can interact with the TH2 LCR on chromosome 11 to stimulate Ifng expression
whilst inhibiting IL4 expression. This interaction is the first interchromosomal
interaction known to regulate gene expression (Spilianakis et al., 2005).
Lomvardas et al. used 3C to demonstrate the association of an olfactory receptor
gene enhancer made specific contacts to multiple other olfactory genes across the
genome (Lomvardas et al., 2006). Mouse dendrites can express one of approx-
imately 1300 odorant receptor genes and Lomvardas et al. suggested that this
enhancer-gene interaction was the mechanism responsible for the expression of that
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gene. However, it should be noted that deletion of this enhancer had little effect on
the usage of olfactory genes outside of its cluster (Fuss et al., 2007).
A number of other studies have shown specific interchromosomal contacts in-
volved in a number of processes ranging from X-inactivation to genomic imprinting,
showing that these interactions may play an important role in chromatin biology
(reviewed in Schneider and Grosschedl, 2007).
1.6.5 Global interaction maps
Our understanding of the three-dimensional organisation of the genome has ad-
vanced in leaps and bounds during the last decade largely because of the develop-
ment of the 3C method and its derivatives (for review, see Osborne et al., 2011).
There are a large number of 3C variants, but they can be grossly categorised into
four classes based on how many loci can be interrogated in a single experiment:
one-to-one (3C, quantitative 3C), one-to-all (4C, e4C, ACT), many-to-many (5C)
and all-to-all (ChIA-PET, Hi-C, TCC).
The recent development of all-to-all methods has allowed the conformation
of the entire genome to be probed in a single experiment. This approach has
many advantages; such an unbiased approach allows the detection of unexpected
interactions and associations can be probed in parallel allowing a far higher rate of
data collection. Whilst these techniques have had great impact on the field, they
are currently limited by the depth of sequencing that is achievable with today’s
technology. To address this Sanyal et al. recently published a paper as part of
the ENCODE project describing the interaction profiles of 628 transcription start
sites (TSS) and 4535 surrounding fragments, representing approximately 1% of the
genome (Sanyal et al., 2012). To achieve the resolution required for the robust
detection of promoter-element interactions, Sanyal et al. used 5C, a many-to-many
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technique that uses a panel of oligonucleotides with common adapters to anneal
to 3C products and create a library capable of being sequenced. They sequenced
libraries from three ENCODE cell lines: K562, HeLa-S3 and GM12878. Only a
small proportion of the looping interactions uncovered were shared between the
three cell types, with approximately 60% of interactions being unique to a single
cell line. The majority of TSS looping interactions could be classified as interacting
with enhancer elements, promoters or regions bound by the structural protein CTCF.
Looping interactions with enhancer elements were significantly enriched for act-
ively expressed TSS, demonstrating the importance of three-dimensional chromatin
contacts in the regulation of gene expression.
1.7 What drives nuclear organisation?
As our understanding of the structure of the nucleus evolves, an increasing number
of structural features and patterns are being uncovered. Teasing apart correlation
and causation to find the driving forces behind nuclear organisation is not an easy
task and remains a major challenge within the field.
1.7.1 Transcription
The discovery of transcription factories has changed our view of nuclear organisa-
tion substantially. If genetic templates are mobile and transcription factories are
fixed, then it maybe be possible to use the process of transcription as a tool to fold
the genome into specific conformations.
Kimura et al. quantified the amount of stable RNA polymerase II in HeLa
cells (Kimura et al., 1999) adding to the work by Jackson et al. demonstrating the
stability of nascent transcripts and polymerase in the nucleus (Jackson et al., 1981;
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Jackson and Cook, 1985). Mitchell and Fraser later demonstrated that RNA poly-
merase II transcription factories remain in the absence of transcription, though gene
association with factories is ablated if transcription initiation is inhibited (Mitchell
and Fraser, 2008). These data, along with the observation that genes are recruited to
pre-existing transcription factories upon activation (Osborne et al., 2004), support a
model whereby transcription factories are attached to a relatively immobile nuclear
substructure. This means that RNA polymerase II can act as a motor, dragging
template chromatin through the nucleus as it is transcribed, powered by the removal
of phosphate groups during RNA synthesis (Cook, 1999). Yin et al. measured the
force produced by a single E. coli RNA polymerase using an immobilised enzyme
transcribing a template bound to a polystyrene bead held by optical tweezers (Yin
et al., 1995). RNA polymerase stalled when the force applied was greater than 14
piconewtons (pN), substantially more than kinesin or myosin, making RNA poly-
merase the most powerful biological motor known. Papantonis et al. demonstrated
the potential of RNA polymerase to pull chromatin transcripts through the nucleus
in vivo by using 3C to measure the change in association between regions of DNA
after activation of the TNFα gene (Papantonis et al., 2010). They found that as the
gene was transcribed, downstream regions of chromatin progressively came into
contact with other transcribing regions at the transcription factory.
The role for transcription in the organisation of the genome is further supported
by the pervasive nature of transcription. As much as 93% of genomic bases in
the human genome are though to be transcribed in at least one cell type (described
in Clark et al., 2011), including many enhancers (Ling et al., 2005; Kim et al.,
2010). In the recent ENCODE study of TSS interactions, Sanyal et al. found
that enhancer elements looping to a TSS were significantly more likely to express
enhancer RNAs (Sanyal et al., 2012), supporting a model that the transcription of a
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chromatin template could be responsible for the formation of chromatin loops.
An attractive model for larger scale genome organisation revolves around the
transcription of housekeeping and tissue-specific genes. Lercher et al. have shown
that genes with high expression in multiple tissue types have a propensity to be
present in clusters within the genome (Lercher et al., 2002) and the mouse alpha
globin locus has been shown to assemble at a transcription factory already transcrib-
ing a cluster of housekeeping genes in erythroid cells (Zhou et al., 2006). Gavrilov
et al. showed that these housekeeping genes were bound stably to the nuclear
matrix and resistant to high salt extraction, whereas the alpha globin genes were
less stable and could be eluted (Gavrilov et al., 2010). These studies may point to a
model of the nucleus where persistently transcribed housekeeping genes are held in
transcription factories, with tissue specific genes being recruited to these sites upon
activation (Mitchell and Fraser, 2008; Gavrilov et al., 2010). Such a system could
have far reaching consequences, with chromosome conformation being determined
by housekeeping gene hubs.
1.7.2 CTCF
CTCF (CCCTC-binding factor) is a highly conserved DNA-binding protein with
eleven zinc finger domains which binds the consensus sequence CCCTC as well as
a range of variant sequences using combinations of different zinc fingers (Filippova
et al., 1996) (Fig 1.7.1, reviewed in Ohlsson et al., 2001). The core sequence has
extremely high sequence conservation between mouse, chicken and human and
mice homozygous for the gene knockout exhibit early embryonic lethality (Splinter
et al., 2006). The protein is expressed ubiquitously and misregulation by over-
expression or RNAi knockdown have a wide range of effects (Torrano et al., 2005).
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Figure 1.7.1 – Putative structure of
CTCF. Adapted from Ohlsson et al.
(2001).
When CTCF was first isolated it was
thought to be a transcriptional repressor
for the c-Myc gene (Lobanenkov et al.,
1990). Since then its proposed func-
tions have included transcriptional activator
(Vostrov and Quitschke, 1997), insulator
and structural protein. Bell, West and
Felsenfeld were the first to characterise the
role of CTCF as an insulator in a study of
the chicken beta-globin locus (Bell et al.,
1999). They showed that CTCF binds the HS4 region of the β -globin LCR, a
region previously shown to act as an insulator in a transgene enhancer-blocking
assay (Chung et al., 1997). One of the best characterised examples of CTCF acting
as an enhancer is at the imprinted H19/Igf2 locus. Four CTCF binding sites were
found in the imprinting control region (ICR) which exhibit methylation-sensitive
binding (Bell and Felsenfeld, 2000; Hark et al., 2000; Szabó et al., 2000). On the
unmethylated maternal allele, CTCF binds the ICR and the downstream enhancer
element stimulates expression of the H19 gene. On the methylated paternal allele,
CTCF binding is abrogated and the enhancer contacts the distal Igf2 gene instead,
causing expression of Igf2 and not H19. This model is supported by 3C data
showing parent-of-origin specific interactions between the enhancer and the two
genes (Murrell et al., 2004; Kurukuti et al., 2006).
Genome wide studies of CTCF binding using ChIP-on-chip and ChIP-Seq have
greatly developed our understanding of this complex protein. The model of CTCF
acting as a global transcriptional activator or repressor has been largely abandoned;
binding by CTCF is not able to predict transcriptional activity or correlate with
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specific classes of genes (Chen et al., 2008). In support of CTCF in the role of a
global insulator, Xie et al. determined a large number of conserved CTCF binding
sites using computational analysis and derived a dataset containing divergent pairs
of genes with and without a CTCF separating them (Xie et al., 2007). Divergent
gene pairs facing away from each other frequently show correlated expression pat-
terns (Trinklein et al., 2004; Li et al., 2006) - as expected, gene pairs not separated
by a CTCF site showed a propensity to be coexpressed, yet those with a CTCF
site had a close to background level chance of coexpression (Xie et al., 2007). Not
all CTCF binding sites appear to act as enhancer-blocking insulators however, as
demonstrated by looping over CTCF sites in the human beta-globin locus (Tolhuis
et al., 2002).
The development of the ChIA-PET technique has allowed an in depth inter-
rogation of chromatin interactions associated with specific proteins by incorpor-
ating a ChIP step with a 3C-derived assay (Fullwood et al., 2009). Handoko et
al. used ChIA-PET to investigate CTCF bound chromatin interactions in mouse
embryonic stem (ES) cells and suggested that CTCF acts in multiple roles with
different sizes of loops (Handoko et al., 2011). Correlative analysis using data
describing surrounding histone modifications allowed the authors to determine five
distinct classes of CTCF-derived loops: active domains enriched for H3K4me1,
H3K4me2 and H3K36me3; repressive domains enriched for H3K9, H3K20 and
H3K27 methylation; putative enhancer-promoter interactions; barrier insulator be-
haviour, separating active and inactive chromatin compartments; and finally, loops
with no known correlation or function (Handoko et al., 2011). This study illustrates
the complexity of CTCF binding within the genome and points to multiple roles
for the protein involving chromatin organisation. It is worth mentioning that the
ChIA-PET technique only identifies DNA fragments bound directly to the protein
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of interest, as such it is subject to some biases due to the necessity for any interacting
fragments to contact the same protein. It is likely that CTCF mediated organisation
involves many different proteins, interactions mediated by some classes of these
complexes may be missed using this technique.
Recent data has shown that CTCF mediated interactions are dependent on protein-
protein contacts between the SA2 subunit of cohesin and the C-terminal domain of
CTCF (Xiao et al., 2011). This raises the intriguing possibility that CTCF and
cohesin may work in concert to establish topological loops of chromatin.
1.7.3 Cohesin
The structural maintenance of chromosome (SMC) proteins, also known as cohesin,
form complexes required for sister chromatid cohesion and chromosome segrega-
tion in mitosis. Cohesins were originally characterised in S. cerevisiae (Guacci
et al., 1997; Michaelis et al., 1997) by screening mutants defective in sister chro-
matid separation. Cohesin complexes are thought to function in mitosis by holding
sister chromatids together via a pentameric complex involving two large coiled-coil
domain proteins (Smc1, Smc3) able to form a topological loop around two strands
of DNA (Haering et al., 2002)
A number of studies suggested that cohesin may play a role in the interphase
nucleus as well as in mitosis, being implicated in gene regulation, recombination,
repair and domain formation (reviewed in Sofueva and Hadjur, 2012). In 2008
three studies showed that the genome-wide binding profiles of cohesin subunits
in mammalian cells correlates highly with that of CTCF (Parelho et al., 2008;
Wendt et al., 2008; Rubio et al., 2008). Parelho et al. expressed a FLAG-tagged
cohesin subunit of Rad21 in mouse lymphoid cell lines which was able to pull down
the SMC1, SMC3 and SA1 cohesin subunits. They generated ChIP-chip libraries
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covering approximately 3% of the mouse genome and determined that cohesin binds
DNAse hypersensitive regions enriched for a motif highly similar to the CTCF
consensus binding sequence (Parelho et al., 2008). Wendt et al. followed a similar
path, using the HeLa cell line to create ChIP-chip libraries covering approximately
1% of the human genome for both SMC3 and CTCF (Wendt et al., 2008). Rubio
et al. studied the binding partners of CTCF by mass spectrometry and found that
Scc3/SA1 was a key binding partner, leading them to create ChIP-chip libraries for
CTCF and Scc3/SA1 in HBL100 cells (Rubio et al., 2008). All three studies came to
the same conclusion - that the majority of CTCF and cohesin binding sites overlap
in mammalian genomes, leading to a model where the sequence specific binding of
CTCF is responsible for the targeting of the cohesin complex.
In these investigations, cohesin has been implicated at many if not most of
the loci described in the above sections. Stedman et al. and Wendt et al. both
demonstrated that cohesin is enriched at the CTCF binding sites of the imprinted
H19/Igf2 locus in the same methylation- and parent of origin- sensitive manner
and that this binding is ablated upon mutation of the CTCF sites (Stedman et al.,
2008; Wendt et al., 2008). Enrichment of cohesin at this locus is also disrupted in
mutants lacking the C-terminal domain of CTCF responsible for binding cohesin
(Xiao et al., 2011) and the presence of cohesin is required for the three-dimensional
conformation of the locus (Nativio et al., 2009). Cohesin has also been implicated
in the control of the beta-globin locus (Wendt et al., 2008; Hou et al., 2010) and Ifng
/ TH2 LCR (Parelho et al., 2008; Hadjur et al., 2009).
Schmidt et al. showed a subset of cohesin bound regions independent of CTCF
binding in MCF-7 cells which colocalise with ER-α binding (Schmidt et al., 2010).
A similar association of cohesin and mediator / Nipb1 at promoters and enhancers
in ES cells has been described (Kagey et al., 2010). These studies suggest an
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attractive hypothesis that multiple tissue-specific proteins may be able to target
cohesin binding to specific sites to affect transcriptional profiles.
1.7.4 Tethering
The nucleus is a structured organelle which contains a number of architectural
features such as nuclear pores, the inner nuclear membrane (nuclear lamina) and
the nucleolus. Chromatin can bind to these regions in a specific nature leading to
changes in nuclear organisation and gene expression.
As microscopy studies have advanced our understanding of how the genomic
positioning of genes can affect expression, it has became clear that association with
the nuclear periphery generally correlates with gene silencing (Kosak et al. (2002);
Dietzel et al. (2004); Zink et al. (2004); Finlan et al. (2008); Reddy et al. (2008);
discussed in Section 1.4.1). In 2008, Guelen et al. used the DamID technique
with lamin-B1 tethered to DNA adenine methyltransferase (Dam) to identify re-
gions of the genome associated with the nuclear lamina in human lung fibroblasts
(Guelen et al., 2008). They found that the fraction of lamina-associated chro-
matin on each chromosome correlated with known CT positioning preferences in
fibroblasts. Their key finding was that chromatin-lamina associations existed as
distinct regions, termed lamina associated domains (LADs). The domains range
from 0.1 to 10 megabases in size and are enriched for chromatin marks associated
with transcriptional repression: H3K27me3, H3K9me2, low H3K4me2, low RNA
polymerase II, low gene expression and low gene density. LAD boundaries are
enriched for CTCF binding and CpG islands, suggesting a mechanism of associ-
ation (Guelen et al., 2008) though no direct evidence has yet been shown for this.
Shimi et al. showed in the same year that Lamins A and B form separate meshes
on the inner nuclear membrane and relatively static structures within the nuclear
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matrix, hinting at the existence of highly complex micro-environments based on the
binding of chromatin to lamin networks (Shimi et al., 2008). A subsequent study
investigating cells with a mutation in the LMNA lamin gene has shown that the
position, compaction and transcriptional activity of some lamin-associated regions
are affected (Mewborn et al., 2010), suggesting that the many diverse conditions
caused by lamin mutations may arise due to changes in chromatin structure and so
gene expression.
Although LADs are associated with low gene expression, not all chromatin at
the nuclear membrane is silenced. Early electron micrographs showed regions of
less dense chromatin at nuclear pores (reviewed in Capelson and Hetzer (2009);
Arib and Akhtar (2011)). This observation was recently validated with the observa-
tion of nuclear pore complexes (NPCs) contacting channels with heterochromatin
using a new form of sub-diffraction limit light microscopy able to simultaneously
image NPCs, lamins and chromatin (Schermelleh et al., 2008). Nuclear pore pro-
teins have been found to be associated with active regions of chromatin and are
present both at NPC and within the nucleoplasm (Vaquerizas et al., 2010; Kalverda
et al., 2010).
1.7.5 Actin and myosin
The presence of nuclear actin has been debated for many years; its initial detection
often labelled as artefacts due to the inability of phalloidin to stain actin fibrils
within the nucleus (reviewed in Hofmann and de Lanerolle, 2006). Despite this
skepticism, nuclear actin research has had a resurgence in recent years with studies
linking filamentous actin to processes such as transcription (Hofmann et al., 2004)
and nuclear export (Hofmann et al., 2001). McDonald et al. used fluorescence
recovery after photobleaching (FRAP) microscopy to study nuclear actin in HeLa
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cells (McDonald et al., 2006). Treatment with latrunculin which inhibits the poly-
merisation of actin lead to a loss of a slow moving population of actin, suggesting
the existence of polymeric actin in the nucleus. Within the cytoplasm, force is
generated through interaction between bundles of filamentous actin and polymer-
ised myosin II. The nucleus does not contain any myosin II, though an isoform of
myosin I incapable of forming filaments has been detected (Pestic-Dragovich et al.,
2000). Two papers from the Belmont and Bridger groups recently demonstrated
active reorganisation of chromosome territory positioning which was dependent on
the action of actin and myosin 1 (Chuang et al., 2006; Mehta et al., 2010).
Our understanding of how nuclear actin and myosin are involved in nuclear
organisation is still in its infancy, yet is rapidly gaining traction as techniques are
developed which allow us to probe and manipulate their behaviour within the nuc-
leus without disrupting cytoplasmic processes.
1.7.6 Replication
Proliferating cells must replicate their genomes once per cell cycle and do so in only
a few hours, despite their size. This is accomplished by simultaneously replicating
many regions of the genome at shared sites called replication factories (Jackson and
Pombo, 1998; Ma et al., 1998). The genome is replicated in an organised manner;
active genes are linked to early replication and inactive genes tend to replicate
late (reviewed in Goren and Cedar, 2003). Clusters of replication foci that share
replication factories continue to associate through multiple cycles of cell division
(Jackson and Pombo, 1998). A recent paper from the David Gilbert’s laboratory
details the replication timing profiles of several mouse and human embryonic cell
lines and finds a strong correlation with interaction domains as defined by contact
enrichment in Hi-C studies (Ryba et al., 2010). This suggests that replication and
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three-dimensional chromatin organisation may be closely linked, potentially due to
varying accessibility of DNA.
1.7.7 Polycomb
Polycomb group (PcG) genes were first studied in Drosophila melanogaster, where
they were found to disrupt normal segmentation during embryonic development
(Lewis, 1949). PcG complexes work as antagonists to the trithorax proteins and
are involved in the establishment and maintenance of gene repression. In mam-
malian cells, two multi-protein complexes named Polycomb Repressive Complex 1
(PRC1) and PRC2 are able to to specifically repress regions up to 100 Kbp in length
(Schwartz et al., 2006; Tolhuis et al., 2006). Mechanistically, it is thought that the
PRC2 complex is recruited to polycomb response elements (PREs) where lysine
27 is trimethylated on histone 3 (H3K27me). This chromatin mark is then able to
recruit PRC1 which catalyses the monoubiquitylation of histone 2A (H2AK119ub)
(reviewed in Margueron and Reinberg, 2011).
Polycomb proteins and the marks they deposit have been shown to form foci
in the nucleus. A number of recent studies have shown that PRE associated genes,
including the canonical polycomb targeted Hox genes, co-localise within the Dro-
sophila melanogaster nucleus (Tolhuis et al., 2011; Bantignies et al., 2011; Noor-
dermeer et al., 2011; Sexton et al., 2012). This co-association of repressed elements
requires PcG proteins and perturbations in clustering of repressed genes affects the
degree of repression (Bantignies et al., 2011). Polycomb foci have been likened
to transcription factories in their organisation. Noordermeer et al. found that the
mouse Hox gene cluster is located in a repressive compartment prior to activation
in embryonic tissues, and transition into a transcriptionally active compartment
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according to the requirements of the developmental programme (Noordermeer et al.,
2011).
1.7.8 The bigger picture
When seen as a whole, many of the models described above are not mutually ex-
clusive. Many hold in common the presence of chromatin loops within the nucleus
and describe domains of chromatin defined by epigenetic marks. It seems entirely
plausible that the overall structure of the nucleus is determined by the combined
result of many different processes directing specific interactions, driven by different
processes and stabilised by different types of contact.
1.8 Chromosomal translocations
One of the major medical implications of genomic organisation is how it may relate
to the formation of chromosomal translocations. Specific chromosomal rearrange-
ments are frequently associated with certain cancer types, and can be highly predict-
ive of patient prognosis. Furthermore, cancers involving different translocations
can respond to treatments in different ways, paving the way for patient-specific
treatment regimes (reviewed in Mitelman et al., 2007). Understanding the principles
of chromosomal translocation formation is an important step in the development of
novel treatments.
1.8.1 Formation of chromosomal translocations
Since the development of chromosome banding microscopy, it has been known
that the genetic material within cancerous cells is frequently disrupted. Chromo-
somal translocations involve the rearrangement of genetic material between non-
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homologous chromosomes through the formation and aberrant repair of at least
two double strand breaks (DSBs) that are situated on different chromosomes. The
resulting product can be a straight swap (balanced translocations) or can result
in deletions or even gain of material after malsegregation in mitosis (unbalanced
translocations). Chromosomal translocations can involve multiple DSBs on dif-
ferent chromosomes resulting in hugely complex karyotypes, especially in cells
predisposed to translocations due to defects in repair.
1.8.1.1 DSB repair
Double strand breaks can be caused by exogenous damage (ionising radiation, free
radicals) and endogenous damage (physiological programmed DSBs). As many as
1 million DNA lesions are formed per cell per day (Alberts Lewis, Raff, Roberts,
Walter, 2007) and can be highly deleterious to the cell, causing loss of genetic
material, translocations and ultimately cell death if left unrepaired. Mammalian
cells have an array of different DSB repair pathways that depend on the cellular
context and type of lesion (Longhese et al., 2006).
Homologous recombination (HR, Fig 1.8.1B) repairs double strand breaks by
using long regions of homology on undamaged sister chromatids or homologous
chromosomes. HR is primarily active during cell replication and rarely leads to
serious chromosomal rearrangements or translocations, although ‘crossing-over’
can sometimes occur, whereby two sections of homologous chromosomes switch
to their partner chromosomes. This process is encouraged during meiosis with
the formation of chiasmata, crossovers that are 104 to 105 times more frequent
than in mitosis (Lee et al., 2009). During meiosis homologous chromosomes are
preferentially used for HR to promote crossovers, but sister chromatids are more
commonly used in mitosis to minimise variation (Schwacha and Kleckner, 1997;
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Figure 1.8.1 – DSB repair. Three double strand break repair pathways. (A) NHEJ
(Non-Homologous End Joining) requires little or no sequence homology and joins any
two nearby ends. (B) HR (Homologous Recombination) uses a strand of homologous
DNA on a duplicated interphase chromosome or sister chromatid to reconstitute
sequence before joining. Although it only requires a single double strand break to
generate a crossover, the extensive region of homology needed makes errors rare.
(C) SSA/NHEJ (Single Strand Annealing / Non-Homologous End Joining) searches for
regions of homology, such as repeat sequences, and deletes any sequence between.
HJ is Holliday junction. From Longhese et al., 2006 (Longhese et al., 2006).
Haber, 2000). Non-allelic homologous recombination (NAHR) is a variation of
HR characterised by the aberrant use of low-copy repeats during strand invasion.
NAHR can result in duplications, inversions and translocations and is responsible
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for a number of spontaneous genetic disorders such as Potocki-Lupski syndrome
(Potocki et al., 2007) and cancers involving recurring breakpoints (Darai-Ramqvist
et al., 2008) (reviewed in Gu et al., 2008).
Single strand annealing (SSA, Fig 1.8.1C) creates a short region of single stran-
ded DNA at the site of the DSB which is used to search for regions of micro-
homology, usually repeat sequences in the same orientation. These regions anneal
and any excess single stranded tails are removed to allow the nicks to be ligated.
SSA is prone to introducing deletions into the genome, and can form chromosomal
translocations if two sequences with similar repeat regions are nearby, and both
suffer simultaneous DSBs.
Non-homologous end joining (NHEJ, Fig 1.8.1A) is a last resort for the cell,
whereby any two adjacent DSBs are ligated, needing little or no sequence homo-
logy. This pathway is extremely prone to errors as it is capable of joining any two
strands of DNA irrespective of their identity.
A number of serious conditions exist due to mutations in genes key in the DSB
repair pathways described above. Ataxia telangiectasia is an autosomal-recessive
neurodegenerative disease caused by mutations in the ATM gene which is involved
in NHEJ and HR (Beucher et al., 2009). Fanconi anaemia is a condition caused
by mutations in one of a number of proteins involved in DSB recognition and
repair which is associated with a high incidence of leukaemia and a number of
congenital defects (Kottemann and Smogorzewska, 2013). Blooms syndrome is
characterised by excessive HR and genomic instability caused by mutations in the
BLM gene (Amor-Guéret, 2006). These, and other similar diseases, are indicative
of the importance of DSB repair and the danger of genomic instability.
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1.9 Leukaemia
Chromosomal translocations are frequently observed within cancer cells and can be
one of the initiating events leading to oncogenesis. Leukaemias are one of the best
studied cancer models due to the ease of accessibility of the affected cells; many of
the best characterised cancer pathologies have been within leukaemias.
1.9.1 Chronic myeloid leukaemia
Chronic myeloid leukaemia (CML) is one of the best studied cancers, despite having
a relatively low occurrence (Hehlmann et al., 2007). The term ’leukaemia’ was
based on CML patients in the mid 1800s (Geary, 2000), and it was the first cancer
for which a direct causative genotype was found (Nowell and Hungerford, 1960)
(see below). A number of standardised therapies exist for CML and up to 87% of
patients achieve complete cytogenetic remission (Hehlmann et al., 2007), making it
one of the success stories of cancer research.
1.9.1.1 The Philadelphia chromosome
This genetic abnormality, primarily associated with CML, was first the first con-
sistent chromosomal abnormality found with any cancer. Identified in 1960 by
Nowell and Hungerford (Nowell and Hungerford, 1960) they noticed the presence
of an abnormal chromosome and called it the Philadelphia chromosome, or Ph
chromosome, after the city in which it was discovered. The chromosome was
initially thought to be the result of a deletion until chromosome banding enabled
its identification as a product of a translocation (Rowley, 1973). The breakpoints
within chromosomes 9 (cytogenetic band q34) and 22 (band q22) were subsequently
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identified as being within the c-ABL and BCR genes, respectively. The c-ABL gene
(also known as ABL1) was named as such because of its similarity to the Abelson
murine leukaemia virus gene v-ABL (Rowley, 2001). Less is known about the
BCR gene, so named because it was found at the Breakpoint Cluster Region of
chromosome 22.
The ABL1 gene encodes a tyrosine kinase which is ubiquitously expressed in
mammalian cells. Involved in cell cycle regulation, it is thought to be involved in
several cell signalling pathways (Deininger et al., 2000). The BCR protein con-
tains a serine-threonine kinase and has GTPase activity, but its function is not
known (Deininger et al., 2000). The t(9;22)(q34;q11) translocation creates a fusion
protein lacking the SH2 domain of ABL1 which normally regulates its activity.
This results in constitutively active tyrosine-kinase activity which drives oncogen-
esis (Deininger et al., 2000). The mechanism of translocation formation is yet to
be characterised, though ionising radiation is known to be a risk factor (Tanaka
et al., 1989; Corso et al., 1995). Identification and characterisation of the BCR-
ABL translocation and its fusion protein led to the development of a number of
kinase inhibitors such as the drug imatinib (also known as gleevec), which achieve
excellent success in the treatment of CML and a number of other cancers involving
the t(9;22)(q34;q11) translocation (Hehlmann et al., 2007).
1.9.2 Mixed lineage leukaemia
Acute leukaemia is typically categorised as either Acute Lymphoblastic Leukaemia
(ALL) or Acute Myeloid Leukaemia (AML) according to which lineage of blood
cells are cancerous. ALL is defined by the uncontrolled proliferation of lympho-
blasts, precursors to lymphocytes which differentiate into B cells, T cells and NK
cells. ALL was estimated to account for approximately 12% of all leukaemia cases
42
Chapter 1: Introduction
in the US in 2008 with around five and a half thousand cases occurring annually. It
is the most common form of cancer in children aged under fourteen (Jemal et al.,
2009).
AML is a cancer of the myeloid lineages of blood cells, responsible for approx-
imately 30% of all cases of leukaemia in the US for 2008 with a higher mortality
rate than ALL (66% and 27% mortality for AML and ALL, respectively) (Jemal
et al., 2009). The incidence of AML increases with age; the median age of AML
diagnosis between 2002 and 2006 in the US was 67 years, and the median age of
mortality was 72 (Jemal et al., 2009).
The biology of leukaemia is not always as discrete as this classification how-
ever, some patients present with expansion of both lymphoid and myeloid lineages
(Matutes et al., 1997). Two genetic abnormalities sometimes found in these patients
include the t(9;22)(q34;q11) Philadelphia chromosome and structural changes in
11q23 (Matutes et al., 1997). Chromosomal translocations within band q23 of
chromosome 11 have been implicated in both AML and ALL, all involve the gene
MLL (also known as ALL-1, Htrx, HRX) identified by Ziemin-van der Poel et al.
in 1991 (Ziemin-van der Poel et al., 1991). Translocations involving the MLL
gene are found in over 70% of all infant leukaemias (Biondi et al., 2000) and
approximately 10% of adult AML cases (Krivtsov and Armstrong, 2007). The
translocation correlates with poor patient prognosis and is of high clinical interest
(Chen et al., 1993).
1.9.2.1 Leukaemia stem cells
In 2002, Armstrong et al. showed that acute lymphoblastic leukaemias containing a
translocation within the MLL gene have a unique expression profile that is different
to ALL and AML, and suggests an origin within a less committed progenitor cell
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which can produce cells in both the myeloid and lymphoid cell lineages (Arm-
strong et al., 2002). They suggest that these leukaemias are substantially different
from AML and ALL and deserve a new, distinct, class of leukaemia called Mixed
Lineage Leukaemia (MLL). Further cytogenetic studies have supported this theory;
leukaemic cells in MLL have been found to express cell surface antigens normally
present on both myeloid and lymphoid cells such as CD14 and CD19 (Krivtsov and
Armstrong, 2007).
The suggestion that MLL is initiated within a progenitor cell is in line with
previous evidence showing that some cases of ALL and AML are initiated within
undifferentiated haematopoietic stem cells (HSCs) (Sutherland et al., 1996; Bonnet
and Dick, 1997). HSCs are present within the CD34+ progenitor cell population,
accounting for approximately 3% of normal human bone marrow and 0.3 to 0.5%
of human cord blood mononuclear cells (Libura et al., 2008). They are long lived
and capable of self-renewal, differentiating into lineage restricted progenitors and
eventually mature terminally differentiated white blood cells. HSCs are necessary
for the long term maintenance of the haematopoietic system and are commonly used
to repopulate bone marrow after myeloablative therapy, as well as in the treatment
of a number of other disorders such as autoimmune, cardiac and vascular diseases
(Burt et al., 2008). Cancer stem cells are thought to be present in both leukaemias
and solid tumours (Hamburger and Salmon, 1977) and HSCs are a probable founder
population due to their ability to self-renew (Reya et al., 2001). The concept of a
small pool of cancer stem-cells driving the large heterogeneous pool of cancer cells
has a number of implications for treatment - these are the cells that must be targeted
for the efficient and long lasting cure of cancer (Reya et al., 2001).
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1.9.2.2 The MLL protein
The MLL protein is a H3K4 methyltransferase involved in the positive regulation of
global gene regulation, including the maintenance of expression of the Hox genes
(Yu et al., 1995). MLL is required for embryonic haematopoiesis (Hess et al., 1997)
and adult bone marrow maintenance (Jude et al., 2007). MLL is a mammalian
homologue of the Drosophila melanogaster trithorax complex and is thought to
bind DNA via an AT-hook domain (Zeleznik-Le et al., 1994) and a zinc finger
domain (Birke et al., 2002). It is thought that the zinc finger domain targets MLL
to unmethylated CpG island DNA (Birke et al., 2002) and ChIP studies have shown
that MLL binds to a subset of transcribed genes (Milne et al., 2005). MLL binds
promoters and gene bodies, associating tightly with RNA polymerase II (Milne
et al., 2005).
All known MLL fusion proteins contain exons 8-13 of MLL and in-frame exons
of a partner gene (Krivtsov and Armstrong, 2007). Fusion proteins always retain
their AT-hook and zinc-finger CxxC motifs, which are essential for their transform-
ing potential (Slany et al., 1998). The H3K4 methyltransferase domain of MLL is
often lost in fusion proteins (Krivtsov and Armstrong, 2007), despite this the fusion
proteins can drive constitutive expression of HOXA9 and MEIS1 which, if over-
expressed together in the absence of a MLL fusion protein, give a similar phenotype
(Zeisig et al., 2004).
1.9.2.3 The MLL gene
Translocations within the MLL gene are found in approximately 10% of all human
leukaemias (Huret et al., 2001). There are over 100 documented MLL translocation
partners of which at least 64 have been characterised at the molecular level (Meyer
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et al., 2009); the five most frequent translocation partners, AF4, AF9, ENL, AF10
and AF6 account for approximately 80% of cases (Meyer et al., 2006). Transloca-
tions within the MLL gene usually occur within an 8.3 kb BamHI fragment known
as the breakpoint cluster region (Gu et al., 1994). This region contains exons 5-11
as well as a number of repeat regions, notably eight direct Alu SINE repeats, five
direct L1 and L2 LINE repeats and two MER elements, as well as a number of
putative topoisomerase II binding sites and a SAR/MAR (Sung et al., 2006) (Fig
1.9.1). An internal promoter is present within the murine Mll breakpoint cluster
region, correlating with etoposide-induced DSBs (Scharf et al., 2007), DNase I
hypersensitive sites (Strissel et al., 1998) and histone modifications associated with
transcription (Khobta et al., 2004).
1.9.2.4 Mechanisms of MLL translocation formation
A clue to how translocations form within the MLL gene comes from the observation
that 11q23 translocations are especially prevalent in therapy-related leukaemias -
secondary leukaemias that develop in patients after treatment for a primary cancer
with topoisomerase II inhibitors (Krivtsov and Armstrong, 2007). Topoisomerases
are found in all eukaryotic nuclei and are able to relieve supercoiling and promote
chromosome disentanglement (Buck and Zechiedrich, 2004). They function by
binding DNA, forming a transient double strand break and passing another strand
of DNA through the gap, before ligating the DSB.
Topoisomerases are important in transcription, which creates supercoils as tem-
plate DNA is processed through static RNA polymerase II enzymes (Liu and Wang,
1987). DNA topoisomerase II associates with gene promoters (Collins et al., 2001)
and is required for the transcription of genes longer than 3 Kbp in yeast (Joshi et al.,
2012). Topoisomerase II induced DSBs have been implicated in the regulation of
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certain genes via the assembly of transcription complexes and changes in chromatin
structure (Ju et al., 2006).
DNA topoisomerase II inhibitors are commonly used as chemotherapeutic agents
and work by decreasing the ligation rate, disrupting the cleavage / ligation equilib-
rium. This leads to an increase in DNA cleavage and an accumulation of DSBs,
triggering the cell DNA damage response and leading to cell death by apoptosis
(Burden and Osheroff, 1998). Topoisomerase II inhibitors are widely used chemo-
therapeutic agents, effective against a range of malignancies including small-cell
lung cancer and gonadal tumours (Arnold and Whitehouse, 1981).
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Figure 1.9.1 – Diagram of the MLL breakpoint cluster region.
The MLL breakpoint cluster region contains a number of putative topoisomerase
II binding sites suggesting a mechanism of topoisomerase inhibitor related translo-
cations (Broeker et al., 1996). Libura et al. showed that CD34+ HSPCs exposed to
etoposide formed 11q23 chromosomal aberrations typical of those seen in clinical
samples (Libura et al., 2005). They went on to show that such exposure to etoposide
increased the proliferative potential of the cells in a bone marrow graft assay using
immune-deficient mice (Libura et al., 2008). This data supports a model whereby
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poisoned topoisomerase II may create double strand breaks within the MLL gene,
allowing the NHEJ machinery to aberrantly repair the locus due to microhomology
found in the nearby repetitive elements (Fig 1.9.1).
1.10 Effect of nuclear organisation on
translocation formation
1.10.1 Breakage first and contact first models
For a chromosomal translocation to form, two double strand breaks must exist
simultaneously and be adjacent in three-dimensional space. Two models have been
described to explain how DSBs may meet in the nucleus – the breakage first model
and the contact first model. The breakage first model states that DSBs can form
anywhere and are able to freely diffuse in the nuclear space. They undergo large
scale movement through the nucleus until they meet and are joined. The contact first
model states that the two DSBs form in sequences already close to each other within
the nuclear space, therefore large scale chromatin movements are not required for
the two breaks to meet.
In support of the breakage first model, Aten et al. showed that DSBs formed
simultaneously in HeLa nuclei clustered together (Aten et al., 2004). However,
others have argued that this may be the result of a higher degree of chromatin
mobility along the ion beam trajectory used to generate the DSBs (Jakob et al.,
2009). A larger body of evidence supports a contact first model; DSBs created with
ultra-soft X-rays by Nelms et al. remained in a fixed position for several hours
after the damage was caused (Nelms et al., 1998) and Jakob et al. used live cell
microscopy to visualise proteins involved in DNA damage signalling and repair.
After accumulation at sites of DNA damage caused by heavy ion impacts, the foci
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exhibited only a small degree of movement (Jakob et al., 2009). Soutoglou et al.
showed a high degree of positional stability of DSB ends created by endonuclease
digestion, with a greater degree of local diffusion seen in the absence of the Ku80
DNA-end binding protein (Soutoglou et al., 2007).
The contact first model of translocation formation has large implications within
the field of nuclear organisation, as it requires specific chromosomal contacts within
cells prior to translocation.
1.10.2 Chromosome territories and translocations
The large scale organisation of chromosome territories has been implicated in trans-
location frequency by a number of studies. Kozubek et al. showed that chromo-
somes 9 and 22 were found in the centre of nuclei more frequently than would be
expected by chance in lymphocytes, T- and B-cells, HL60 cells and bone marrow
cells (Kozubek et al., 1999). They used neutron irradiation to show that transfer
of genetic material was much higher than that found with chromosome 8, which
was situated towards the nuclear periphery (Kozubek et al., 1999). Parada et al.
investigated the positions of chromosomes 12, 14 and 15 in a mouse lymphoma cell
line and mouse splenocytes (Parada et al., 2002). They found that two translocated
chromosomes preferentially paired together in the nucleus of the cell line as well
as in normal cells not containing the translocation. (Parada et al., 2002). Parada
et al. went on in a further study to examine the positioning of a larger range of
chromosomes in a number of different tissue types (Parada et al., 2004). They found
that chromosome pairing was tissue specific and correlated with the occurrence of
tissue-specific translocation events (Parada et al., 2004). Kuroda et al. published a
similar study in the same year, showing that association between chromomes 12 and
16 varies through adipocyte differentiation. These two chromosomes are involved
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in a chromosomal translocation that can lead to liposarcomas, thought to be initiated
within pre-adipocytes (Kuroda et al., 2004).
In 2006, Branco and Pombo published a study where they developed a new
technique known as cryo-FISH to enhance the resolution of chromosome territory
detection (Branco and Pombo, 2006). This technique had sufficient resolution to
study the degree of intermingling between chromosome territories and they found
that the degree of intermingling between chromosome pairs correlated strongly with
their propensity to form translocations when subjected to radiation (Fig 1.10.1,
Branco and Pombo, 2006).
Figure 1.10.1 – Correlation of CT intermingling and radiation induced
translocation frequencies. Adapted from Branco and Pombo, 2006 (Branco and
Pombo, 2006).
Interestingly, derivative chromosomes that result from balanced translocations
affect the organisation of CTs within the nucleus (Harewood et al., 2010), raising
the possibility that the global changes in gene expression observed after oncogenic
translocation formation could be in part due to changes in genome organisation
(Harewood et al., 2010). In support of this hypothesis is the observation that the
organisation of nuclei within a breast cancer model differs to that of a nonmalignant
control (Meaburn and Misteli, 2008).
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1.10.3 Transcription factories and translocations
Mounting evidence has shown that in addition to CT pairing, the position of specific
genes involved in chromosomal translocations are frequently found in close proxim-
ity (Neves et al., 1999; Roix et al., 2003). As discussed in Section 1.7.1, localisation
at transcription factories can drive organisation within the genome. Osborne et al.
used DNA- and RNA-FISH to study the localisation of the Myc proto-oncogene
upon activation of B cells (Osborne et al., 2007). They showed that Myc, on
mouse chromosome 15, is dynamically recruited to an existing transcription factory
and that this transcription factory was preferentially occupied by Igh, on mouse
chromosome 12. These observations of preferential association at transcription
factories support a model whereby genes sharing transcription factories are pre-
disposed to the formation of chromosomal translocations (Osborne et al., 2007).
Similar transcriptional associations have recently been observed for MLL and its
frequent translocation partners AF4 and AF9 (Cowell et al., 2012).
Transcription represents a high risk process for the integrity of DNA; torsional
stress created by the rotation of the double helix as it is processed through the
static RNA polymerase II holoenzyme and protective nucleosomes are temporarily
stripped (Nelson, 1999; Sathyanarayana et al., 1999). Protein factors involved in
repair have been found to colocalise with transcription factories, such as the Ku
protein, involved in stabilising DSBs (Mo and Dynan, 2002). This suggests that
transcription factories may aid the efficient repair of DSBs created during transcrip-
tion.
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1.11 Thesis overview
1.11.1 Hypothesis
Our understanding of nuclear architecture and organisation has developed rapidly in
the last twenty years, in concert with the development of techniques allowing ever
larger and less biased studies. It is now widely accepted that nuclear structure can
affect the function of the nucleus and that preferred states of nuclear organisation ex-
ist. These observations raise the possibility that the frequent association of specific
regions of chromatin may lead to an elevated level of chromosomal translocation
rates between loci. I hypothesised that genes known to be frequently engaged
in chromosomal translocations may be found adjacent to each other in healthy
cells and that this association may lead to a predisposition to form chromosomal
translocations. Specifically, I proposed that the canonical proto-oncogenes BCR and
ABL1 may be adjacent in CD34+ cells, where their leukaemogenic translocations
are thought to occur. Additionally, I proposed that the proto-oncogene MLL may be
found adjacent to its portfolio of translocation partners with frequencies correlating
to its rate of translocation.
1.11.2 Existing evidence
The association of the BCR and ABL1 genes has been studied using microscopy in
several publications. In 1997, two papers were published by the Horneck laborat-
ory studying the localisation of BCR and ABL1 in human lymphocytes (Kozubek
et al., 1997) and bone marrow cells (Lukásová et al., 1997). The authors describe
distances between the two genes which are closer than between homologous alleles
and suggest that this could lead to increased levels of translocation in bone marrow
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cells (Lukásová et al., 1997). Conclusions from these papers about the variation
in positioning throughout the cell cycle were queried in a later paper (Neves et al.,
1999) although the observation that these two genes are found closer than would be
expected by chance was replicated. Kozubek et al. (1999) studied the organisation
of chromosomes 9 and 22, upon which the BCR and ABL1 genes reside, using
chromosome painting and found a high level of territory pairing. Schwarz-Finsterle
et al. (2005) later used a new microscopy methodology termed COMBO-FISH and
also showed the same finding.
Similar microscopy studies have been conducted with the MLL gene and its
translocation partners. Murmann et al. (2005) found enhanced association of genes
which they attributed to a correlation with gene density. Gué et al. (2006) used
triple-label DNA-FISH to simultaneously visualise the location of the MLL gene
with two of its translocation partners. They found that MLL was more tightly
associated with ENL than AF4, opposing the relative translocation frequencies of
the two genes. It is worth noting that these gene pairings were not compared to any
control genes which do not partake in MLL translocations. A recent paper by Cowell
et al. (2012) investigated the location of actively transcribing MLL alleles with
respect to the translocation partner genes AF4 and AF9. They found an enriched
pool of alleles close enough to be transcribing in a shared transcription factory,
above that seen for MLL with genes not found as translocation partners.
1.11.3 Aims
A limitation of many the studies described above is their scope: either they describe
the gross organisation of chromosomes and large genomic features, or they describe
the association of specific loci. Gross nuclear organisation is valuable in determ-
ining global rules and patterns of genomic organisation, but lacks the resolution
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needed to study specific loci. Studying the positions of individual genes is also
useful, but limited to the study of anticipated associations, leading to candidate
choice bias.
In this thesis, I aimed to modify the 4C method, previously used to study nuclear
architecture using microarrays, for next generation sequencing. Such an assay using
a bait region localised within the BCR and MLL genes would reveal the genome-
wide contacts made by these loci in a relatively unbiased way. This technique would
be able to detect previously unpredicted associations and empirically quantify the
strengths of known interactions in a genomic context.
1.11.4 Summary of chapters
In this thesis I describe the further development of the e4C technique which allows
the interrogation of the three-dimensional contacts made by a chosen locus in a
relatively unbiased, genome-wide manner. I investigate the association profiles of
three proto-oncogenes: BCR, ABL1 and MLL. I do so in human CD34+ haematopoi-
etic stem cells, the tissue thought to be the site of initial chromosomal translocations
for these genes, and the human lymphoblastoid cell line GM12878.
The e4C protocol was previously used in mouse foetal liver cells for analysis
with microarrays (Schoenfelder et al., 2010). In chapter three I describe my modi-
fication of the protocol for use with limited numbers of human CD34+ cells and
analysis with high-throughput sequencing technologies. This work demonstrates
the potential of the technique to analyse the interaction profiles of any genomic
locus, as well as a number of pitfalls which must be negotiated in its use. Similar
adaptation of the 4C protocol has recently been published by another group which
shares many parallels to my work (van de Werken et al., 2012b;a).
54
Chapter 1: Introduction
Chapter four describes my subsequent development of analysis tools and tech-
niques which I use to understand the sequencing data. At the time this work was
carried out, such genome-wide interaction datasets were being produced for the first
time and a great deal of exploration was required in order to find useful forms of ana-
lysis which could provide accurate and unbiased representations of the association
data. In this chapter I describe a number of steps developed to normalise biases and
analyse the data, several of which can be found in parallel studies published during
the same period.
In chapter five I describe the initial analysis of association data from the three
genes, which exhibit a common association with actively transcribed regions of the
genome. This analysis is feasible due to the availability of a number of publicly
accessible datasets describing the binding profiles of RNA polymerase, histone
modifications and abundance of transcripts. The patterns I uncover support similar
findings by other groups showing the separation of the genome into active and
inactive compartments.
In chapter six I analyse the interaction of BCR with the telomeric region of chro-
mosome 9, containing its recurrent translocation partner ABL1. I demonstrate that
this interaction is the strongest in the genome and highly significant. Interestingly,
the maximal point of association with BCR is not at the ABL1 locus, but rather in
three loci several megabases away. I describe my use of DNA-FISH to validate
these interactions in CD34+ cells and GM12878 cells.
Unbiased yet specific studies of genomic interactions such as those described
within this thesis help to demonstrate the importance of genomic organisation in
the formation of chromosomal translocations and initiation of cancer. By furthering
our understanding of how healthy cells are regulated, we may better understand how
to prevent disease causing events.
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Materials and Methods
2.1 CD34+ cell handling
2.1.1 Peripheral blood collections
Mobilised CD34+ cells were collected from peripheral blood samples supplied by
Dr George Follows with the help of apheresis coordinator / specialist nurse Paul
Boraks. These blood samples were taken with consent from the patient at the same
time as clinical samples used to test the mobilisation efficacy of the GCSF stimula-
tion. Blood samples were collected and immediately diluted into 5 ml RPMI with
heparin to prevent agglutination. Samples were transported from Addenbrookes
Haematology Day Unit to the Babraham Institute.
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2.1.1.1 Buffy coat isolation and fixation of cells
Samples were diluted with 2 - 4 volumes of PBS (Dulbecco’s PBS; PAA) containing
2 mM EDTA [GIBCO]. 15 ml Ficoll (Ficoll-Paque Premium; [GE Healthcare]) was
added to empty 50 ml tubes, and 35 ml cell suspension was layered on top. Samples
were centrifuged at 400× g for 40 minutes at at room temperature. The central
buffy coat found at the interface between the plasma and Ficoll layer, containing
primarily mononuclear cells, was carefully pipetted into a new labelled 50 ml tube.
This was washed in PBS containing 2 mM EDTA and centrifuged at 300× g for
10 minutes at room temperature. Cell pellets were washed twice by resuspending
in 50 ml MACS Buffer (D-PBS [PAA] with 0.5% BSA [Sigma] and 2 mM EDTA
[Gibco]) and re-centrifuged at 200× g for 15 minutes at room temperature. Cell
pellets were resuspend cells in 2 ml total volume MACS Buffer and transferred
to tubes containing DMEM [PAA] with 10% FBS [PAA]. Cells were then fixed
with 2% formaldehyde (histology-grade, minimum 37% free from acid [Merck]) for
10 minutes at room temperature with constant mixing. The fixation was quenched
by adding glycine to a final concentration of 0.125 M. Fixed cells were centrifuged
at 300× g for 10 minutes at 4 °C before being resuspend in 50 ml ice-cold MACS
Buffer. Cells were counted using a haemocytometer.
2.1.2 Leukapheresis collections
Mobilised CD34+cells were collected from leukapheresis collections supplied by
Dr George Follows and Dr Kevin Jestice. These samples were made available
after the harvesting of mobilised CD34+ cells from patients who had responded
to GCSF stimulation exceptionally well, meaning that there was an excess of cells
not required for clinical use. Leukapheresis samples were refrigerated in serum
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bags until collection from Addenbrookes National Blood Service, and transported
to the Babraham Institute.
2.1.2.1 Cell washing and fixation of cells
Because white blood cells are already separated from the blood in the leukapheresis
samples, buffy coat isolation is not necessary. The much higher number of cells to
be processed is also a point of consideration in the processing of these samples.
The sample was aliquoted into 50 ml tubes and diluted with 2 - 4 volumes of
PBS with 2 mM EDTA, to a final volume of 50 ml . Tubes were centrifuged at
300× g for 10 minutes at room temperature. Cells were washed twice by resus-
pending in 50 ml PBS with 2 mM EDTA and centrifuged at 200× g for 15 minutes
at room temperature. Each cell pellet was resuspended in 50 ml PBS with 2 mM
EDTA and transferred to a 500 ml bottle of DMEM [PAA] supplemented with 10%
FBS [PAA]. Cells were fixed by adding 26 ml 37% formaldehyde was added to a
final concentration of 2% (histology-grade, minimum 37% free from acid [Merck])
and being placed on a rocker for 10 minutes at room temperature. The fixation
was quenched by adding glycine to a final concentration of 0.125 M. Samples were
centrifuged at 300× g for 10 minutes at 4 °C. The supernatant was removed and
each cell pellet resuspended in 50 ml ice-cold MACS buffer. Cells were counted
using a haemocytometer.
2.1.3 CD34+ cell separation
CD34+ cells were separated from the mixture of fixed buffy coat cells using either
the Invitrogen Dynal CD34 Progenitor Cell Selection System or the Miltenyi MACS
CD34 MicroBead Kit. See section 3.4 for the results of both separation methods.
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2.1.3.1 Cell separation using the Invitrogen Dynal CD34
Progenitor Cell Selection System
Cell separation was carried out as per the manufacturer’s instructions. Samples
were centrifuged at 400× g for 8 minutes at 4 °C and resuspended in Sort Buffer
(D-PBS [PAA] supplemented with 0.1% BSA [Sigma] and 2 mM EDTA [Gibco])
at a concentration of 4× 107 to 1× 108 per ml in 2 ml microcentrifuge tubes.
Invitrogen Dynalbeads were pipetted into a 2 ml microcentrifuge tube (100 µl per ml
sample). 1 ml Sort Buffer was added and the tubes placed on a separation magnet.
The supernatant was removed and the beads resuspended in 100 µl sort buffer
per ml sample. The beads were then added to the samples and mixed, before
incubating on a rotating wheel at 4 °C for 30 minutes. 700 µl Sort Buffer was
added to each tube before placing each tube on the separation magnet for at least
2 minutes. The supernatant was then removed and kept at 4 °C to use as a negative
control in the FACS analysis. The beads were then washed three times in 2 ml
Sort Buffer, separating on the magnet for at least 1 minute each wash. The beads
were resuspended in 100 µl Sort Buffer and 100 µl DETACHaBEAD added per
tube. Samples were incubated at room temperature on a shaker at 600 rpm for
45 minutes. 1.8 ml Sort Buffer was added to each tube before being placed on the
separation magnet for at least 2 minutes. The supernatant was then transferred to a
15 ml tube and the beads washed three times with 500 µl Sort Buffer, the supernatant
being added to the 15 ml tube each time. An aliquot was taken to count the cells
using a haemocytometer and the remaining sample was made up to 15 ml with
Sort Buffer. 1 ml was removed into fresh tube for the FACS purity analysis. The
remaining sample was centrifuged at 400× g for 8 minutes at 4 °C. The supernatant
was discarded and the cell pellet flash frozen in liquid nitrogen before storage at
-80 °C.
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2.1.3.2 Cell separation using the Miltenyi MACS CD34 MicroBead Kit
Samples were centrifuged at 300× g for 10 minutes at 4 °C and resuspend in 300 µl
MACS buffer per 1×108 cells. The following assumes a single aliquot of 1×108
cells, and was scaled up as necessary. Some leukapheresis samples had enough
cells to warrant thousands of pounds worth of MACS beads, in these cases I used
aliquots of greater than 1×108 cells.
Cell separation was carried out as per the manufacturer’s instructions. In brief,
100 µl MACS FcR Blocking reagent was added to block non-specific binding of
the MicroBeads before adding 100 µl CD34 MicroBeads. Samples were mixed and
refrigerated for 30 minutes at 4 °C. 10 ml MACS Buffer was added and samples
centrifuged at 300× g for 10 minutes at 4 °C. Samples were resuspend in 500 µl
MACS Buffer and applied to pre-wetted MACS MS columns held in an OctoMACS
separator magnet at 4 °C. Flow through was collected and stored at 4 °C to use
as a control in the later FACS analysis. Columns were washed three times with
500 µl MACS Buffer and cells were eluted from their columns in 1 ml MACS
Buffer directly into a second pre-wetted MACS MS column. Multiple samples were
combined into a single column at this point. This second magnetic separation step
greatly increases the purity of the separated cells. The column was washed three
times with 500 µl MACS buffer and cells eluted in 1 ml MACS Buffer. Purified
cells were counted and made up to 15 ml with MACS buffer. A 1 ml aliquot was
taken for later FACS purity analysis before the remaining sample was centrifuged
at 300× g for 10 minutes at 4 °C. The supernatant was discarded and the cell pellet
flash frozen in liquid nitrogen before storage at -80 °C.
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2.1.3.3 FACS CD34+ purity analysis
FACS analysis was used to quantify the percentage of cells staining positively for
the CD34 antigen. Representative FACS plots can be seen in Figure 3.4.1.
The 1 ml aliquot taken after the magnetic sort was transferred into a 2 ml mi-
crocentrifuge tube, along with two aliquots of no more than 1×106 cells was taken
from the unbound magnetic sort. Cells were centrifuged at 300× g for 10 minutes
at 4 °C and resuspended in 100 µl in MACS buffer. 10 µl CD34-APC antibody was
added to the purified sample and one of the two unbound controls, and all three
samples were and incubated in the dark at 4 °C for 10 minutes. Cells were diluted
with 1.8 ml MACS buffer and centrifuged at 300× g for 10 minutes at 4 °C. Cell
pellets were resuspend in 200 µl PBS and analysed using a BD FACSCalibur flow
cytometer.
2.2 Cell culture
ENCODE cell lines GM12878 and GM06990 were grown in cell culture facilities
at the Babraham Institute. Both cell lines were obtained from Coriell Cell Repos-
itories and grown according to their recommendations. Cell lines were grown in
RPMI 1640 with 2 mM L-glutamine [PAA], supplemented with 15% foetal bovine
serum [PAA] and 1× Penicillin / Streptomycin [PAA]. Separate bottles of culture
were kept for each cell line. Cultures were kept in T25 flasks, stood upright with
loose caps at 37 ºC in 5% CO2.
Cultures were passaged when cell densities reached 1×106 cells / ml, typically
every other day. Cell culture media was made up if required and warmed to 37 ºC in
a water bath. Cell cultures were removed from the incubators into a cell culture lam-
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inar flood hood, and resuspended using a 10 ml pipette. Cultures were transferred
to a 50 ml tube and counted using a haemocytometer. Tubes were centrifuged at
300× g for 3 minutes at room temperature. Supernatants were discarded, and the
cell pellet resuspended in fresh media to between 2× 105 and 5× 105 cells / ml .
Resuspended cell solutions were transferred to fresh T25 flasks and put back into
the incubator.
Stocks of both cell lines were stored in liquid nitrogen, frozen in 1 ml aliquots of
5×106 cells in RPMI 1640 with 2 mM L-glutamine [PAA], supplemented with 20%
foetal bovine serum [PAA] and 6% Dimethyl Sulfoxide (DMSO [Sigma-Aldrich]).
2.3 3C
Chromosome Conformation Capture (3C) is a ligation based proximity assay used
to determine the physical association of sequences of DNA in within the nucleus
(Dekker et al., 2002) (Fig 3.1.1). The 3C protocol used was based on that published
by Cope and Fraser (Cope and Fraser, 2009), with some modifications for using
CD34+ cells and different restriction endonucleases. See Chapter 3 for more details
about the development of this assay.
2.3.1 Nuclei preparation and digestion
CD34+ cells were fixed, sorted and flash frozen in cell pellets as described in Section
2.1. GM12878 cells were fixed in 2% formaldehyde and quenched in glycine and
washed in PBS twice. Cell pellets were thawed on ice and resuspended in 50 ml per-
meabilisation buffer (10 mM Tris-HCl, 10 mM NaCl, 0.2% Igepal CA-360 [Sigma],
1 tablet complete EDTA-free protease inhibitor [Roche]). Cells were incubated on
ice for 30 minutes on a rocker whilst an aliquot was taken to count the nuclei using
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a haemocytometer. Samples were centrifuged at 760× g for 5 minutes at 4 °C
and resuspended in 500 µl 1.2× NEB3 buffer (100 mM NaCl, 50 mM Tris-HCl,
10 mM MgCl2, 1 mM Dithiothreitol, pH 7.9 [New England Biolabs]). Samples
were transferred into a 1.5 ml microcentrifuge tube and centrifuged at 760× g for
5 minutes at 4 °C. Nuclei pellets were resuspended in 500 µl fresh 1.2× NEB3 and
SDS was added to a final concentration of 0.3% to further permeabilise the nuclei
and remove protein that has not been cross linked. Nuclei were incubated at 37 °C
for 1 hour, shaking at 950 rpm. Triton-X100 was added to a final concentration
of 1.8% to sequester the SDS and samples incubated at 37 °C for 1 hour, shaking
at 950 rpm. A 10 µl aliquot was taken for later digestion efficiency analysis (See
Section 2.3.3).
To digest the cross linked chromatin 30 µl high concentration AseI was added
(1500 units [New England Biolabs]) and samples incubated at 37 °C overnight,
shaking at 950 rpm. An additional 10 µl AseI (500 units) was added and incubated
for a further 3 hours at 37 °C, 950 rpm. Another 10 µl aliquot was taken to check
for digestion efficiency later and the digestion stopped by the addition of SDS to a
final concentration of 1.6% before incubating at 65 °C, 950 rpm for 25 minutes.
2.3.2 Ligation and purification
Samples were cooled to room temperature and added to 15 ml tubes containing
7 ml 1.1× T4 DNA ligase buffer (Made using 10× buffer [New England Biolabs]
- 55 mM Tris-HCl pH 7.5, 11 mM MgCl2, 1.1 mM ATP, 11 mM DTT, 27.5 µg/ml
BSA). To sequester the SDS, Triton-X100 was added to a final concentration of
1% and samples incubated at 37 °C for 1 hour with mixing by inversion every
10 minutes. Samples were allowed to equilibrate in a 16 °C in water bath before
the addition of 2 µl T4 DNA ligase (800 units [NEB]). Samples were incubated at
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16 °C for 4 hours, then at room temperature for 30 minutes. Proteinase K was added
to a final concentration of 100 µg/ml and samples incubated at 65 °C overnight.
Tubes were cooled to room temperature and RNase A added to a final concentration
of 40 µg/ml before incubation at 37 °C for 1 hour. Samples were split into two
and transferred into 15 ml Phase Lock Gel Tubes (Phase Lock Gel Light 15 ml
[5 PRIME]). DNA was purified using a phenol / chloroform extraction followed
by precipitation in ethanol and sodium acetate. DNA pellets were resuspended in
250 µl Molecular Biology grade water [Qiagen].
3C samples were quantified using the Quant-iT PicoGreen assay [Invitrogen].
Dilutions of 3C product in TE Buffer (200 mM Tris-HCl, 20 mM EDTA, pH 7.5)
were measured in duplicate and compared to standard curves made using lambda
DNA supplied within the Quant-iT PicoGreen kit. Fluorescence of the PicoGreen
dye was assayed using a Cytofluor II multi-well plate reader (485 nm excitation
wavelength , 530 nm emission wavelength [PerSeptive Biosystems]).
2.3.3 Digestion efficiency analysis
To determine the efficiency of the restriction enzyme digestion step in the 3C pro-
tocol, I used quantitative PCR. In brief, primers are designed that flank a known
restriction enzyme site, and their performance in quantitative PCR is compared to
a set of primers nearby that don’t flank a restriction enzyme site. This is done for
samples taken before and after the restriction enzyme digestion step.
5 µl aliquots are taken from the 3C samples, before the addition of the restriction
enzyme and after the end of the digestion incubation. 500 µl of Proteinase K buffer
(5 mM EDTA, pH 8.0; 10 mM Tris-HCl, pH 8.0; 0.5% SDS) was added with 1 µl of
10 mg/ml Proteinase K (10 µg final). Samples were incubated at 65 ºC for at least
30 minutes before being equilibrated at 37 ºC. 1 µl of 1 mg/ml RNase A (1 µg final)
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was then added, and samples incubated for 2 hours at 37 ºC. Samples were then
phenol-chloroform extracted with ethanol precipitation and resuspended in 60 µl of
molecular biology grade water.
Samples are now assayed for digestion efficiency using qPCR. I used SYBR
Green Master [Roche], with the manufacturer’s protocol. Restriction digestion
efficiency is calculated using cycle thresholds, Ct values:
%Restriction = 100− 100
2(CtR−CtC)DIG−(CtR−CtC)UND
Where CtR is the Ct value of the primer pair spanning a restriction enzyme site,
CtC is the control primer pair. DIG is the digested sample and UND is the pre-
digestion sample. Typically, primers were designed for the region of interest (for
example, the e4C bait region) as well as an inactive region of heterochromatin.
2.3.4 Detection of 3C products by qPCR
Quantitative analysis of relative nuclear association strengths can be done with real-
time quantitative PCR of 3C products (RT-qPCR 3C). The SYBRgreen dye binds to
double stranded DNA, and can be used to track the concentration of PCR products
throughout the amplification. By comparing the PCR cycle at which a threshold
concentration is reached (Ct), the relative starting concentrations of 3C ligation
products can be calculated.
2.3.4.1 Primer design
RT-qPCR primers were designed surrounding both ends of restriction fragments
of interest. Primers were designed using primer3 (Rozen and Skaletsky, 2000).
Primers were designed with the following parameters: primer size - minimum 20
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bp, ideal 22 bp, optimal 24 bp; primer Tm - minimum 60 °C, optimal 62 °C,
maximum 64 °C; primer GC% - minimum 30%, optimal 50%, maximum 70%;
product size ~ 150-230 bp; difference in Tm between primers - 1.5 °C. Chosen
primers were analysed using Primera to check for secondary structure and primer
dimer potential. Primers were then blasted using ensembl to check for unique
binding. Primers were ordered from Sigma-Aldrich as dehydrated and deionised
oligos before being resuspended in molecular biology grade water [Qiagen] at a
concentration of 100 µM for stock and a 10 µM working dilution.
See Appendix A.1.1 for primer sequences.
2.3.4.2 Equimolar mix
An equimolar mix is used with RT-qPCR 3C to standardise primer efficiencies and
quantify products using a standard curve. Primer pairs were used to amplify gen-
omic DNA using Qiagen HotStar Taq. Products were cleaned using a Qiagen PCR
cleanup kit and run on a 1% agarose gel to confirm sizes and clean bands. Products
were quantified using a Invitrogen Quant-iT™ PicoGreen ® dsDNA Kit. Molar
concentrations were calculated and the PCR products mixed in equimolar amounts
(0.2 pmol each) and digested with 150 units HindIII [New England Biolabs] in 90 µl
volume for 2 hours at 37 °C. Mix was then incubated at 65 °C for 30 minutes to heat-
kill the restriction endonuclease. Samples were cooled and spun down before being
added to a 15 ml tube with 800 units T4 ligase [New England Biolabs], 700 µl 10×
T4 ligase buffer and 6208 µl molecular biology grade water. Sample was incubated
at 16 °C for four hours and then room temperature for 30 minutes. Equimolar mix
was stored at 4 °C. Mix was tested by using combinations of 3C primers in a PCR
using Qiagen HotStar Taq and running products on a gel to check size of bands.
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2.3.4.3 qPCR
RT-qPCR 3C was done using an ABI Prism Sequence Detection System. A standard
curve was created using the 200 fmol equimolar mix with the following dilutions:
1× 10−1, 2× 10−2, 4× 10−3, 8× 10−4, 1.6× 10−4, 3.2× 10−5 and a no template
control. Four replicates of 3C template were used, 125 ng each. Reaction mixtures
were set up to a final volume of 25 µl with 6 µl H2O, 5 µl 3C material, 0.75 µl
forward and reverse primers (final 300 nM) and 12.5 µl SYBRgreen 2× mix [ABI].
qPCR was run with an step of 50 °C for 2 minutes and 95 °C for 10 minutes followed
by 40 cycles of 95 °C for 15 seconds and 60 °C for 1 min. Upon completion
of amplification a dissociation curve was run at 95 °C for 1 minute, 55 °C for
30 seconds, 95 °C for 30 seconds and 60 °C for 1 minute.
2.3.4.4 Analysis
Analysis of RT-qPCR 3C data was done with a combination of the ABI Prism
Sequence Detection System (to calculate Ct values) and Microsoft Excel. Standard
curves were created for each primer pair by plotting log10 Ct against log10 concen-
tration. A linear fit was calculated from the plot and used to derive concentrations
for 3C sample templates from their Ct values. The mean and standard calcula-
tions were calculated from the four replicates. Dissociation curves were visually
inspected to check for non-specific amplification and 3C products were run on a 1%
agarose gel to check for bands.
2.4 e4C
e4C is a ligation based proximity assay based on chromosome confirmation capture
(Dekker et al., 2002; Simonis et al., 2006; Schoenfelder et al., 2010). The protocol
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I used changed a great deal during my PhD, the final method used to generate the
majority of e4C association data presented in this thesis is described below.
2.4.1 Primer extension and primary NlaIII digestion
12 µg of 3C material was defrosted and cleaned using solid-phase reversible immob-
ilisation (SPRI), as described in the manufacturer’s protocol (Beckman & Coulter
Agencourt AMPure XP+ beads). Samples were eluted in 252 µl molecular biology
grade water. Six primer extensions were set up with 2 µg template 3C material,
alongside a positive control primer extension using 1 µg of human genomic DNA,
cut with EcoRI. 50 µl reaction volumes were made up containing capture DNA,
1× ThermoPol buffer (supplied with Vent), 200 µM each dNTPs, 10 pmol biot-
inylated bait enrichment primer and 2 units Vent (exo-) DNA polymerase (NEB).
The primer extension was then run on a thermocycler with the following cycle
parameters: 95 °C for 4 min, 61 °C for 2 minutes (primer specific; ~2.5 °C below
Tmof biotinylated primer), 72 °C for 10 min. Tubes were snap chilled on ice and
then briefly pulsed in the microcentrifuge. The six sample tubes were pooled into
two microcentrifuge tubes and cleaned using a SPRI cleanup. Samples were eluted
in 80 µl molecular biology water (40 µl for the genomic DNA positive control).
Samples were digested with 20 units of NlaIII (NEB) in 1× NEB4 buffer and 1×
BSA (both supplied with NlaIII) for 3 hours at 37 °C. Samples were purified using
SPRI beads and eluted in 50 µl of Molecular Biology water.
2.4.2 Bait enrichment and secondary NlaIII digestion
To enrich the e4C bait regions, bound with biotinylated primers from the extension
step, the magnetic streptavidin Invitrogen Dynalbeads kilobaseBINDER Kit (M-
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280) was used. Beads were aliquoted into microcentrifuge tubes, 10 µl (100 µg)
per sample. The preservative was removed on a magnet and the beads resuspended
in 50 µl binding buffer (provided in Dynalbeads kilobaseBINDER kit). This was
removed on the magnet and the beads resuspended in 50 µl fresh binding buffer.
The primer extension material (50 µl) was added and the tubes incubated on a shaker
set to 1200 rpm overnight at room temperature. The supernatant was then removed
on a magnet and the beads washed twice in 100 µl wash buffer, once in 100 µl 1×
TE Buffer and once in 50 µl 1× NEB4 buffer with 1× BSA (NEB) before being
resuspended in 50 µl NEB4 with BSA.
A second digestion step was then carried out with the enriched 3C material. To
the resuspended beads, 0.5 µl (2.5 units) NlaIII was added and tubes were incubate
for 2 hours at 37 °C, shaking at 1200 rpm. The supernatant was then removed on
the magnet and the beads washed twice in 100 µl wash buffer, once in 100 µl 1×
TE Buffer and once in 50 µl 1× NEB Ligase Buffer (supplied with NEB T4 ligase).
Beads were resuspended in 50 µl fresh 1× NEB Ligase Buffer heated to 55 °C for
5 minutes on a heating block along side a 7.5 µl aliquot of 100 µM stock PE Ad 2.0
NlaIII adapter. Both were snap chilled on ice. Beads were placed on the magnet
and the supernatant removed before being resuspended in 40 µl ligation mixture
(1× NEB Ligase Buffer; 200 pmol PE Ad 2.0 NlaIII adapter; 2000 units NEB T4
DNA ligase). Tubes were incubated at room temperature for 2 hours on a rotating
wheel. The supernatant was removed on a magnet and the beads washed twice in
100 µl wash buffer and twice in 100 µl 1× TE Buffer.
2.4.3 PCR and genomic sequence removal
Beads were washed in PCR wash mix (1× Phusion HF Reaction Buffer [NEB] with
200 µM each dNTPs) and split into a strip of 8 PCR tubes. 4 strip PCR tubes were
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used for half of the gDNA positive control and two tubes were used as no template
controls. Using the magnet outside its housing, the PCR wash mix was removed
and the beads resuspended in 50 µl of PCR master mix - 1× Phusion HF Reaction
Buffer [NEB]; 200 µM each dNTPs; 10 pmol PE Ad 1.0 + nested primer; 10 pmol
PE Ad 2.0 NlaIII adaptor primer; 1 unit HF Phusion Pol II [NEB]. The PCR was
run on a thermocycler with the following program: 98 °C for 30 seconds; 35 cycles
of 98 °C for 10 seconds, 65 °C for 30 seconds and 72 °C for 30 seconds; 72 °C
for 5 minutes; hold at 4 °C. The PCR tubes were pooled back into single sample
tubes and the PCR supernatant transferred into a fresh microcentrifuge tube using a
magnet. The beads were washed twice in 100 µl wash buffer and once in 100 µl 1×
TE Buffer before storing at 4 °C as a backup. The PCR supernatant was cleaned
using SPRI beads and eluted in 400 µl Molecular Biology water. 5 µl sample was
kept back for the later gel.
To avoid sequencing re-ligation events, which make up the majority of the e4C
library, a digestion step is undertaken using a rare-cutting enzyme that recognises
a sequence within the genomic configuration after the AseI site. Aliquots of each
sample were taken and processed from this point forwards, taking 100 µl aliquots
and keeping the remainder as a backup. Each aliquot was made up to 1× with NEB
buffer for the relevant restriction enzyme and then ~65 units of restriction enzyme
(BspEI for MLL, BglII for BCR ). Samples were incubated at 37 °C for 2 hours
before being cleaned with SPRI beads and eluted in 100 µl of molecular biology
grade water. A 1.5% gel was run with 5 µl of the digested gDNA sample and 5 µl
of the undigested gDNA sample to check removal of genomic sequence bands.
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2.4.4 Gel extraction and second round PCR
Half of the e4C sample was run on a 1.5% gel and stained in fresh Ethidium
Bromide. Using a UV box to visualise the samples, a gel block was cut out for
each sample from 250bp to 700bp. The samples were extracted from these gel
blocks using the Qiagen Gel Extraction Kit, as per the manufacturer’s instructions
(without heating to resuspend). Samples were eluted in 30 µl Qiagen Elution Buffer.
To add the full illumina adapters for sequencing, a second PCR is used. 3 µl
e4C sample is made up to a 50 µl PCR mix with 1× Phusion HF Reaction Buffer
[NEB]; 200 µM each dNTPs; 10 pmol PE PCR 1.0 Primer; 10 pmol PE PCR 2.0
Primer; 1 unit Phusion HF Taq [NEB]. The Phusion two step PCR was then run:
98 °C for 30 seconds; 15 cycles of 98 °C for 10 seconds and 72 °C for 30 seconds;
72 °C for 5 minutes; hold at 4 °C. PCR products were cleaned using SPRI beads
and eluted in 40 µl molecular biology grade water. To check the products, 10 µl was
run on a 1% gel.
2.4.5 e4C library quality control
To test the e4C library before sequencing a panel of PCR reactions were done using
two sense primers facing adjacent AseI recognition sites. Samples were quantified
by qPCR with TaqMan probes and run on an Agilent 2100 Bioanalyzer by Kristina
Tabbada of the Babraham Sequencing Facility. Library size and quantities were
assessed before deciding to sequence each sample.
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2.5 DNA fluorescence in-situ hybridisation
DNA fluorescence in-situ hybridisation (DNA-FISH) is a microscopy technique
using fluorescently labelled DNA probes to hybridise to and identify genomic se-
quences within fixed cell nuclei. I used a technique developed by Dr Daniel Bolland
which was based on work by Dr Ieuan Clay and originally came from the laborat-
ories of Dr Thomas Ried and Dr Thomas Cremer.
2.5.1 BAC preparation
The DNA used to create the DNA-FISH probes was generated using bacterial ar-
tificial chromosomes (BACs). BACs were ordered from Invitrogen and grown on
agar plates with chloramphenicol. A single BAC colony was picked into 3 ml of
LB containing chloramphenicol and incubated at 37 ˚C with shaking for 8 hours.
Cultures were diluted 1500 to
1
1000 in 100 ml of LB with chloramphenicol according
to growth and placed in a large conical flask before incubation for 16 hours at 37 ˚C
with shaking.
Cells were centrifuged in 50 ml tubes at 3500 rpm, 4 ˚C for 10 minutes. Cell
pellets were resuspended in 4ml of buffer P1 [Qiagen] before adding 8ml buffer
P2 [Qiagen] and mixing by inversion. Cells were incubated at room temperature
for 5 minutes. 8ml buffer P3 [Qiagen] was added and mixed by inversion then
left on ice for 5 minutes. Solutions were centrifuged at 4500 rpm for 10 minutes.
Supernatant was filtered through pre-wetted filter papers placed inside clean glass
funnels, held in centrifuge tubes. 0.7 volumes of isopropanol was added and BAC
DNA allowed to precipitate for 10 minutes on ice.
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DNA was centrifuged at 20,000× g for 15 minutes at 4 ˚C. The supernatant was
discarded and the pellet resuspended in 1 ml 70% ethanol before being transferred
to 1.5ml microcentrifuge tubes. Tubes were centrifuged at 13,000 rpm for 5 minutes
before aspiration of the ethanol. Pellets were allowed to dry briefly at room temper-
ature and resuspended in 400 µl molecular biology grade water [Qiagen]. DNA
was precipitated with 100 µl of 4M NaCl and 540 µl 13% PEG-8000 solution
(autoclaved). Tubes were centrifuged for 1 minute at 13,000 rpm and the pellet
washed with 500 µl 70% EtOH. Tubes were again spun at 13,000 rpm for 1 minute
and the pellete allowed to air dry briefly.
Pellets were resuspend in 250 µl TE buffer and added to 250 µl Phenol: chlo-
roform: isoamyl alcohol (25: 24: 1, pH 8). Tubes were vortexed and centrifuged
before removal of the aqueous phase into a fresh microcentrifuge tube. DNA was
precipitated with 0.1 volume of 3M NaOAc (pH 5.2) and 2.5 volumes of 100%
ethanol. Tubes were spun at 13,000 rpm for 10 minutes. DNA was washed with
500 µl 70% ethanol and then spun again 13,000 rpm for 1 minute. Ethanol was
removed and the pellet allowed to air dry pellet before being resuspended in 100 µl
molecular biology grade water [Qiagen]. DNA was quantified using a NanoDrop
machine.
2.5.2 Probe generation
I used directly-labeled DNA probes for the FISH, generated with nick translation
using aminoallyl-dUTP followed by chemical-coupling with an Invitrogen Alexa
Fluor® reactive dye.
To generate nick translated aminoallyl-dUTP labelled probes I added 4 µg BAC
DNA in H2O to 20 µl 10 × NTB 5 µl (for 5 ml - 2.5 ml 1 M Tris-HCl, pH 7.5,
0.25 ml 1 M MgCl2, 250 µl 10 mg/ml BSA fraction V, 2 ml nuclease-free water),
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20 µl 0.1M DTT [invitrogen], 16 µl d(GAC)TP mix (0.5mM each), 4 µl 0.5 mM
dTTP, 24 µl 0.5mM aminoallyl-dUTP, 40 units DNA Polymerase I [NEB], 4 µl 1:30
dilution DNase I [Roche] (dilution tested empirically for each new tube) and H2O
to a final volume 200 µl.
Tubes were incubated at 16 °C for 2 hours. A 1 µl aliquot was run on a 2%
agarose gel to check the size of the fragments - the optimal size is a smear of
products from 1kb to 150bp with the peak around 200-300bp. Samples were heated
to 75 ˚C for 5 minutes to inactivate the DNase I. Amine-modified DNA was cleaned
using a Qiagen PCR purification kit, eluted in 200 µl molecular biology grade H2O
[Qiagen] and precipitated with 20 µl NaOAc and 550 µl 100% ethanol at -20 ˚C for
at least an hour (typically overnight). Samples were centrifuged at 13,500 rpm for
15 minutes at 4 Pellets were washed with 100 µl 70% ethanol, spun and dried at
room temperature. Pellets were then resuspended in 5 µl molecular biology grade
H2O. Amine-modified DNA was stored at -20 ˚C.
For labelling, Invitrogen Alexa Fluor® reactive dyes were warmed to room
temperature and resuspended in 2 µl anhydrous DMSO. One tube was used for
4 µg aminoallyl labelled DNA in 5 µl with 3 µl 0.2 M NaHCO3 buffer (pH 8.3
[Sigma]) to make a total volume of 10 µl (tubes were split to label different probes
on occasion, but ratios kept the same). Amine-modified DNA was heated to 95 ˚C
for 5 and snap cooled on ice before addition. Reaction mixture was vortexed, spun
down and incubated at room temperature in the dark for at least 1 hour.
To remove unincorporated dye, 40 µl molecular biology grade H2O was added
and probes cleaned using a Qiagen PCR cleanup kit, washing the column twice
with PE. Probes were eluted in 200 µl H2O (less if the dye was split). Probes were
analysed on a Thermo Scientific NanoDrop using the ‘proteins and labels’ setting
to measure dye incorporation and DNA concentration and stored at -20 ˚C.
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Before use, 20 ng of probe was added to 1 µg Cot-1 DNA [Roche] and 9.7 µg
salmon sperm DNA [Roche] before precipitation with sodium acetate and 100%
ethanol at -20 °C overnight. Tubes were spun, washed in 70% ethanol and dried.
Pellets were resuspended in 5 µl deionized formamide (pH 7.0 [Sigma]) and incub-
ated at 37 °C, shaking at 300 - 500 rpm, for at least 30 min. 5 µl 50% dextran sulfate
in in 2×SSC was added before vortexing and centrifugation (all quantities in final
paragraph are for one slide).
2.5.3 Slide preparation
CD34+ cells and GM12878 cells were fixed in 2% formaldehyde and sorted as de-
scribed in Sections 2.1 and 2.2. Cell pellets were resuspended in PBS and counted.
100 µl containing approximately 1×105 cells was pipetted into into an assembled
cytospin funnel [Thermo Scientific] and polypro poly-L-lysine slide [Sigma] and
spin at 300 rpm for 3 minutes in the Shandon cytospinner. Slides were placed into
a coplin jar containing PBS. Cells were permeabilised in 0.1% saponin and 0.1%
triton X-100 in PBS for 10 minutes at room temperature. Slides were washed in
PBS for 5 minutes twice and stored in 50% glycerol and PBS at -20 ˚C for at least
two days.
2.5.4 Probe hybridisation and washing
Slides were removed from -20 ˚C storage and placed in 20% glycerol and PBS at
room temperature for 5 minutes. Nuclei were permeabilised using three freeze -
thaw cycles in liquid nitrogen; slides were placed in the liquid N2 for 3 - 4 seconds
or until a characteristic ’popping’ noise was heard. Slides were laid on tissue to
thaw and placed back in 20% glycerol and PBS. After three repeats of this freeze
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- thaw cycle slides were washed in PBS for 5 minutes twice. Slides were then
incubated in 0.1 N HCl at room temperature for 30 minutes. Slides were washed in
PBS for 5 minutes before the addition of 100 µl of 100 µg/ml RNase A [Roche] in
2×SSC on a coverslip. Slides were incubated horizontally at 37 ˚C for 60 minutes.
Slides were washed in 2×SSC for 5 minutes and then PBS for 5 minutes. Slides
were permeabilised in 0.5% saponin with 0.5% triton X-100 in PBS for 30 minutes
at room temperature. Slides were washed in PBS for five minutes, twice. Slides
were then equilibrated in 50% formamide and 2×SSC for at least 10 minutes.
10 µl of probe mix was pipetted onto a 22×22 mm coverslip. Slides were taken
out of the formamide one by one, excess liquid was wiped off and coverslips with
probe mixes were inverted and placed onto the cell spot. Slides were sealed with
Fixogum rubber cement [Marabu] and heated to 78 ˚C for 2 minutes on a hot plate.
Slides were then incubated at 37 ˚C in a humidified chamber overnight.
Slides were removed from the humidified chamber the following day and had
the rubber cement removed. Slides were placed in 2×SSC to remove coverslips and
washed in 50% formamide with 2×SSC for 15 minutes at 45 ˚C. Slides were then
washed in 0.2×SSC at 63 ˚C for 15 minutes and then 2×SSC at 45 ˚C for 5 minutes.
Slides were equilibrated back to room temperature in 2×SSC for five minutes and
rinsed in PBS for 5 minutes. Slides were then stained in 80 ng/ml DAPI and 2×SSC
for 2 minutes at room temperature. Slides were washed in PBS for 10 minutes
and fixed in 3.7% formaldehyde and PBS for 5 minutes.Slides were quenched in
155 mM glycine for at least 30 minutes before being washed in PBS for 5 minutes.
Slides had 64×22 mm coverslips mounted with a drop of Vectashield [Vector labs].
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2.5.5 Visualising signals
Slides were analysed using a MetaSystems MetaCyte at 100× magnification. Nuc-
lei with greater than two signals in either channel or no signals in either channel
were discarded. A custom perl script was used to calculate the shortest BCR - target
loci distance for both BCR foci. Target loci could be counted twice if one locus is
closest to both BCR loci.
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3.1 Introduction
To characterise the genome-wide association profiles of the proto-oncogenes BCR,
ABL1 and MLL I used e4C, a technique based on chromosome conformation capture
(3C).
The e4C protocol was developed by Dr. Tom Sexton in the laboratory of Dr.
Peter Fraser (Schoenfelder et al., 2010), extended from an earlier methodology
called chromosome conformation capture on chip (4C, not to be confused with
circularised chromosome conformation capture) (Simonis et al., 2006). Schoen-
felder et al. used e4C to probe the genome-wide associations of the globin genes
Hba and Hbb in mouse foetal liver cells. They used ChIP to purify ligation products
associated with hyper-phosphorylated RNA polymerase II and identified association
partners by hybridising the e4C library to a microarray.
In this project I made a number of modifications to the protocol - I used a
different cell type, different bait regions, I removed the ChIP step (see Section 3.5.1)
and I adapted the protocol for use with next generation sequencing analysis instead
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of microarrays. In this chapter I discuss that process, the challenges it presented
and reasons for modifications that I made.
3.1.1 Chromosome Conformation Capture
Chromosome Conformation Capture (3C) is a ligation based proximity assay. De-
veloped in 2002 by Dr Job Dekker and colleagues, it allows the physical association
of chromatin to be interrogated (Dekker et al., 2002). 3C has become a key method-
ology in the field of nuclear organisation and the foundation for a range of variant
techniques (reviewed in Osborne et al., 2011).
The 3C protocol begins with formaldehyde fixation used to preserve nuclear
structure. A restriction endonuclease is used to cut the DNA, typically recognising a
6 base pair sequence cutting on average once every 4 Kb (46 = 4096). This results in
“hairballs” of cross linked DNA and protein which are diluted into a large volume.
A ligation reaction is carried out which favours ligations between sequences held
together by formaldehyde linkages. These cross links are reversed and the DNA is
purified, resulting in a 3C library (Fig 3.1.1). The frequency with which restriction
fragments are found ligated together corresponds to the degree of their association
within the nucleus.
Restriction endonuclease 
digestion
DNA puri!cation
Dilute ligation
Removal of
Formaldehyde
crosslinks
Detection of
products
R
R
R R
Formaldehyde
!xation
Figure 3.1.1 – Overview of the 3C methodology. R denotes the recognition sites for
the first six-cutter restriction endonuclease.
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Traditional 3C uses PCR with primers positioned adjacent to the restriction
endonuclease recognition sites of two loci of interest. If a PCR product is detected,
these two sequences were physically close within the nucleus. The relative strengths
of associations can be assessed by quantifying intensities of bands on a gel or with
RT-qPCR threshold values. In this way, chromatin contacts can be studied on a
one-to-one basis, investigating the association between two candidate loci.
3.1.2 Enriched 4C
A 3C library contains fragments representing the association frequencies of all se-
quences in the genome. Enriched 4C (e4C) purifies all ligation products containing
a specific bait (sequence of interest) by using a biotinylated primer with annealing
and extension steps. Magnetic streptavidin beads then enrich ligation products con-
taining the bait. A second restriction enzyme is used to cut the unknown sequence at
a 4 base pair recognition site (approximately once every 256 base pairs: 44 = 256),
giving a region of single stranded DNA used to ligate an adapter. The resulting e4C
library has known sequence at both ends of every fragment and can be amplified
using PCR (Fig 3.1.2).
To use the e4C library with the Illumina Genome Analyser IIx (GAIIx) next
generation sequencing platform, I incorporated a second PCR step using primers
with overhanging tails. This adds the sequences needed for cluster generation
with the Illumina GA IIx flow cells (Fig 3.1.2). Libraries were then purified and
quantified using the Agilent 2100 Bioanalyzer and TaqMan qPCR before being
loaded onto flow cells for cluster generation and sequencing. To avoid sequencing
the known bait sequence with the standard single-end Illumina sequencing primer,
a custom sequencing primer was used which binds to the bait region immediately
before the first restriction enzyme cut site. A few remaining base pairs were left
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BC
R’
Biotinylated primer
extension
Streptavidin
enrichment
4-cutter restriction
endonuclease digestion
Adapter ligation
Second round PCRFirst round PCR Sequencing
Figure 3.1.2 – Overview of the e4C methodology. R’ denotes the recognition site for
the second four-cutter restriction endonuclease. BC denotes the barcode region used
to confirm the identity of the bait sequence and identify sequences when multiplexing
libraries for sequencing.
between the sequencing primer and the cut site to use as a barcode region, allowing
multiplexing of libraries on the a single flow cell lane (see Section 3.8). This
sequence is also used to confirm the identity of the bait sequence. The remaining
base pairs beyond the cut site are aligned to the genome and their distribution used
to plot a genome-wide association profile for the bait sequence.
For discussion of e4C data analysis see Chapter 4.
3.2 3C Restriction Enzyme Choice
The first step in designing an e4C experiment is the choice of a bait region and
six-cutting restriction endonuclease. This enzyme defines the 3C fragments to be
ligated and the position of the bait sequence to be enriched.
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50 kb
MLL
100 kb
ABL1
50 kb
BCR
Figure 3.1.3 – Position of e4C bait sequences. Genes of interest shown overlaid
with AseI recognition sites (vertical grey lines). Biotinylated primers shown as black
arrows with yellow background. Fragments enriched by the e4C highlighted in yellow.
Bait primer sequences can be seen in Table 3.3.2. Figure adapted from UCSC genome
browser: http://genome.ucsc.edu
The majority of chromosomal translocations within the BCR and MLL genes
occur within tight breakpoint cluster regions. The MLL breakpoint cluster region
is an 8.3 Kb region between exons 6 and 14 delimited by two BamHI restriction
sites (Gu et al., 1994), making this a natural choice for the primary 3C restriction
endonuclease.
After a number of test e4C runs using human buffy coat cells it became clear
that the assay was not working to its full potential. When run on a gel e4C lib-
raries should appear as a smear due to the range of different restriction fragments
ligated to the bait sequence (eg. Mouse HindIII e4C library, Fig 3.2.1). Bands are
sometimes visible due to the genomic religation sequences being the most common
ligation products, removed at a later state by digestion with a rare-cutting restriction
endonuclease. In my human BamHI e4C libraries the genomic configuration band
was visible but little or no smear was present (Fig 3.2.1).
The lack of a smear could be the result of a number of factors - inefficient PCR
amplification; loss of library through purification steps; inefficient enrichment of
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1 2 3
Figure 3.2.1 – BamHI e4C Libraries. Test e4C library prepared from human buffy
coat cells using BamHI as the primary 3C restriction endonuclease. 1 - Human BamHI
e4C test library. 2 - Human BamHI e4C library at 4x concentration. 3 - Mouse HindIII
e4C library positive control prepared with a Myc bait. White filled arrow indicates
genomic sequence religation events for MLL bait. Filled black arrow indicates band
for BCR genomic religations. Filled red arrow indicates non-specific PCR amplification
products. Bracket at side outlines approximate range of smear seen in the positive
control Mouse library (not visible in the BamHI libraries). Middle control lanes removed
for clarity.
bait; low ligation efficiency in 3C or adapter ligation or poor digestion in initial 3C
and e4C four cutter digestion steps. I ran a series of diagnostic tests to identify the
cause, including a digestion efficiency assay which quantifies the amount of PCR
product produced by primers spanning a restriction endonuclease recognition site
(see Section 2.3.3 for method). This showed that only 44% of BamHI recognition
sites were being cut in the 3C digestion step. Typically the digestion efficiency for
this digestion step should be greater than 80% (Cope and Fraser, 2009).
The steps immediately before the BamHI digestion in the protocol include an
SDS treatment to permeabilise the fixed nuclei to aid access for the restriction
enzyme, followed by treatment with Triton-X100 to quench the SDS. To test if the
SDS was inhibiting BamHI digestion, I digested purified plasmid DNA after SDS
treatment and a range of Triton-X100 concentrations (1.8% to 5% Triton-X100, Fig
3.2.2 A).
83
Chapter 3: Developing an assay for
gene association
Triton X-100 ConcentrationTriton X-100 Concentration
P P S T B P T B P B
A B
Figure 3.2.2 – Effect of Triton-X100 on BamHI digestion. (A) BamHI digestion
efficiency of purified plasmid DNA with increasing Triton-X100 concentrations (1.8% to
5%) after SDS treatment. P, S, T and B show presence of Plasmid, SDS, Triton-X100
and BamHI. (B) - Digestion of crosslinked chromatin with BamHI after treatment with
SDS and Triton-X100 (3.8%, 5%).
This showed that BamHI digestion is inhibited if the SDS is not adequately
sequestered. To test the effect of an increased Triton-X100 concentration in fixed
nuclei I prepared human buffy coat cells as described in the e4C protocol (Section
2.3) and ran BamHI digestions after treatment with SDS and two Triton-X100
concentrations (Fig 3.2.2 B). The nuclei treated with the higher concentration of
Triton-X100 showed a higher digestion efficiency, though still unsatisfactory for
e4C.
To compare the digestion efficiencies of BamHI against a number of other re-
striction enzymes commonly used for 3C in the literature, I ran another test 3C with
human buffy coat cells varying the degree of formaldehyde fixation and trying the
removal of the SDS / Triton-X100 steps (Fig 3.2.3).
BamHI showed markedly improved digestion for nuclei fixed in 1% formalde-
hyde without SDS or Triton-X100, as shown by the extended smear in the bottom
right gel. However, restriction enzymes AseI, HindIII and PvuII all showed far
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1 2 3 4 5 6
1% Fix, without SDS / Triton Step
1 2 3 4 5 6
2% Fix, without SDS / Triton Step
1 2 3 4 5 6
1% Fix, with SDS / Triton Step
1 2 3 4 5 6
2% Fix, with SDS / Triton Step
1  :  AseI
2  :  BamHI
3  :  HindIII
4  :  NdeI
5  :  PvuII
6  :  XbaI
A B
gD
N
A
N
LC 3C
Figure 3.2.3 – Restriction Enzyme Tests. (A) Digestion tests with six enzymes in four
different conditions. Cells were fixed in either 1% or 2% formaldehyde as described
in Materials and Methods: 3C (Section 2.3), with or without the pre-digestion SDS /
Triton-X100 steps. Samples were treated with proteinase K, RNase A and cleaned
with a phenol / chloroform extraction and precipitation, as described in Section 2.3. (B)
Composite reference gel showing purified genomic DNA, an AseI digested 3C sample
without ligation (NLC: no ligase control) and a re-ligated 3C sample.
superior digestion efficiency in all conditions (Fig 3.2.3).
I chose to use AseI for future e4C experiments because it produces suitable
fragment sizes around the break point cluster regions of both BCR and MLL. Further
digestion efficiency qPCR tests showed its efficiency at a far superior 81 - 99% of
sites being cut. Completion of test e4C libraries using AseI showed a gel smear
comparable to that shown in Fig 3.2.1 for the mouse HindIII e4C library (Fig 3.2.4).
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1 2 3 4
Figure 3.2.4 – Gel of AseI e4C libraries. 1% agarose gel of e4C libraries generated
using AseI with BCR and MLL baits. 1 - Sample 1 AseI e4C, no SPRI. 2 - Sample 1
AseI e4C after SPRI. 3 - Sample 2 AseI e4C, no SPRI. 4 - Sample 2 AseI e4C after
SPRI. Samples 1 and 2 were libraries generated in parallel from CD34+ material.
3.3 Primer Design
3.3.1 Paired end sequencing or single end sequencing?
When I started my project, the intention was to use Illumina Paired End Sequencing
to sequence the libraries. I designed primers and adapters so that the first read
would be from the NlaIII adapter end of the e4C fragment and would give sequence
information about the unknown, captured fragment. The second read of the paired
end run would sequence from the bait end of the fragment, and confirm the identity
of the e4C bait region. However, Dr Cameron Osborne was sequencing mouse e4C
libraries and ran into problems with this approach; read lengths were not sufficient
to sequence through the entire captured region and into the bait sequence on the first
round of sequencing, so we could not be certain that the first read was not from a
ligation concatemer and not directly ligated to the bait sequence.
To circumvent this problem, I switched to using single end sequencing. To
avoid sequencing the known bait region, I used custom sequencing primers that
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anneal to the bait region adjacent to the AseI ligation junction (Fig 3.3.1). This
site was chosen to leave enough known sequence to confirm the identity of the bait
product while returning long enough reads in the unknown partner to be aligned
to the genome. The sequences of the Illumina sequencing primers had recently
became publicly available, allowing me to design our custom sequencing primers
with similar length, Tm and GC content to the official Illumina Sequencing Primer
1.0 (Table 3.3.1, sequences in Table 3.3.2).
Bait sequence Unknown sequence
R’
Figure 3.3.1 – Custom sequencing primer design. Illumina adapters shown in light
blue, bait sequence in green and unknown sequence in red. Traditional sequencing
primer and read on top in grey, custom sequencing primer annealing to bait sequence
below in orange. R’ denotes AseI cut site. Position of bait sequences relative to genes
of interest shown in Figure 3.1.3. Sequences in Table 3.3.2.
Length (bp) Tm GC Content
Illumina Sequencing Primer 1.0 33 77.4°C 51.5%
BCR Sequencing Primer 38 73.4°C 36.8%
MLL Sequencing Primer 35 74.2°C 34.3%
ABL Sequencing Primer 32 77.9°C 46.9%
MLL-p1 Sequencing Primer 34 76.1°C 41.2%
MLL-p2 Sequencing Primer 40 74.7°C 42.5%
Table 3.3.1 – e4C sequencing primer properties. Custom primers designed to be
as close to the official Illumina sequencing primer as possible in length, Tm and GC
content.
3.3.2 Bait specific primers
A number of bait-specific primers need to be designed for each e4C library: an
extension primer, a first round PCR primer with an overhanging tail consisting of
half the Illumina Paired End Adapter 1.0 (PE Ad 1.0) and a sequencing primer
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complementary to the library bait sequence. The sequencing primer must anneal
close to the restriction endonuclease cut site but leaving a barcode sequence of at
least 3 base pairs. This bar code region is important - it allows us to multiplex e4C
libraries (see Section 3.8) and confirms that the sequenced fragment is the expected
bait - it is not present in any primers so must result from original genomic sequence.
Primers unaffected by the bait region are also used: a first round PCR primer
complementary to the NlaIII adapter and second round PCR primers to generate the
full Illumina cluster generation sequences. These bind the NlaIII adapter and the
overhanging sequence produced by the nested bait specific primer in the first round
PCR (see Fig 3.1.2).
When designing these primers, a suitable bait fragment must be chosen; for my
MLL and BCR e4C libraries I picked AseI fragments which lay within the break-
point cluster regions (hg19 chr22:23,596,608-23,612,941 and chr11:118,354,804-
118,356,061, respectively). Bait fragments should not be smaller than 1 Kb or
larger than 30 Kb as very small or very large fragment sizes can affect the ligation
efficiency in the generation of the 3C library (van de Werken et al., 2012a; Yaffe
and Tanay, 2011). One end of the bait fragment is used for the e4C, this must be
free of repetitive DNA and have enough sequence in which to fit a primer before the
first NlaIII restriction site.
3.4 Preparation of CD34+ cells
It has been proposed that translocations involving BCR and MLL in leukaemia
occur within the a progenitor cell compartment (Sutherland et al., 1996; Bonnet
and Dick, 1997). The CD34 antigen is a marker for primitive blood- and bone
marrow derived progenitor cells and anti-CD34 cell sorting is commonly used to
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study blood progenitor cells (Khobta et al., 2004; Libura et al., 2008). The CD34
protein is a glycoprotein thought to be involved in cell-cell adhesion (reviewed in
Furness and McNagny, 2006).
Samples were collected from consenting patients suffering from lymphoid leuk-
aemias or multiple-myeloma, undergoing GCSF treatment to mobilise progenitor
cells into the bloodstream. These cancers affect blood cells which are downstream
of CD34+ haematopoietic stem cells in the blood lineages, meaning that their CD34+
cells are healthy. Any translocations affecting my genes of interest would be very
clear in analysis: e4C associations show characteristic cis profiles which would be
spread across two chromosomes if a translocation were present. Such profiles are
present in a publicly available HiC dataset from K562 cells which have a highly
rearranged karyotype (Lieberman-Aiden et al., 2009), but are not present within my
data.
To best preserve the nuclear organisation of the nuclei I fixed them with form-
aldehyde as quickly as possible; immediately after a Ficoll separation to isolate
the lymphoblasts but before sorting with anti-CD34+ beads. Finally, I analysed
an aliquot of the purified cells using FACS (using an antibody against a different
epitope of CD34) to determine the purity of the samples.
3.4.1 CD34+ isolation
The first kit I used to isolate the fixed CD34+ cells was the Invitrogen Dynal CD34
Progenitor Cell Selection System. I used this to process 17 blood samples. The
FACS plots showed some material with low front scatter, likely to be platelets or
debris resulting from the fix and sort (Fig 3.4.1). I used gating within the FACS
analysis software to ignore these fragments. To determine CD34+ purity, I used an
empirically determined threshold for anti-CD34+ fluorescence. The purity varied
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from 17% - 91%, with a median of 67%. 10 of 17 samples collected using the
Invitrogen kit had to be discarded due to low purity.
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Figure 3.4.1 – CD34+ Separation FACS Plots. Diagnostic FACS plots after magnetic
bead separation of fixed CD34+ cells using the (A) Invitrogen Dynal CD34 Progenitor
Cell Selection System and the (B) Miltenyi MACS CD34 MicroBead Kit. Upper right
quadrant of Front vs. Side Scatter plot in (A) shows heavy granulocyte contamination.
(C) Histogram plots of anti-CD34 fluorescence on an unstained control and stained
sorted cells. A threshold was set on the left of the stained peak to determine CD34+
purity. All FACS plots generated using a BD FACSCalibur flow cytometer with Miltenyi
Biotec anti-CD34-PE antibodies.
I attempted a number of alterations to the cell separation protocol to improve
this purity, one of which was the use of the Miltenyi MACS CD34 MicroBead Kit.
This immediately gave much better performance, with purities ranging from 90% -
97% with a median of 96% purity (typical FACS plot shown in Fig 3.4.1). All data
described in this thesis is derived from cell collections using the Miltenyi kit with
CD34+ cell purities above 92%.
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3.5 e4C with low cell numbers
Initially, CD34+ cells were collected from peripheral blood supplied by Dr. George
Follows in the Addenbrookes Haemotology Day Unit, with the help of apheresis
coordinator / specialist nurse Paul Boraks (see Section 2.1.1 for details). Samples
were collected on a weekly basis before being fixed and sorted as described in Sec-
tion 2.1. Typically, between 12 and 30 ml whole blood was received in each sample,
giving a median final count of 3.6×105 CD34+ cells per collection. Typically, 3C
experiments use 1×107 cells, equivalent to 28 collections pooled together. Between
2008 and 2009 I managed to collect and sort 23 peripheral blood samples, giving
a total of 1.04× 106 total cells, however 10 of these samples had to be discarded
due to poor purity (see Section 3.4). This left me with 13 samples and a total of
7× 106 cells (minimum 76% purity, average 91.6% purity). Because of this low
cell number I worked on optimising the 3C protocol for use with low cell numbers.
Some of this work was done with the help of Dr Mayra Furlan-Magaril, who was a
visiting student in our laboratory at the time.
3.5.1 ChIP e4C
I had originally intended to incorporate a chromatin immunoprecipitation (ChIP)
step to purify 3C complexes containing RNA polymerase II, enriching for chromatin
associations at transcription factories. This protocol was used with some success in
my lab by Dr Cameron Osborne and Allen Chong, though the immunoprecipitation
step meant that little 3C material was available for the e4C stage. This resulted
in association datasets that were very low in complexity. This was offset to some
degree by the specific nature of the hits and low signal to noise ratio (unpublished
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data).
Although the chromatin immunoprecipitation steps worked well in my hands
with test mouse B cell samples, I soon decided to remove this enrichment step
in favour of keeping as much library DNA as possible, due to the scarcity of my
CD34+ samples. I showed by RT-PCR that BCR, ABL1 and MLL are expressed in
CD34+ cells to some extent (Figure 3.5.1). All associations may be relevant to the
formation of chromosomal translocations, so association data outside transcription
factories is still useful.
B C G B C G B C G
BCR ABL1 MLL
Figure 3.5.1 – CD34+ RT-PCR. B = Buffy Coat cells, C = CD34+ cells, G = genomic
DNA control. Genomic DNA marked with black arrows, RNA bands marked with white
arrows. CD34+ cells were not treated with DNaseI due to low cell numbers and limited
sample, hence genomic band contamination.
3.5.2 Carrier e4C
An established technique when using low cell numbers for methods such as ChIP
and MeDIP is to use ‘carrier’ chromatin to buffer loss of sample DNA (O’Neill
et al., 2006; Ficz et al., 2011). This is achieved by spiking in cells or DNA from an-
other organism, giving larger quantities of DNA with which to work. Loss through
non-specific binding to plastic such as tubes and pipette tips has less of an effect on
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the sample DNA and steps such as precipitations are aided by having larger pellets
to work with.
I started using this technique with the Sf9 cell line derived from Spodoptera
frugiperda (Fall Armyworm) obtained from Maureen Hamon at the Babraham In-
stitute. Cells were processed in parallel with the sample as described in Section 2.3,
up until the point of permeabilisation. Sf9 cells were then split into two aliquots
of 1×107 cells, and 1×106 sample cells were added to one aliquot. Both samples
were then processed as normal for the rest of the 3C protocol.
After this initial test run, I switched to using the Schneider’s line 2 (S2R+)
cell line derived from Drosophila melanogaster, grown with help from Dr. Sarah
Toscano at the Babraham Institute. The reason for this change was because the gen-
ome of Drosophila melanogaster is known, allowing easy design of PCR primers
to test for carrier DNA contamination and allowing identification of any products
occurring as a result of a non-specific ligation events in the e4C.
Initial tests with the carrier e4C were promising, showing good recovery of
sample DNA and successful 3C product detection using primers designed for the
Drosophila melanogaster genome (Fig 3.5.2). However, due to the removal of the
RNA polymerase II ChIP step (Section 3.5.1) and subsequent acquisition of much
larger CD34+ cell collections (Section 3.6), the carrier e4C protocol was not needed.
3.6 e4C with large cell numbers
In December 2009 I was able to obtain a leukapheresis sample from Dr. George
Follows with the help of Kevin Jestice, the chief biomedical scientist within the
Haematology Department at Addenbrookes Hospital, Cambridge. This sample came
from a patient who had responded exceptionally well to G-CSF treatment and had
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Figure 3.5.2 – Drosophila melanogaster S2R+ 3C Tests. PCR was performed on
S2R+ 3C material using combinations of the primers shown. Lower bands are the
expected sizes, higher bands are likely to be caused by concatemer ligation products
containing additional 3C fragments between those being tested.
enough mobilised peripheral CD34+ cells that there was leukapheresis sample spare
after use by the Haematology Department. I processed this sample as described
in Section 2.1.2. The final yield of CD34+ cells from this single collection was
2.88×107 cells, over four times the number of cells collected from a year of weekly
peripheral blood CD34+ sample collections. These collections also had the added
benefit of coming from a single patient, so not risking any population variation we
may see within the association datasets. In a further two leukapheresis collections
3.99× 107 and 1.4× 108 CD34+ cells were collected, with an average purity of
95.3%.
The first CD34+ collection was used to generate a 3C library which was used as
the basis for the e4C libraries. The second CD34+ collection was used to generate
3C material used in the 3C RT-qPCR validation (Section 6.5). The third CD34+
collection was used to generate HindIII 3C material by Alice Young, a fellow PhD
student in my group. She went on to create Hi-C libraries with this material.
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3.7 BCR e4C library preparation
A typical example of e4C library preparation is described below, detailing the res-
ults of the experiments to create the BCR Run 2 e4C library (chosen due to clear
gels). This preparation came in several steps: the collection, fixation, sorting and
flash freezing of CD34+cells, the creation of 3C material from that cell pellet and
finally the generation of an e4C library from an aliquot of that 3C material.
CD34+ cell collection is described in Section 3.4. The patient identifier was
Ref 2593P, undergoing treatment for T-cell lymphoma. I collected 2.88× 107
CD34+ cells from a total count of 7.88× 109 white blood cells. FACS analysis
showed a CD34+ purity of 96.39% (Fig 3.7.1, Table 3.7.1).
Figure 3.7.1 – CD34+ FACS analysis plot.
Marker Events % Gated % Total
All 50000 100.00 98.68
M1 47478 94.96 93.71
M2 2416 4.83 4.77
Table 3.7.1 – CD34+ FACS analysis analysis.
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CD34+ 3C material was generated as described in the protocol in Section 2.3.
PicoGreen analysis showed the yield to be 130 µg, 75% efficiency (assuming a
hypothetical potential yield of 172.8 µg calculated by number of cells × 6 pg DNA
per nucleus). I ran 1 µg of 3C material on a 1% gel which appeared as expected,
despite some distortion due to salt remaining after the ethanol precipitation (Fig
3.7.2).
Figure 3.7.2 – CD34+ 3C library gel. 1% agarose gel showing 3C library smear.
Distortion due to presence of salt.
CD34+ e4C 3C material was cleaned using SPRI to remove salt contamination
and processed according to the method described in Section 2.4. Genomic DNA
(gDNA) control was used as a positive control for genomic configuration religation
bands and a no template control (NTC) was used as a negative control. Figure 3.7.3
A shows the BCR e4C library after the first round PCR and genomic configuration
band digestion. It can be seen that the strong genomic sequence band is digested in
the gDNA control and that non-specific primer dimers are reduced in the NTC with
SPRI (Fig 3.7.3 A).
To size select fragments of a length suitable for sequencing, the e4C library was
purified using a gel extraction with a band from approximately 250 bp to 700 bp
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e4C gDNA gDNA NTC gDNA NTC
+GR +SPRI -GR +SPRI -GR -SPRI
Figure 3.7.3 – BCR e4C libraries after first round PCR. e4C: BCR CD34+ e4C
library. gDNA: genomic DNA positive control. NTC: No template control. +/- GR: With /
without genomic sequence religation digestion. +/- SPRI: With / without SPRI cleanup.
Hollow arrow shows band present due to genomic sequence religation events. Filled
arrow shows this DNA shifted down the gel after digestion. Lowest band is product
from non-specific amplification. This band is later removed using a gel-extraction step
(Fig 3.7.4).
(Fig 3.7.4).
Figure 3.7.4 – CD34+ e4C library gel extraction. 1% agarose gels showing e4C
library gel before and after gel extraction. Several empty lanes were run between the
ladder and library to avoid contamination which have been removed from this image
for clarity.
After the gel extraction the second round PCR was prepared to add the full
Illumina sequencing adapters (Fig 3.7.5). The smear was the correct size for se-
quencing so I submitted the sample to the Babraham Sequencing Facility. Kristina
Tabbada then quantified and sequenced the sample on a Illumina Genome Analyser
IIx. Data analysis is described in Chapter 4.
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Figure 3.7.5 – Completed BCR e4C library. Mouse e4C: Positive control library
generated from mouse tissue. BCR e4C: BCR CD34+ e4C library. NTC: No template
control. BCR library shows optimal smear through range of sizes appropriate for
Illumina GAIIx sequencing.
3.8 Multiplexing e4C libraries
Although the cost of next generation sequencing is rapidly decreasing, sequencing
an Illumina library is an expensive process. In order to make libraries cheaper,
multiplexing is a common practice. All multiplexing uses the same principle: Il-
lumina libraries are created with a small number of base pairs constant within
each sequence - a barcode. Multiple libraries with different barcodes are mixed
and simultaneously sequenced in a single flow cell lane. After the sequences are
retrieved from the sequencing run, the libraries are separated by identifying the
barcode present at within each sequence. The greater the number of libraries which
are multiplexed within a single lane, the fewer the reads retrieved for each library.
The total number of returned sequences is often in excess of what is needed; in the
case of my e4C libraries a great number of duplicates were returned.
A number of variants of multiplexing methods have been used with the Illu-
mina Genome Analyser IIx and Illumina itself produces a kit for the production of
multiplexed libraries which uses an additional read from adapter 2. Because I was
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sequencing my e4C libraries with custom sequencing primers, I was able to specify
the sequence present at the start of each read. As such, I designed the sequencing
primers to leave a few base pairs for sequencing before the AseI restriction site.
This has the dual benefit of allowing the multiplexing of multiple e4C libraries
with different baits, and ensuring that the sequenced products are not the result of
unspecific primer binding; genomic sequence is used as the barcode which is not
incorporated with any primers used.
3.8.1 Multiplexed libraries
For the first sequencing runs with my e4C libraries, I multiplexed two libraries: a
CD34+ BCR breakpoint region bait and a CD34+ MLL breakpoint region bait. These
libraries are known as BCR Run 1 and MLL Run 1 for the rest of this thesis. Primers
for both baits were used together through the e4C library preparation. Once the raw
reads were available from the sequencing run, we separated the two e4C libraries
in-silico (for details, see Section 4.1). The MLL library only returned 55,868 reads
vs. the BCR library with 22,390,498, a 400-fold difference. This difference is likely
to be due to a variation in primer efficiencies causing the BCR bait ligation products
to be preferentially amplified above the level of the MLL bait products.
For my second multiplexed run, I prepared the e4C libraries separately in par-
allel and mixed them immediately before sequencing in equimolar amounts. This
time, the MLL library returned 9,960,249 reads and the BCR library returned 12,616,122
reads, only a 1.2 fold difference.
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3.8.2 Crossover products
Initial analysis of the MLL Run 3 e4C library showed much higher complexity
than the previous two MLL libraries (Section 5.2.3). Upon closer inspection it
became clear that a large number of hits in the BCR Run 2 e4C, multiplexed on
the same lane, were present with the MLL barcode. These “crossover products”
were characterised by low duplicate counts compared to what appear to be genuine
MLL e4C reads (under 20 duplicates vs. 2,000 - 40,000 duplicates).
e4C libraries exhibit strong association in close cis linked chromatin due to
physical linkage (Section 5.3). When viewing the region of chromosome 22 con-
taining the BCR bait characteristic bait enrichment can be seen in the MLL e4C
library (Figure 3.8.1 A), a feature that could only be caused by e4C ligation products
with a BCR bait. Interestingly, the crossover reads seem to be unidirectional; no cis
bait enrichment around the MLL bait locus is seen in the BCR e4C library (Figure
3.8.1 B).
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Figure 3.8.1 – Crossover reads between multiplexed e4C libraries. (A) 35 Mb
region of chromosome 22, showing enrichment around the BCR bait for both the BCR
and multiplexed MLL e4C libraries. There is no enrichment in the phiX MLL control
library. (B) 35 Mb region of chromosome 11, showing enrichment around the MLL bait
for the two MLL e4c libraries, but not the multiplexed BCR library. Bait regions shown
by yellow bars. X axes show chromosomal position in Mb. Y axes show absolute read
counts.
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To rule out errors in the in-silico processing of the libraries I examined the
original sequencing data before processing to confirm that the crossover sequences
began with the MLL barcode sequence. The MLL barcodes were present exactly as
would be expected for an MLL e4C library product.
3.8.2.1 MLL Run 3 phiX
To confirm that the reads are definitely as a result of the multiplexing and not due
to contamination during e4C library preparation, we spiked an aliquot of the MLL
Run 3 e4C library into the phiX control lane on a subsequent Illumina sequencing
run. The presence of the standard Illumina sequencing primer for the phiX library
resulted in the majority of MLL library reads just containing bait sequence (Fig
3.3.1), however enough reads from the custom primer were returned for analysis.
As can be seen in Figure 3.8.1, the MLL phiX reads correlate precisely with peaks of
large read numbers in the multiplexed MLL library but not any suspected crossover
reads.
After removing the two bait chromosomes 11 and 22 and removing all duplicate
reads, I analysed the hit AseI fragments between libraries. The multiplexed MLL
library had a correlation of 0.656 with the multiplexed BCR library and a correlation
of 0.36 with the MLL phiX library. If a threshold of 20 reads was set before removal
of duplicate reads, these two correlations became 0.009 and 0.782, respectively.
This demonstrates that only a small number of reads are crossing over between
libraries, as can be seen in Figure 3.8.1. Unfortunately this threshold was chosen
empirically and could lead to inaccurate analysis results. As such, the thresholded
library was not used for further analysis.
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3.8.2.2 Reasons for crossover reads
It seems likely that these crossover reads result from an error in the cluster identi-
fication during the Illumina sequencing process. We approached Illumina with our
observations but never came to a satisfactory explanation for the effect. Because we
could not address this problem without a known cause, we did not multiplex any
further e4C libraries.
3.9 Increasing e4C library complexity
Due to the low coverage of the e4C libraries (see Section 5.2), I attempted to modify
the e4C protocol to increase the diversity of the sequencing reads.
3.9.1 Barcoded NlaIII adapter
In an attempt to retain quantitative data about the frequency of 3C ligation products
before the PCR steps, I designed a new NlaIII adapter which included 4 base pairs
of unspecified sequence in the oligo to use as a barcode. The idea behind this new
adapter was to use it in a paired end Illumina sequencing run. Read one would use
the same custom sequencing primer and methodology as that described above for
the single end sequenced e4C libraries. The second read would use the standard
Illumina sequencing primer two, which would read through the barcode and into
the unknown sequence. The barcode could be used to deconvolute quantitative
information about the number of pre-PCR 3C ligation products, and the unknown
sequence would provide additional validation of the ligation product. Every pre-
PCR 3C product should give two different barcodes from the two strands of random
barcode, which could then be quantified to give ligation frequencies and greater
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coverage information. This approach should allow the e4C data to be treated quant-
itatively.
In order to ensure that the two single stranded oligos would hybridise to form
a functional adapter, I added a 6 base pair GC-clamp after the barcode before the
NlaIII sticky end (Fig 3.9.1). After the first round of PCR, the barcode will have
a complementary sequence, so the initially different bases should not cause any
problems in the sequencing.
N
N NN
XXXXXXXXXXGTACGCCGCC
XXXXXXXXXXCATGCGGCGG N
NNN
AGATCGGAAGAGCGGTTCAGCAG
TCTAGCCTTCTCGCCAAGTCGTC
Unknown
Sequence
NlaIII
Site
GC Clamp Barcode Illumina Adapter Sequence
AseI
NlaIII
Bait Sequence
Unknown
Sequence
Read 1
Read 2
Figure 3.9.1 – Diagram showing design of the barcoded NlaIII adapter. Top panel
shows an overview of a typical e4C library product. Read 1 confirms the identity of the
bait region with a few bases of genomic configuration sequence before reading through
the AseI restriction endonuclease recognition site into the unknown ligated sequence.
Read 2 reads the random adapter barcode before the GC clamp, NlaIII restriction site
and unknown sequence.
3.9.2 Multiplexing same-bait e4C libraries
The high number of duplicates seen for every read in the e4C libraries (Section
5.2.1) suggests that there is a lack of complexity in the e4C libraries, and we were
sequencing the full depth of the libraries. In an effort to increase the diversity in a
sequencing run, I created eight e4C libraries using the BCR breakpoint region bait
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and the new NlaIII adapter described above. The e4C libraries were prepared as
biological replicates from new CD34+ 3C material generated from a second patient.
While multiplexing e4C libraries with different bait regions in a single Illumina
lane caused crossover reads which skewed downstream analysis, any crossover
reads between libraries sharing the same bait would not affect analysis. Combined
with the new NlaIII adapter able to identify unique 3C ligation products, such
multiplexing should not suffer the same problems as previous runs.
3.9.3 Results of e4C modifications
In order to test the e4C protocol modifications described above, I spiked a small
amount of the multiplexed e4C libraries with the new NlaIII adapter into the phiX
control lane on an Illumina GAIIx sequencing run. 111,897 reads were returned, of
which only 2,541 (2.27%) had a second paired end read with the expected structure
(barcode, GC clamp, NlaIII site, unknown). The structure of the remaining reads
were either NlaIII site > GC clamp > NlaIII site (4,394 - 3.93%); NlaIII site but no
clamp (102,284 - 91.41%); or something else (2678 - 2.39%).
To attempt to determine why the paired end reads did not conform to the expec-
ted structure, I analysed all paired end reads from bait clusters irrespective of their
sequencing primer in read 1. Over 2.7 million began with the NlaIII recognition
site CATG. Of these, the majority had very similar sequences. Most of these were
not mappable to the human genome and a number of the highly represented reads
mapped to the NlaIII adapter. The presence of these reads suggests that there were
problems with either the oligo hybridisation used to anneal the NlaIII adapter or the
ligation reaction used to ligate the adapter to the 3C library. Both of these problems
could be exacerbated by the presence of the non-homologous barcode region.
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Due to the problems with the barcoded adapter, the second read from the paired
end run was not reliable. The low numbers of reads from read 1 meant that this e4C
sequencing run did not yield any useful information in its own right. Because of
time and money constraints I did not continue the development of this modification.
Had I the chance, I would use one NlaIII barcode per e4C library. This should
remove problems caused by non-homologous sequence in the barcode. Although
this would lose the ability to differentiate between individual ligation products, it
would keep the ability to differentiate between separate e4C libraries multiplexed
on a single flow cell. This approach would increase coverage depth and give semi-
quantitative information in the association data.
3.10 Discussion
The past ten years has seen a rapid adoption of 3C and 3C-derived techniques. The
slew of protocols to investigate the composition of 3C libraries has allowed us to
investigate differences in association between loci in an increasingly high through-
put manner. The e4C sequencing technique discussed in this chapter represents a
further step towards the high throughput investigation of genome-wide associations.
The data presented here is not without its flaws. The clearest example of this is
the poor quality of the CD34+ MLL e4C libraries. These libraries exhibit approx-
imately ten-fold less coverage than the BCR bait e4C libraries for reasons currently
unknown (Section 5.2.3).
In a recent paper Cowell et al. attempted to use traditional 3C to measure
contact frequencies between the MLL gene and its translocation partner AF9 without
success (Cowell et al., 2012). Although the study was able to demonstrate tran-
scriptional co-association between these genes using RNA-FISH, they were unable
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to detect any products by 3C. The authors attribute this to the low overall proportion
of the cell population exhibiting a close interaction (2-3% cells) and the possibility
that the large size of transcription factories may not allow efficient cross-linking of
the fragments (Cowell et al., 2012).
It is an interesting possibility that the MLL locus may not be amenable to ana-
lysis by 3C based techniques, perhaps due to local inaccessibility of the chromatin.
However, this explanation does not fully explain the variation in complexity seen
between my libraries: the low complexity of the GM12878 ABL e4C library or
the difference in complexity between the GM12878 and CD34+ MLL e4C libraries
(Section 5.2.3). Given extra time and funds, it would be interesting to replicate my
e4C libraries for all baits in both cell types to examine the influence of cell type and
bait fragments.
In Section 3.8, I describe my efforts to further develop the e4C method to im-
prove library complexity through the incorporation of a random barcode sequence
to track individual ligation products and the multiplexing of e4C libraries prepared
in parallel. While this experiment resulted in captured sequences that suggested
problems in the library preparation, I believe that the concepts behind the attempt
are sound. Multiplexed e4C libraries prepared in parallel have the potential to
greatly improve the standard of data produced by e4C. It seems likely that the
lack of homology in the random barcode sequence caused the problems in library
preparation, using NlaIII adapters prepared using homologous oligos with a single
barcode sequence may not cause the same problems and could still be used to detect
identical ligation products found in multiple multiplexed libraries. Up to eight e4C
libraries can be prepared in parallel without difficulty, so it would be feasible to
multiplex many tens of libraries with the same bait on a single flow cell, greatly
improving the coverage of the resulting data.
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At the time that my first e4C libraries were sequenced, the method was novel.
Unlike RNA-Seq and ChIP-Seq which are established and have accepted analysis
pipelines, e4C data analysis had not been developed. As such I created a method to
analyse the data in a way that is accurate and informative.
4.1 Initial data handling
All of the e4C libraries discussed were sequenced using the Illumina Genome Ana-
lyser IIx. Initial data processing up to the point of a SeqMonk library was done
by the Babraham Bioinformatics team, primarily Dr. Felix Krueger and Dr. Simon
Andrews.
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4.1.1 Bareback processing
The Illumina next generation sequencing technologies, including the Genome Ana-
lyser IIx (GA IIx), determine the order of nucleotides by using fluorescently tagged
nucleotides: “sequencing by synthesis”. Libraries are hybridised to oligonucleotides
on a chip and clusters are generated surrounding each library sequence with multiple
rounds of amplification. Fluorescent bases are then added one by one, and the chip
imaged each round. The colour information collected in the image can be used to
determine the base being added to the cluster according to its colour, and so the
sequence of each cluster is determined.
Central to this technique is the process of calling cluster locations, typically
done by the Illumina Sequence Control Software (SCS) with Real Time Analysis
(RTA) once the first fluorescent base is added. Once determined, the cluster po-
sitions are used for the remaining base pair calling. If the cluster density on the
chip is large, then spots can start to merge. This isn’t a problem with a typical
Illumina library, as the different spots will usually be different colours, and so
discernible from each other. However, every sequence within e4C libraries begins
with a barcode region followed by the restriction enzyme recognition sequence.
This lack of diversity within the first bases of the sequence can cause problems
for the cluster calling; merged clusters may be called as one which can be thrown out
by the purity filter because of its size, or rejected later when the sequence diverges
and it starts to exhibit mixed fluorescence signals. This has the effect of a vastly
reduced number of reads being processed (Fig 4.1.1). The same effect can happen
in multiplexed libraries using barcodes to identify different samples on the same
chip.
This problem was first experienced in our institute with Dr. Cameron Osborne’s
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Figure 4.1.1 – Bareback overview. Diagram showing problematic cluster calling with
samples containing low complexity in the initial sequencing cycles. Taken from Krueger
et al. (2011).
e4C libraries, and also strongly affected my sequencing runs. To overcome the ini-
tial lack of diversity, Dr. Felix Krueger of the Babraham bioinformatics department
and Dr. Osborne developed a package called Bareback (barcode back-processing)
(Krueger et al., 2011). Bareback uses the raw image files generated by the Genome
Analyser IIx and moves the images taken during low diversity to the back of the
stack by renaming the files. These are then analysed using the Illumina GOAT
(General Oligo Analysis Tool) pipeline, now part of the Illumina OLB (Off-Line
basecaller).
Bareback processing greatly increased the number of sequence reads returned
from my e4C libraries (Table 4.1.1), completely rescuing the ABL library with
particularly dense clusters from which the standard SCS processing returned no
reads.
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Illumina SCS processing Bareback processing Fold increase
BCR and MLL 14,409,580 22,167,823 1.54
MLL 13,147,751 16,704,073 1.27
BCR and MLL 18,434,991 23,251,377 1.26
MLL p1 4,690,956 27,868,955 5.94
MLL p2 272,927 30,632,135 112.24
ABL 0 33,157,523 ∞
MLL phiX 24,349,038 26,284,182 1.08
BCR phiX
Table 4.1.1 – Illumina sequence processing statistics with Bareback. Number of
sequences returned from the standard Illumina SCS processing pipeline and from the
bareback processing pipeline. Numbers shown for analysis of identical sequencing
images.
4.1.2 Quality control
Once sequences had been produced by the Bareback processing, the quality of
the sequence data was assessed using two tools written by Dr. Simon Andrews
of the Babraham bioinformatics department, FastQC and FastQ Screen. I was
involved in development of FastQC version 0.9.3 (released 16/6/11) by contributing
a new cascading style sheet (web page theme) to the report structure allowing
simultaneous viewing of the overview navigation and report results.
All e4C libraries passed the quality control steps without any cause for concern.
Representative results are shown in Figure 4.1.2.
4.1.3 Sequence trimming
Before the sequenced e4C library reads can be analysed, they need to be aligned
to the human genome. To do this the bait sequence must be removed up to the
AseI recognition site. Over 97% of the sequences from each sequencing run started
with an expected barcode sequence, with the exception of the MLL Run 3 phiX run
which suffered from competition with the standard Illumina sequencing primer.
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A B
Figure 4.1.2 – Representative e4C Library FastQC and FastQ Screen. (A) FastQC
- average sequence quality. (B) FastQ Screen - species alignment. Both statistics are
for the second CD34+ BCR e4C sequencing run.
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Figure 4.1.3 – Expected structure of
reads in each e4C library.
The expected structure of each e4C after
the bait specific region is an AseI recog-
nition site followed by unknown partner
sequence (Fig 4.1.3). This partner sequence
must also be processed to remove any
unwanted sequence. Two such scenarios
exist: the ligated fragment can be short
due to a nearby NlaIII recognition site,
in which case the read will run into
the NlaIII site and on into the adapter.
Secondly, due to the possibility of 3C
concatemers forming from multiple AseI
fragments ligated together, a second AseI
site could be encountered followed by a
third ligation product which we are not
interested in. In both cases the sequence
beyond the restriction endonuclease binding
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site must be trimmed. A threshold is set to check the length of the sequence to be
mapped after trimming and reads are discarded if they are too short.
To pre-process the e4C library reads, Dr. Felix Krueger in the Babraham Bioin-
formatics group wrote a script in Perl, which I later modified and used myself. The
script loops through the FastQ file and attempts to match the first three base pairs
against expected barcodes. If so, the barcode is trimmed and the next six base pairs
are matched against the AseI recognition site (ATTAAT). Next, the script searches
for AseI and NlaIII sites in the unknown sequence. If a second AseI site is found, the
sequence is rejected. If a NlaIII site is found, the sequence is trimmed to that site. If
the remaining sequence is less than 25 bp long it is rejected. The remaining content
in the FastQ read, such as quality scores, are trimmed to the same length and the line
is printed to the output file, which is then aligned to the genome. The processing
statistics from the e4C libraries can be seen in Figure 4.1.4. See Appendix A.2.4
for full statistics.
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Figure 4.1.4 – Library trimming and alignments. Proportion of e4C libraries
discarded due to AseI or NlaIII sites being too close to the bait, or not being mapped to
the genome / being suppressed due to multiple alignments. Full statistics can be seen
in Appendix Table A.2.4.
114
Chapter 4: Developing the analysis of e4C data
4.1.4 Sequence alignment
The resulting trimmed reads were next passed through the genome alignment tool
Bowtie (Langmead et al., 2009). Reads were aligned with 82% - 92% efficiency
(Fig 4.1.4, Table A.2.4). Parameters were used as described in Fig 4.1.5. Reads not
mapped to the genome are likely to have been removed from the strict alignment
parameters which removed any reads with more than one alignment. Additionally,
the aligned sequences were up to six base pairs shorter than regular Illumina GA
IIx sequencing runs due to having the bait identifier removed.
bowtie -q --phred64-quals -p 8 -m 1 hg19 <input> <output>
Figure 4.1.5 – Bowtie alignment parameters. -q: Input is in FastQ format.
--phred64-quals: Correct interpretation of ASCII quality scores. -p 8: Use
eight CPU cores for the alignment. -m 1: Ignore any read with more than one
alignment. hg19: Name of the reference genome used for alignment. UCSC
genome build hg19 was used.
4.1.5 Importing into SeqMonk
For analysis and quantitation of the e4C libraries, I used a program called SeqMonk
(http://www.bioinformatics.babraham.ac.uk/projects/seqmonk).
SeqMonk has been developed by Dr. Simon Andrews, head of the Babraham
Bioinformatics team, and is written in Java with a graphical user interface. It
has been built from the ground up for analysis and visualisation of next generation
sequencing data, and has grown extensively throughout the duration of my PhD.
SeqMonk works with aligned sequence reads, and can quantify them with “probes”.
Probes are sets of paired genomic co-ordinates and can be created over any feature
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(such as gene or restriction fragment) or as running windows. These probes are then
used as bins within which reads can be quantified.
4.2 e4C library biases
In 2011, Dr Amos Tanay’s group wrote a paper reanalysing a previously published
Hi-C dataset (Yaffe and Tanay, 2011; Lieberman-Aiden et al., 2009). They showed
biases present within the Hi-C data towards higher GC content and particular re-
striction fragment lengths (Yaffe and Tanay, 2011). To investigate whether my
e4C interaction datasets were affected by the same biases, I wrote perl scripts
to compare the characteristics of the observed AseI - NlaIII fragments versus all
possible fragments.
4.2.1 Potential fragment libraries
A prerequisite for the analysis of these biases is the generation of an in-silico library
of all potential fragments. The original perl script to generate these libraries was
written by Marek Piatek, in the Babraham bioinformatics department. I have since
re-written the script from scratch, as well as writing other scripts including an online
tool to generate lists of restriction enzyme recognition sites (Appendix A.3.1). I
have made some of these available as online tools at http://www.tallphil.
co.uk/bioinformatics/ (Appendix A.4).
In principle, all of the scripts are similar - the genome is loaded into memory one
chromosome at a time, and perl’s index function is used to search for the restriction
enzyme recognition sites. For AseI - NlaIII fragments, once an AseI site is found
the next NlaIII site is searched for. If one is found before the next AseI site, the
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resulting fragment length is tested; if it is shorter than 35 base pairs or longer than
700 base pairs then it is discarded due to the gel extraction size selection used in the
e4C protocol. The resulting library of fragments is then aligned using Bowtie and
so filtered for unique mappability (Table 4.2.1).
Fragments Removed Total Fragments
All AseI – NlaIII fragments 0 2407346
Filter for length < 35bp 283205 2124141 (88.24%)
Filter for length > 700bp 74398 2049743 (85.15%)
Filter for unique mappability 153862 1895881 (78.75%)
Table 4.2.1 – in-silico potential AseI - NlaIII fragment library statistics.
4.2.2 GC content bias and fragment length bias
The in-silico library described above was imported into SeqMonk as an annotation
track, and a probe created over each potential fragment. A binary value was as-
signed to each fragment by using Minimum Coverage Depth quantitation. Results
were exported as an annotated probe report, containing the co-ordinates of every po-
tential AseI - NlaIII fragment with a binary flag to indicate whether it was observed
or not. I wrote a Perl script to process these datasets (Appendix A.3.2). The script
fetches the genomic sequence for each set of co-ordinates and increments counters
representing 5% GC content bins, according to the %GC content of the sequence.
A second set of counters were also incremented if the sequence was observed. A
modified version of this script was then used to calculate AseI - NlaIII fragment
lengths.
The resulting counts were plotted and can be seen in Figure 4.2.1. It can be
seen that the e4C libraries are biased towards greater %GC content and shorter
fragments. This bias towards increased GC content and shorter fragment lengths
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Figure 4.2.1 – e4C library biases. (A) %GC content distribution. GC content of
each sequence calculated and quantified in 5% GC bins for all potential AseI-NlaIII
fragments (blue) and all observed AseI-NlaIII fragments (red). An enrichment for
higher GC content can be seen in the observed fragments. (B) Fragment length
distribution. AseI-NlaIII fragments were quantified by their fragment length. An
enrichment of shorter fragments can be seen in the observed AseI-NlaIII fragments
(red).
is similar to observations made by Yaffe and Tanay in HiC data (Yaffe and Tanay,
2011). These are likely to be experimental biases that come from the digestion,
ligation, PCR and sequencing steps. It should be noted that the interaction libraries
are enriched for GC rich regions (Section 5.4), so this bias may be a reflection of
the specificity of the interaction data.
4.2.2.1 Bias correction
To correct the e4C libraries for systematic biases that are due to GC content and
fragment length, a library of all potential AseI - NlaIII fragments was created with
associated ’expected probability’ values. These were generated with a perl script
which calculates a correction value for each bin of GC % and fragment length:
(Appendix A.3.2)
C =
hit f ragments in bin
hit f ragments
/
all f ragments in bin
all f ragments
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Then, for every potential fragment, the appropriate correction values for %GC
and fragment length were multiplied against the overall chance of any fragment
being hit:
ρ f rag =
observed f ragments
potential f ragments
×C%GC×C f rag length
This library of expected observation rates for every potential fragment was then
used in single window testing (Section 4.3).
4.2.2.2 Validation
To check that the values produced by this script were reliable, I wrote a small Perl
script to generate in-silico e4C libraries using the correction values. The script
loops through every potential fragment and outputs it as a hit if a random number
between 0 and 1 is greater than or equal to the correction factor. This was repeated 5
times to generate a suitable number of reads. This in-silico library was then loaded
into SeqMonk for visual inspection before being analysed for biases as described in
Section 4.2.2. The resulting plot showed the in-silico library to have identical biases
to the observed library, with the same GC and fragment length profiles plotted with
a red line in Figure 4.2.1.
4.3 Significance of single regions
To test the significance of the observed hits in a single region, I wrote a script that
generates in-silico random libraries for defined regions of the genome. This process
can be repeated many times and the number of in-silico fragment hits generated for
each run compared to the number of observed reads in the real e4C library. A p
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value can be calculated for a single window using this approach by counting the
number of times that the in-silico fragment hit counts are≥ the number of observed
fragments hit for the region.
p =
∑(in−silico runs≥ observed f ragments)
∑(in−silico runs < observed f ragments)
For an example of this analysis in use, see Section 6.1.1.
4.4 AseI site distribution normalisation
Because e4C uses restriction fragments to analyse sequence proximity, there is a
chance that the unequal distribution of AseI sites across the genome could skew the
results. To correct for this, I used a Perl script written by Dr. Simon Andrews in the
Babraham Bioinformatics department. The script loads a list of potential fragments
with binary flags indicating whether they are observed or not, prepared as described
in Section 4.2.2. It creates 100 Kb rolling windows and counts the number of AseI
fragments present. If there are greater than 5 fragments in a window, it calculates an
( observedpotential ) value and outputs this to the results file. If there are less than 5 fragments
it outputs 0; as calculating percentages with such small numbers of fragments can
give uninformative values for regions with few restriction sites, such as centromeres.
To allow the analysis of these percentage values within SeqMonk, I wrote a Perl
script to create a number of “virtual reads” over each 100 Kb window according to
the percentage score. These can then be imported into SeqMonk and quantified by
whatever method is desired (Fig 4.4.1).
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Figure 4.4.1 – AseI site distribution normalisation. Genome wide plots of BCR e4C
Run 2 before and after AseI site distribution normalisation. Standard scores calculated
with 10Mb windows separated by 1Mb. Y axes are normalised for clarity. Raw y axes
are 0 - 5, Normalised are 0 - 16.
4.4.1 In-silico testing
To validate this normalisation, I wrote a Perl script which creates randomised virtual
e4C libraries from the list of potential AseI - NlaIII fragments and loaded this
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into SeqMonk. I then ran the AseI normalisation as described above and loaded
the resulting normalised library back into SeqMonk. The randomised library had
peaks across the genome whereas the normalised library looked almost perfectly
flat (Fig 4.4.2) suggesting that my normalisation is capable of removing bias due to
the unequal distribution of AseI sites.
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Figure 4.4.2 – AseI normalisation in-silico test. Chromosome 1 showing the in-
silico e4C randomised library before and after normalisation for AseI site distribution.
Y axis shows read count per million reads.
4.4.2 Standard scores
To allow the comparison of different e4C libraries with varying degrees of coverage,
I typically converted and final quantification values to standard scores, also known
as Z scores. A standard score represents how many standard deviations from the
mean a single value lies within a dataset. I initially calculated these values by
exporting data from SeqMonk and importing it into IBM SPSS Statistics. I later
wrote a script in perl capable of this. The ability to requantify probes with standard
scores has since been built into SeqMonk.
4.5 Discussion
In this chapter I discuss my development of new analysis methodologies to extract,
normalise and quantify e4C sequencing association data.
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Because e4C sequencing is a novel technique under active development, custom
bioinformatics tools must be written to process the raw sequence reads into a form
that can be used for analysis. Large sequencing datasets are prone to systematic bias
which can affect coverage (Cheung et al., 2011; Yaffe and Tanay, 2011). I describe
a method to normalise variation across the genome in AseI cut site distribution. GC
content and 3C fragment lengths have also been shown to bias 3C- derived datasets
(Yaffe and Tanay, 2011) and I describe a method to create a normalised matrix
of expected fragment hit probabilities. The use observedexpected enrichment is a common
method for analysing association data (Lieberman-Aiden et al., 2009; Yaffe and
Tanay, 2011; Kalhor et al., 2011). Developing methods to test these normalisation
techniques in-silico is a valuable exercise and helps to identify any problems in their
development.
A useful control experiment would be to sequence an “input” e4C library, cre-
ated by removing formaldehyde cross-links prior to the ligation step. This control
would include all biases introduced by the methodology and could be used to nor-
malise experimental libraries. Unfortunately, such control libraries would need to
be sequenced for each different bait fragment to control for variations in primer
efficiencies and represents a significant expenditure.
In depth understanding of the processes generating the data is needed for proper
analysis. In this chapter I describe how I chose to analyse association by quanti-
fication of the proportion of AseI fragments observed. This avoids any bias caused
by differences in the efficiency of amplification between ligation products. Such
binarisation of association data in trans analysis has been used by other groups for
this reason (van de Werken et al., 2012a).
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5.1 Introduction
In this thesis I investigate the hypothesis that proto-oncogenes involves in leuk-
aemic chromosomal translocations may physically associate in human haematopoi-
etic cells. In this chapter, I describe the initial analysis of e4C association profiles
of BCR, ABL1 and MLL in human CD34+ cells and the lymphoblastoid cell line
GM12878. I study the association frequencies of the genes in cis and in trans and
demonstrate that these genes interact with an active nuclear compartment.
5.1.1 Overview of e4C libraries
To give context to the e4C libraries discussed in this thesis see an overview in Table
5.1.1. In brief, I began by sequencing e4C libraries generated from CD34+ 3C
material for BCR and MLL breakpoint region baits. Due to low read counts in
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the MLL 1 run (see Section 3.8.1) I sequenced a second MLL e4C library in its
own lane (MLL 2). I sequenced a second multiplexed lane with further technical
repeats of the BCR and MLL e4C libraries (BCR 2, MLL 3) and to investigate the
crossover reads I repeated sequencing of this MLL library in a phiX lane (MLL 3
phiX, see Section 3.8.2). To take advantage of plentiful cell numbers and available
epigenomic datasets, I created e4C libraries for ABL1 and MLL with the promoter
AseI fragments in the GM12878 cell line and sequenced these three libraries in their
own lanes.
Name Date Bait Position Description
BCR 1 June 2010 chr22: 23,596,613 -
23,612,935
Breakpoint region of
BCR gene.
First e4C library sequenced, multiplexed library
preparation with MLL 1. CD34+ cells.
BCR 2 Oct 2010
Technical replicated of BCR 1, library generated from
the same 3C material. Sequenced in multiplex with MLL
3. CD34+ cells.
BCR phiX Mar 2011
Test of new multiplexing and barcode protocol. See
Section 3.9. CD34+ cells.
MLL 1 June 2010 chr11: 118,354,809 -
118,356,055
Breakpoint region of
MLL gene
First e4C library sequenced, multiplexed library
preparation with BCR 1. CD34+ cells.
MLL 2 Sept 2010
Technical replicate of MLL 1, generated from the same
3C material. Sequenced in its own lane. CD34+ cells.
MLL 3 Oct 2010
Technical replicate of MLL 1, generated from the same
3C material. Sequenced in multiplex with BCR 2.
CD34+ cells.
MLL 3 phiX Dec 2010
Repeat sequencing of MLL 3, multiplexed in phiX lane.
CD34+ cells.
ABL Dec 2010
chr9: 133,576,435 -
133,591,823
Promoter of ABL1 gene. GM12878 cells.
MLL p1 Dec 2010
chr11: 118,304,771 -
118,311,258
Promoter of MLL gene (centromeric end of AseI
fragment). GM12878 cells.
MLL p2 Dec 2010
chr11: 118,304,771 -
118,311,258
Promoter of MLL gene (telomeric end of AseI fragment).
GM12878 cells.
Table 5.1.1 – e4C Libraries. Chromosomal positions in Bait Position column describe
the co-ordinates of the bait AseI fragment in UCSC genome build hg19. All e4C
libraries described above were prepared from a single CD34+ 3C library.
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5.2 Concerning raw data
5.2.1 Duplicate reads
Visual inspection of the e4C library sequence data within SeqMonk quickly reveals
a large degree of sequence duplication. The e4C protocol involves two rounds PCR
resulting in multiple copies of each initial 3C product being sequenced. It is clear
that some quantitative information is present within the numbers of reads found, as
shown by the increased number of duplicates per unique read in near cis (< 5 Mb
from the bait region) compared to trans (Fig 5.2.1, Appendix Table A.2.5).
Because each e4C fragment end is defined by a restriction enzyme cut site,
duplicates from multiple 3C ligation events are indistinguishable from duplicates
generated by the PCR amplification. Because of this inability to distinguish bio-
logically relevant duplicates from technical duplicates, I removed all non-unique
reads from the data and analysed binary fragment observations instead of sequence
read counts.
5.2.2 AseI fragment saturation
Because the e4C assay uses 3C libraries at its core, the highest achievable resolution
is dependant on the length of AseI fragments. A concern when analysing the cis data
was that we could reach a point of saturation. To determine the degree of saturation
I reduced all e4C reads to binary observations of AseI fragments, represented as a
percentage of potential fragments (Fig 5.2.2, Appendix Table A.2.2).
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Figure 5.2.1 – e4C duplicate frequency. Histogram showing the frequency of
duplicate counts per unique read for BCR e4C libraries. X axis shows the number
of duplicates per unique read (log10 count), Y axis shows percentage of that collection
that the number of duplicates applies to. Grey bars show median number of duplicates.
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Figure 5.2.2 – e4C AseI fragment saturation. Degree of AseI fragment saturation in
trans (t), near cis (n, within 2.5 Mb either side of bait) and far cis (f, beyond 2.5 Mb
either side of bait). Raw numbers can be seen in Table A.2.2.
5.2.3 Library complexity
The level of library complexity and coverage can be seen in Fig 5.2.3 and Appendix
Table A.2.2. Figure 5.2.3 A shows the aligned raw read counts for near cis, far
cis and trans. Reads within near cis (5 Mb window surrounding the bait) can be
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Figure 5.2.3 – e4C library read statistics. (A) Aligned raw read counts for near
cis, far cis and trans. (B) Read counts after removal of duplicate reads. (C) Number
of duplicates per unique read. Numbers were calculated in SeqMonk and plotted in
Microsoft Excel and Adobe Illustrator.
seen to represent a large proportion of all reads due to physical linkage in cis.
Low read counts can be seen for MLL Run 1 (due to biased multiplexing, see
Section 3.8.1) and MLL Run 3 phiX (due to competition with Illumina sequencing
primer). Increased total read counts can be seen in the ABL, MLL p1 and MLL
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p2 libraries due to advances in the Illumina GA IIx sequencing chemistry allowing
greater cluster densities and so number of sequenced reads.
Figure 5.2.3 B shows the read counts for the same libraries after removal of
duplicate reads. The number of near cis reads can be seen to drop relative to Figure
5.2.3 A, due to saturation of AseI fragments near the bait. A large number of trans
reads can be seen in MLL Run 3 due to crossover reads from the BCR Run 2 in
multiplexing (see Section 3.8.2). This plot shows the ~ 10 fold difference in library
complexity between the BCR bait and all other baits.
Figure 5.2.3 C shows the number of duplicates per unique read. Profiles of
duplication can be seen to be similar for all e4C libraries, despite highly variant
total read counts. Near cis and far cis have many more duplicates per unique read
than the trans hits. The number of duplicates per read is high for all e4C libraries,
showing that they are being sequenced to saturation.
Two general observations can be made from these plots: the detail in coverage
is not very great in trans, meaning that association at the level of individual genes
cannot be probed. Secondly, the two BCR breakpoint region bait libraries have
approximately ten fold greater complexity than the MLL, ABL, MLL p1 or MLL
p2 baits. The reason for this difference in complexity is not known but is likely to be
due to a primer-specific effect in bait enrichment, PCR amplification or sequencing.
This hypothesis is supported by the preferential amplification of the BCR bait in
the first e4C library sequenced, where BCR and MLL baits were multiplexed in the
same tubes for e4C library preparation (Section 3.8).
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5.3 cis association profiles
The linear separation of two DNA sequences is a highly constraining factor in
the three dimensional organisation of chromatin. If two regions are on the same
chromosome, they are physically linked and the maximum distance that they may
separate by is constrained by the length of sequence separating them. As such, the
linear separation of two sequences is the strongest predictor of three dimensional in-
teraction. This effect can clearly be seen within all of the e4C libraries, with a large
proportion of the libraries (29 - 45% raw reads) mapping to the cis chromosome (Fig
5.2.3, Appendix Table A.2.5). Sequence density variations are so large between the
cis and trans chromosomes that I analyse them independently. This observation is
in line with other reports in the literature (Yokota et al., 1995; Dekker et al., 2002;
Lieberman-Aiden et al., 2009).
5.3.1 Association frequency in cis declines as a function
of linear separation
To quantify cis association I plotted cis association data normalised against AseI
fragment distribution in SeqMonk (100 Kb windows with a minimum of five frag-
ments), summing the percentage of fragments hit in ten megabase windows separ-
ated by one megabase (Fig 5.3.1).
Large association peaks can be seen surrounding the bait regions (grey bars) as
expected, falling off sharply ~ 2.5 Mb from the bait region on either side (the 5 Mb
window I refer to as near cis). A similar observation of biphasic cis association
within this range has been made using DNA-FISH and HiC (Yokota et al., 1995;
Lieberman-Aiden et al., 2009), though other studies investigating local cis con-
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Figure 5.3.1 – e4C cis association profiles. Profiles generated using 1 mb windows
separated by 100 kb, summing normalised 100kb hit frequencies and quantified with
standard scores. Grey bars show position of bait genes. X axis shows chromosomal
position in Mb, Y axis shows standard scores ranging from 0 to 200. Association
profiles of the (A) BCR bait in CD34+ cells, (B) MLL bait CD34+ cells, (C) MLL promoter
baits in GM12878 cells and (D) ABL1 bait in GM12878 cells.
formation show abrupt drops in association much closer to the bait (Tolhuis et al.,
2002; Noordermeer et al., 2011).
5.3.2 Specific associations in cis
In addition to the obvious peak of cis association common to all of the e4C associ-
ation datasets, some cis bait-specific associations can be seen (Fig 5.3.1, Fig 5.3.2).
The ABL bait interacts with the telomeric region of chromosome 9 more strongly
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with the rest of the chromosome and the BCR bait can be seen to make a number
of contacts in both replicates, including a shoulder centromeric to the bait and four
clusters telomeric (Fig 5.3.1).
To examine cis associations in more detail in the BCR datasets with higher com-
plexity, I plotted the fragment association percentages summed in ten fold smaller
one megabase windows separated by 100 Kb (Fig 5.3.2 A). To ensure that any
observed peaks are not artefacts caused by my method of AseI fragment distribution
normalisation, I also plotted association using a different method of normalisation:
sliding windows covering ten AseI fragments separated by two fragments as done
in analysis by van de Werken et al. (2012a) (Fig 5.3.2 B).
A
B
BCR
BCR
BCR Run 1
Chr 22
BCR Run 1
Chr 22
BCR Run 2
Chr 22
BCR Run 2
Chr 22
20 30 40 50
20 30 40 50
Figure 5.3.2 – BCR e4C cis association. cis association profile of the BCR bait on
chromosome 22 in CD34+ cells. (A) Association shown as the proportion of AseI
– NlaIII fragments hit within a 50 kb sliding window (minimum 5 fragments). (B)
Association shown using a sliding windows of 10 AseI fragments separated by 2
fragments. X axes show position on chromosome 22 in Mb. Y axes show standard
scores, ranging from 0 to 50.
Both normalisation techniques show several hits above the expected baseline in
both replicates. To the centromeric (left) side of the BCR bait three distinct clusters
of association can be seen.
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5.4 BCR, ABL1 and MLL reside in an
active nuclear compartment
Upon plotting the e4C trans association profiles of the different bait genes, it was
clear that they share a number of features. My bait genes are actively transcribed
within CD34+ cells (Figure 3.5.1) and visual inspection of the association profiles
appeared to share some features with previously described active regions (Versteeg
et al., 2003), so I was interested in whether my e4C association libraries showed
correlations with RNA polymerase II binding and other active chromatin marks.
5.4.1 Correlation with active epigenetic marks
To investigate the correlation between e4C association frequency and chromatin
marks, I analysed publicly available genome-wide datasets (Bernstein et al., 2010;
Raha et al., 2010; Hu et al., 2011; See Appendix A.2.3 for NCBI GEO accession
numbers). Gene density was calculated by counting genes labelled as ’protein-
coding’ in ensembl (Flicek et al., 2012). These datasets were quantified by their read
counts and the resulting standard scores compared to the those from the trans e4C
association data. Pearson’s correlation coefficients were calculated using SeqMonk.
The resulting correlation R scores are shown in Table 5.4.1.
The strong correlation between bait association and active mark association
score shows that the e4C bait genes are frequently interacting with active regions of
the genome. The low scores seen with the inactive histone modifications signify that
there is not more association with these regions that could be expected by chance.
The correlation of the shape of the profiles can be clearly seen when plotted genome
wide (Fig 5.4.1).
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BCR 1 BCR 2 MLL 1 MLL 2 MLL 3 MLL 3 X ABL MLL p1 MLL p2
Gene Density 0.707 0.741 0.228 0.201 0.284 0.258 0.614 0.503 0.577
RNA-Seq 0.700 0.723 0.216 0.240 0.294 0.249 0.635 0.533 0.613
DNase 0.672 0.682 0.281 0.387 0.218 0.376 0.547 0.491 0.605
H3K27ac 0.629 0.639 0.279 0.379 0.227 0.363 0.558 0.501 0.610
H3K36me3 0.607 0.622 0.263 0.333 0.232 0.348 0.549 0.483 0.622
H3K4me1 0.749 0.757 0.306 0.366 0.292 0.379 0.630 0.551 0.655
H3K4me3 0.636 0.659 0.263 0.345 0.198 0.329 0.548 0.463 0.583
DNase 0.718 0.731 0.275 0.351 0.268 0.386 0.589 0.547 0.648
RNA-Seq 0.688 0.713 0.242 0.241 0.280 0.241 0.672 0.553 0.637
RNAPII 0.743 0.760 0.291 0.316 0.275 0.320 0.659 0.573 0.654
H3K27ac 0.584 0.588 0.222 0.295 0.215 0.216 0.554 0.458 0.544
H3K36me3 0.598 0.607 0.259 0.324 0.229 0.335 0.575 0.507 0.635
H3K4me1 0.660 0.661 0.298 0.350 0.261 0.329 0.616 0.540 0.648
H3K4me3 0.550 0.557 0.252 0.331 0.182 0.290 0.522 0.447 0.553
K562 RNAPII 0.773 0.794 0.305 0.239 0.401 0.355 0.653 0.527 0.641
HeLa RNAPII 0.770 0.799 0.178 0.253 0.225 0.279 0.660 0.543 0.629
NB4 RNAPII 0.729 0.767 0.174 0.267 0.201 0.321 0.622 0.504 0.631
H3K9me3 0.064 0.080 0.032 0.185 0.055 0.157 0.034 0.016 0.132
H3K27me3 0.353 0.344 0.140 0.230 0.084 0.227 0.303 0.317 0.374
H3K9me3 0.120 0.119 0.090 0.229 -0.020 0.158 0.099 0.115 0.210
H3K27me3 0.356 0.342 0.188 0.319 0.100 0.250 0.359 0.344 0.406
Control GM12878 ChIP-Seq Input 0.254 0.247 0.136 0.164 0.212 0.127 0.016 0.087 0.096
0 0.4 0.8Colour scale
CD34 GM12878
CD34
GM12878
CD34
GM12878
Active 
Marks 
Inactive 
Marks 
Table 5.4.1 – e4C: active epigenomic mark correlation scores. Standard scores
were calculated using quantified reads in ten megabase windows separated by one
megabase. e4C bait cis chromosomes were removed from analysis. Gene density was
calculated using protein coding genes only. Values shown in italics are comparisons
across different cell types. See Appendix A.2.3 for NCBI GEO accession numbers
Many of the differences in correlation scores between the BCR, MLL and ABL1
e4C datasets can be attributed to differences in e4C coverage. The CD34+ MLL
libraries do not have enough reads to show strong enrichment regions. Although
the difference between the CD34+ MLL library correlations with active and inactive
marks are difficult to see in Table 5.4.1 the majority of the correlation R scores are
greater for active marks than inactive, a pattern that can be seen more clearly if the
colour scale is adjusted.
It should be noted that these correlations are not dependent on cell type; this is
consistent with the large scale organisation of ridges and anti-ridges in the genome
(Lercher et al., 2002; Versteeg et al., 2003). The lack of correlation with inactive
histone marks instead of anti-correlation is supported by the recently published
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Figure 5.4.1 – BCR e4C correlation with H3K4me1. Genome wide association
profiles of the two BCR e4C technical replicates (green and blue lines) normalised
for AseI distribution in 100 Kb sliding windows (minimum five fragments) and summed
in ten megabase windows with one megabase separation and quantified with standard
scores. H3K4me1 ChIP-Seq data quantified in the same windows with standard scores
(orange fill) (Bernstein et al., 2010). BCR e4C y axes show standard scores of 0 - 16.
H3K4me1 ChIP-Seq y axis shows standard scores of 0 - 5.
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ENCODE 5C dataset, where Sanyal et al. also observe a lack of enrichment for
H3K27me3 (Sanyal et al., 2012).
5.4.2 Correlations between e4C libraries
Due to the association of the bait e4C profiles with active marks, I was interested
to see the correlation scores between the different datasets. Pearson’s correlation
coefficients were calculated as described above, though with both bait cis chro-
mosomes removed. A number of interesting observations can be made from the
resulting correlation scores: the higher data complexity and reproducible nature of
the BCR technical replicates can be seen by their strong correlation; the effect of
the crossover reads in the MLL Run 3 library can be seen by its correlation with
the BCR profiles; MLL 1 and MLL 3 show good correlation which could be due
to them both being multiplexed with BCR runs, MLL 1 had very low complexity
which could explain its lack of correlation with BCR.
BCR 1 BCR 2 MLL 1 MLL 2 MLL 3 MLL 3 X ABL MLL p1 MLL p2
BCR 1 1.000 0.893 0.146 0.146 0.722 0.122 0.625 0.126 0.130
BCR 2 0.893 1.000 0.171 0.187 0.817 0.153 0.634 0.165 0.166
MLL 1 0.146 0.171 1.000 0.213 0.679 0.197 0.280 0.249 0.262
MLL 2 0.146 0.187 0.213 1.000 0.083 0.093 0.152 0.169 0.250
MLL 3 0.722 0.817 0.679 0.083 1.000 0.401 0.304 0.229 0.247
MLL 3     X 0.122 0.153 0.197 0.093 0.401 1.000 0.195 0.193 0.254
ABL 0.625 0.634 0.280 0.152 0.304 0.195 1.000 0.535 0.546
MLL p1 0.126 0.165 0.249 0.169 0.229 0.193 0.535 1.000 0.476
MLL p2 0.130 0.166 0.262 0.250 0.247 0.254 0.546 0.476 1.000
0 0.4 0.8Colour scale
CD34 GM12878
CD34
GM12878
Figure 5.4.2 – e4C library correlations. Standard scores were calculated using
quantified reads in ten megabase windows separated by one megabase. Both e4C bait
cis chromosomes were removed from analysisValues shown in italics are comparisons
across different cell types.
Interestingly, the GM12878 ABL dataset shows strong correlation with the CD34+
BCR datasets. This is unlikely to be due to differences in complexity as the GM12878
MLL p1 and MLL p2 which have similar read numbers and complexity do not show
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this correlation. This correlation could indicate a matching of specific genome-wide
association profiles by the two loci due to bait colocalisation within the nucleus.
Using genome-wide association correlations to measure proximity instead of direct
contact frequency as measured by 3C product reads has been used for Hi-C data
analysis in the literature (Lieberman-Aiden et al., 2009; Yaffe and Tanay, 2011;
Kalhor et al., 2011).
5.5 Different genes have different preferred
association partners
To investigate bait-specific trans associations within the datasets, I normalised the
association profiles using the most correlated active marks: H3K4me1 for the CD34+
e4C libraries (Fig 5.5.1) and GM12878 RNA polymerase II ChIP-Seq for the GM12878
e4C libraries (data not shown). Standard scores from the epigenomic datasets were
subtracted from the association library standard scores for each window position.
This normalisation against has the effect of largely flattening the genome wide pro-
file (Figure 5.5.1), as expected by the observed correlations (Table 5.4.1). Despite
this, some noticeable peaks remain within the BCR datasets. The low coverage of
the MLL and ABL1 association datasets makes the detection of any specific local
association regions difficult, and those observed unreliable. I discuss the main peak
of the BCR datasets in Chapter 6.
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Figure 5.5.1 – BCR e4C normalisation against H3K4me1. Association profiles
normalised against a H3K4me1 ChIP-Seq profile (Bernstein et al., 2010). Standard
scores were calculated for the normalised association datasets and the ChIP-Seq
dataset. Association datasets were normalised against the ChIP-Seq dataset by
subtraction.
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5.6 Discussion
In this chapter I describe the initial analysis performed on all of my e4C associ-
ation libraries. I detail the problems encountered with the high level of duplicate
sequences and low complexity encountered in the libraries and the common features
observed between association profiles in cis. I discuss the specific associations seen
within the e4C data in cis and demonstrate that the more complex and informative
association libraries correlate well with active epigenetic marks, suggesting that
these genes reside within an active genomic compartment. I go on to describe
specific associations seen in trans beyond that expected by genome-wide profiles
of active epigenetic marks.
My observations of cis profiles are similar to those seen in other association
studies (Simonis et al., 2006; Lieberman-Aiden et al., 2009; Sanyal et al., 2012),
demonstrating the universal principle that cis linkage is the most dominant force
in determining chromatin contacts. This concept has a number of implications for
genomic organisation, such as evolutionary pressure on sequences required to co-
associate within the nucleus to cluster within regions of the genome. An example
where this evolutionary pressure is manifested is the clustering of highly expressed
housekeeping genes throughout the genome (Lercher et al., 2002).
The correlation of bait gene association with regions enriched for active epigen-
etic marks is supported by a number of studies published during the course of my
PhD (Lieberman-Aiden et al., 2009; Kalhor et al., 2011; Yaffe and Tanay, 2011;
Simonis et al., 2006). I discuss the implications of this finding in more detail in
Chapter 7.
139
Chapter 6
Preferential association of BCR
with Chromosome 9
6.1 BCR preferentially co-associates with 9q34
in CD34+ cells
The most prominent association observed in the two replicate BCR association
profiles is on chromosome 9, cytogenetic band q34. When the two replicates are
combined this association gives approximately 7 fold enrichment of association
above the mean with a maximal standard score of 17.04. This is the strongest trans
association that I found in any of my e4C association datasets.
80 100 120 140
ABL1
Figure 6.1.1 – BCR association with 9q34. Association of the combined BCR
replicates, normalised for AseI site distribution, across the q arm of chromosome 9.
Association calculated using ten megabase windows with one megabase separation
(light blue fill) and one megabase windows with 100 Kb separation (dark blue line). X
axis shows chromosome position in megabases. ABL1 is shown as a grey bar.
140
Chapter 6: Preferential association of BCR with Chromosome 9
Chromosome 9 q34 is a gene dense region containing a large number of highly
transcribed genes. It contains the gene ABL1, a recurrent translocation partner
with BCR. The t(9;22)(q34;q11) translocation is found in 95% of chronic myeloid
leukaemia cases (Hehlmann et al., 2007) and was the first cytogenetic abnormality
of its kind to be characterised (Nowell and Hungerford, 1960). For more discussion
about the BCR-ABL1 translocation, please see Section 1.9.1.
6.1.1 Single window testing
To confirm that this association is not an artefact of bias introduced through GC
content or restriction fragment length, I used the single-window testing method
described in Section 4.3. The script was run with one million loops to generate one
million in-silico single window scores. The the resulting frequency of each number
of in-silico scores is plotted in Figure 6.1.2.
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Figure 6.1.2 – Frequency of in-silico hits for single window in telomeric
Chromosome 9. Result of in-silico random e4C libraries accounting for GC% and
fragment length bias. X axis shows the number of fragments hit per interaction, Y
axis shows the frequency with which that number was observed. Actual number of
fragments observed in the BCR e4C shown as a red line.
The observed hit count for this region is clearly far above what would be expec-
ted from GC content and fragment length of the region. To generate a probability
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score for the number of observed fragments, I ran the script a second time for ten
trillion iterations. None of the resulting scores were greater than or equal to the
number of observed fragments, meaning that p < 3x10-13 for this region.
6.2 ABL e4C associations in GM12878 cells
6.2.1 A GM12878 ABL e4C library overview
If BCR preferentially contacts regions in telomeric chromosome 9, I should be able
to detect reciprocal ligation products by using a bait region within this region. To
investigate the association profile of this region, I made e4C libraries with a bait in
the ABL1 promoter in GM12878 cells. This cell line is a tier 1 ENCODE project
cell type and has numerous publicly accessible epigenomic datasets available.
As described in chapter 5, the ABL e4C library did not reach the level of
coverage of either of the BCR e4C libraries, with approximately five fold fewer
unique reads. The ABL e4C library shows stronger correlation with the BCR
libraries than any of the MLL libraries (Table 5.4.2), suggesting that these two
regions have similar genome-wide associations. When visually inspected, the trans
association plot of the e4C library has somewhat sharp peaks of association due
to the lack of complexity (Fig 6.2.1). While the BCR locus on chromosome 22 is
enriched to a significant level (p < 0.01), it is not the strongest association genome-
wide. This could be due to the low coverage not providing enough resolution to pick
out specific associations, a lack of association between these regions in GM12878
cells, or it could be due to the lack of a direct specific association between the BCR
and ABL genes.
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Figure 6.2.1 – ABL e4C trans association profile. Genome-wide plot of ABL e4C
trans associations in GM12878 cells. Reads normalised for AseI distribution with 100
Kb windows, minimum five fragments. Association scores summed in ten megabase
windows separated by one megabase.
6.2.2 BCR: chr9 association in high resolution
When the BCR e4C libraries are combined and the trans association plotted with
ten fold smaller one megabase windows separated by 100 Kb, a triplet peak can be
seen to emerge over the 9q34 locus (Fig 6.1.1). The ABL1 gene sits between two
of these peaks, leading to the intriguing possibility that the BCR - ABL1 association
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could be driven by the association of other nearby loci. The ABL1 locus shows
strong association with the entire 9q34 region, above the expected base level of cis
associations (Fig 5.3.1). These observations suggest that BCR and ABL1 could be
bystander genes brought together through associations of different genes within the
region. Such a model would explain the triplet peak of BCR association over the
region, with ABL1 sitting in a trough above the base level of genome-wide trans
association but not at the maximum point of association. It might also explain why
I do not see specific BCR - ABL1 associations from the viewpoint of ABL1.
6.3 Validation using publicly available datasets
To gather additional evidence about the association between these regions, I made
use of publicly available Hi-C and TCC datasets published at the time I was gener-
ating the e4C association data (Lieberman-Aiden et al., 2009; Kalhor et al., 2011).
6.3.1 Hi-C associations in GM06990 cells
In 2009 Dr Job Dekker’s group, responsible for the first use of 3C to probe nuclear
structure (Dekker et al., 2002), published a study using a new technique called Hi-C
(Lieberman-Aiden et al., 2009). Hi-C is a technique based on 3C able to capture
all associations within the nucleus (all-to-all). In brief, 3C ligation products are
enriched using the incorporation of a biotin moiety, adapters are added and the
entire library sequenced. Hi-C libraries are incredibly complex due to the huge
range of ligation events captured and require great sequencing power to achieve a
useful resolution.
The study by Lieberman-Aiden et al. investigated associations in the ENCODE
cell lines K562 and GM06990. Like GM12878 cells, the GM06990 cell line is
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a lymphoblastoid cell line. Lymphoblasts are multi-potent progenitor cells which
later develop into the different lymphocyte cell types: NK cells, T lymphocytes
and B lymphocytes. They are derived from CD34+ haematopoietic stem cells via
common lymphoid progenitor cells. Initial analysis using the Hi-C heat map tool
available at http://hic.umassmed.edu shows that telomeric chromosome 9 does inter-
act strongly with two large regions of chromosome 22 with the strongest association
slightly centromeric of BCR and either side of ABL1 (Fig 6.3.1).
70 80 90 100 110 120 130 140
Chromosome 9 (mb)
50
40
30
20 Chrom
osom
e 22 (m
b)
ABL1
BCR
Figure 6.3.1 – GM06990 Hi-C heat map. Association heat map showing the q
arm of chromosomes 9 and 22. Colours represent observed / expected ratios; blue
colours are weak associations, red are strong. Each block represents a one megabase
window. Generated using the Hi-C data browser: http://hic.umassmed.edu, data from
(Lieberman-Aiden et al., 2009).
To analyse the association profiles in the Hi-C data in more detail, I took paired
reads with one end within a one megabase region surrounding the BCR gene from
the GM06990 NcoI Hi-C replicates and analysed the partner reads. I did not use
the HindIII Hi-C replicates as they had four fold fewer reads (4395 for HindIII vs.
18388 for NcoI). I analysed the partner reads as if they were from an e4C experiment
with normalisation for NcoI restriction site distribution.
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The Hi-C data has a lower signal to noise ratio, and so a flatter profile, but a
peak of association over the same region of chromosome 9 is visible (Fig 6.3.2).
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Figure 6.3.2 – GM06990 Hi-C BCR locus association with chromosome 9.
Association of reads within one megabase of the BCR gene, normalised for NcoI site
distribution, across the q arm of chromosome 9 (centromere to the left, telomere to
the right). Light green fill shows quantification using ten megabase windows with one
megabase separation. Darker green line shows quantification using one megabase
windows with 100 Kb separation. X axis shows chromosome position in megabases.
ABL1 is shown as a grey bar.
6.3.2 Hi-C and TCC associations in GM12878 cells
In 2011 a study by Kalhor et al. described a modified version of Hi-C called tethered
chromosome capture (TCC) (Kalhor et al., 2011). This study used GM12878 cells
and the Hi-C dataset was sequenced to a greater depth. The authors claim that
TCC, a modified version of Hi-C which tethers proteinaceous 3C complexes to solid
phase beads before ligation, reduces non-specific ligation events and so removes
background noise from the association data (Kalhor et al., 2011).
As with with the Hi-C data described above, genome-wide profiles of specific
loci can be generated from this data. I plotted the association of a one megabase
window surrounding the BCR gene on chromosome 9 after normalisation against
HindIII restriction fragment distribution (Fig 6.3.3). A strong association can be
seen over telomeric chromosome 9 using ten megabase windows. This splits into
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smaller peaks when the window size is dropped to one megabase, similar to the
profile of the e4C association.
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Figure 6.3.3 – GM12878 HiC and TCC BCR locus association with chromosome
9. Association of reads within one megabase of the BCR gene, normalised for HindIII
site distribution, across the q arm of chromosome 9 (centromere to the left, telomere to
the right). Light orange fill shows quantification using ten megabase windows with one
megabase separation. Darker orange line shows quantification using one megabase
windows with 100 Kb separation. X axis shows chromosome position in megabases.
ABL1 is shown as a grey bar. Genome wide association plot can be seen in Appendix
A.2.6.
6.4 Narrowing the window of associations
To investigate the hypothesis that BCR-ABL1 association could be driven by a
bystander effect of nearby gene associations, I studied the genes present within
the vicinity of ABL1. This region is very gene dense, containing approximately 50
to 80 genes per one megabase window. Using RNA-Seq and RNA pol II ChIP-
Seq datasets (Appendix A.2.3 for NCBI GEO accession numbers) I selected highly
expressed genes in the region. I investigated their associations with chromosome
22 by generating 4C-like association datasets from HiC data. Taking this approach
instead of studying two-dimensional heatmaps gives better resolution and allows
finer control of association visualisations.
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6.4.1 The Surfeit Cluster
The consensus association for BCR across the datasets is that there are three major
peaks of association in chromosome 9 q34. The ABL1 gene sits between the two
most centromeric of these. The closest of these peaks contains the Surfeit cluster of
genes. This is a cluster six housekeeping genes not related in sequence contained
within 45 Kb. The SURF1 - SURF5 genes alternate in orientation (Huxley and
Fried, 1990) and SURF1 and SURF2 share a bidirectional promoter (Lennard et al.,
1994). SURF3 (also known as RPL7A) encodes the 60S ribosomal protein L7a and
is co-transcribed with the small nucleolar RNA genes U24, U36a, U36b, and U36c
(Giallongo et al., 1989; Nicoloso et al., 1996). The cluster is highly conserved from
mouse and chicken to human (Duhig et al., 1998).
I hypothesised that a cluster of genes with such high expression may be re-
sponsible for the organisation of the surrounding chromatin and could be driving the
observed association with chromosome 22. Generating 4C like association profiles
from Hi-C and TCC reads in the Surfeit cluster shows strong associations over the
region of chromosome 22 containing the BCR gene (Fig 6.4.1).
20 25 30 35 40 45 50
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Figure 6.4.1 – GM06990 HiC Surfeit locus association with chromosome 22.
Association of reads in a one megabase surrounding the Surfeit cluster, normalised
for NcoI site distribution, across chromosome 22 (centromere to the left, telomere to
the right). Light purple fill shows quantification using ten megabase windows with one
megabase separation. Darker purple line shows quantification using one megabase
windows with 100 Kb separation. X axis shows chromosome position in megabases.
BCR is shown as a grey bar.
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6.5 Validation by 3C
The results of the e4C indicate association frequencies. The analysis of the data
makes a number of assumptions, namely that the results of the e4C library se-
quencing accurately represent the frequency of ligation products found within the
original 3C libraries. There are a number of steps within the e4C library prepar-
ation which could affect this representation, notably the two PCR amplification
steps which may preferentially amplify some ligation products irrespective of their
initial frequency. Because of these potential biases traditional RT-qPCR 3C was
a logical method to validate the association. Additionally, the RT-qPCR 3C may
provide a resolution of association frequencies superior to that of the e4C, both in
terms of quantitative association of individual fragments and in differences between
fragments within close proximity.
6.5.1 Design
Primers for the qPCR were designed for a number of HindIII fragments within
the promoters of candidate genes described above. Four primers were used for
each fragment, two either side of both restriction sites. 3C material was prepared
with HindIII to avoid any biases that may be introduced by AseI digestion. An
equimolar mix library to control for varying primer efficiencies was prepared by
amplifying the fragments with genomic DNA, digesting with HindIII, mixing in
equimolar concentrations and randomly ligating as described in Dekker (2006);
Cope and Fraser (2009).
I interrogated three HindIII fragments covering the Surfeit locus, two fragments
covering the ABL1 promoters 1a and 1b. For use as a negative control I used
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a HindIII fragment covering the promoter of SMC2, an expressed gene 27 Mb
centromeric of ABL1 with low BCR e4C association.
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Figure 6.5.1 – 3C RT-qPCR Primer Locations. (A) BCR e4C association over
telomeric chromosome 9 (shading - ten megabase windows, line - one megabase
windows). (B) Screenshots of candidate genes taken from UCSC. HindIII restriction
sites shown as blue lines, named fragments labelled in black text. Not shown at equal
scale.
I ran the 3C RT-qPCR using GM12878 3C material prepared with HindIII. I
used GM12878 cells because the method uses a lot of 3C material and I wanted to
do any optimisation required using a plentiful supply of cells.
6.5.2 Results
I ran two biological replicates of the 3C RT-qPCR with four technical replicates
per primer pair. To calculate 3C product concentration I used a standard curve for
each primer pair generated from six concentrations of the randomly ligated control
library and a no template control. To reach a final value for each primer pair I
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averaged the concentrations of the four technical replicates and plotted this with a
standard deviation (Fig 6.5.2).
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Figure 6.5.2 – 3C qPCR Results. Two repeats (A) and (B) showing average values for
four replicates per sample in 3C RT-qPCR. Y values are concentration in µM, calculated
from standard curve for each primer pair. Error bars show standard deviations.
As can be seen in Fig 6.5.2, 3C ligation product concentrations were not re-
producible between biological or technical replicates. To check for non-specific
amplification I plotted a dissociation curve of samples from 58 °C to 85 °C. The
dissociation curve for the standard curve samples looked as expected, however the
3C samples and lowest standard curve concentration showed very small peaks at
varying temperatures, suggesting that the qPCR Ct values are not reliable. To look
for specific amplification visually, I ran the 3C qPCR samples and the two least
concentrated standard curve samples on a gel (Fig 6.5.3). This shows specific bands
in the more concentrated standard curve lanes for all replicates, but a mixture of
specific bands, non-specific smears and empty lanes for the 3C samples and lowest
concentration of standard curve (Fig 6.5.3). From the 8 lanes for each primer pair,
Surf H1 appears to have one band, Surf H4 eight bands, ABL H1 seven bands, ABL
H2 four bands and SMC2 two very weak bands.
Empirically, this suggests that the Surfeit cluster and ABL1 have stronger asso-
ciations with BCR gene than SMC2. The binary nature of the presence and absence
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Figure 6.5.3 – Gel showing 3C qPCR Products. 1% agarose gel showing 3C RT-
qPCR products, stained with Ethidium Bromide. Std = Standard curve products, 1.28
and 0.25 µM. 3C = four 3C RT-qPCR duplicates. NTC = No template control.
of bands in replicates demonstrates that these ligation products are very rare, due
to the weak nature of trans contacts. This very low level of 3C ligation events and
non-specific smearing due to lack of template means that 3C RT-qPCR cannot be
used to accurately discern the relative association frequencies of these loci.
6.6 Validation by microscopy
Microscopy techniques are commonly used to investigate the association between
genomic loci and offer a suitable method for validating e4C data. Because the
protocols are fundamentally different, they do not suffer the same biases as 3C-
derived techniques. Light microscopy techniques do not have as good resolution as
3C- derived methods, but are able to give information on a single - cell basis
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6.6.1 RNA-FISH and DNA-FISH
Initially, I attempted to use RNA-Fluorescence In-Situ Hybridisation (RNA-FISH)
to show the association of actively transcribed genes. Due to human blood products
being a category II sample, they must be fixed before being brought to the main
laboratory. This change in the RNA-FISH protocol caused problems and I was never
able to collect any meaningful data. Because of this I switched to using DNA-FISH.
DNA-FISH labels regions of genomic DNA using fluorescently labelled bac-
terial artificial chromosomes (BACs). It is more resistant to modifications than
RNA-FISH due to the relative stability of DNA and the larger labelling target;
a BAC is typically around one hundred kilobases in length whereas RNA-FISH
probes are designed in intron sequences, usually a few hundred base pairs long.
DNA-FISH labels two genomic loci in every nuclei, whereas RNA-FISH labels
nascent transcripts which may be fewer in number.
6.6.2 DNA-FISH study design
For use in the DNA-FISH I used BAC probes covering target genes. These BACs
were directly labelled with fluorescent moieties (555 nm for BCR, 488 nm for other
genes). I used the genes tested in the 3C RT-qPCR: BCR, ABL1, Surfeit cluster and
the SMC2 negative control. I also used two new loci, SPTAN1 and QSOX2, which
are found at the apex of the centromeric and telomeric triplet peaks of association
in chromosome 9 (Fig 6.6.1). For use as a negative control in the DNA-FISH I
also used HLA-DMA, a highly expressed gene on chromosome 6 within a region
enriched for active marks but not displaying a specific association with BCR in the
e4C (Table 6.6.1).
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Gene BAC ID Chromosomal Position
BCR CTD-2571K3 chr22:23,455,715-23,679,062
ABL1 RP11-83J21 chr9:133,652,008-133,828,473
Surfeit RP11-152J3 chr9:136,206,288-136,374,469
SPTAN1 RP11-589E16 chr9:131,241,008-131,450,093
QSOX2 RP11-83N9 chr9:138,981,971-139,136,889
SMC2 RP11-989F24 chr9:106,791,249-106,969,527
HLA-DMA RP11-629J17 chr6:32,449,530-32,684,058
Table 6.6.1 – DNA-FISH BACs. Table showing the BAC name and chromosomal
position for each DNA-FISH probe used.
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Figure 6.6.1 – DNA-FISH probe locations. Location of DNA-FISH probes on
chromosome 9. e4C association profile with BCR using ten megabase windows
with one megabase separation shown in light blue solid colour; association using one
megabase windows with 100 Kb separation shown as solid blue line. HLA-DMA probe
is located on chromosome 6. Identities and exact locations of BAC probes can be
found in Table 6.6.1.
6.6.3 DNA-FISH analysis
Slides were analysed with the MetaSystems MetaCyte microscope and analysis
software with a classifier set up able to identify DNA-FISH signals accurately. I
exported data from the MetaCyte workstation with three-dimensional co-ordinates
of each signal. Using a perl script written by Dr Felix Krueger in the Babraham
Bioinformatics department I then calculated the distance between each pair of sig-
nals. I filtered this data in Microsoft Excel to give a list of signals corresponding to
the shortest pair distance between each BCR signal and any target signal. I imported
this data into GraphPad Prism for statistical analysis, using a one-way ANOVA test
with a Tukey’s range test to calculate significance and create box plots.
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6.6.4 DNA-FISH in CD34+ cells
For the DNA-FISH with human CD34+ cells I was able to make two sets of bio-
logical replicate slides. Cell numbers were limiting so I was not able to test all
probe combinations for each sample. With slides from the first sample I tested
the association of BCR (555 nm, red) against the HLA-DMA, SMC2, ABL1 and
Surf probes (Fig 6.6.2, Run 1). BCR was found significantly closer to ABL1 and
Surf than the negative control SMC2 (p < 0.001), validating the observation of
increased association over chromosome 9 q34 seen in the e4C (Fig 6.6.1). The
median association of BCR with the control probe HLA-DMA was found to be
slightly closer than ABL1 and Surf in this experiment (p < 0.1, Fig 6.6.2). This
gene was chosen as a control because the e4C data suggested that its association
with BCR was no stronger than would be expected by the activity of the region.
The expression of HLA-DMA is very strong in CD34+ cells, so BCR may associate
specifically with this gene below the level of resolution achieved in the e4C.
The second biological replicate experiment was not as successful as the first,
with a number of slides not reaching the required number of cells for analysis: any
slides with less than 200 signals were discarded. I was able to record association of
BCR with ABL1 and QSOX2. The BCR signals were found slightly closer to QSOX2
signals than ABL1, though this margin was not significant (Fig 6.6.2).
6.6.5 DNA-FISH in GM12878 cells
I performed two replicate experiments with GM12878 cells using independent cell
collections. In the first experiment I tested BCR (555 nm, red) in combination with
the HLA-DMA, SMC2, ABL1 and Surf genes (Fig 6.6.3). A similar pattern was
observed to that seen in CD34+ cells (Fig 6.6.2), with BCR exhibiting significantly
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Figure 6.6.2 – CD34+ DNA-FISH results. (A) Box plots showing target gene
separation with BCR in CD34+ cells. Nuclei with zero or greater than two signals
in either channel were ignored. Central line shows median, box edges show 10th and
90th percentiles, whiskers show 5th and 95th percentiles. Grey numbers below x axis
denote number of signals counted. (B) Representative DNA-FISH images in CD34+
nuclei. Scale bar is 2 µm.
closer association with ABL1, Surf and HLA-DMA than with the negative control
SMC2 (p < 0.001, Fig 6.6.3). In this experiment, the association of BCR with ABL1
and Surf was closer than that with HLA-DMA (p < 0.1, Fig 6.6.3).
With the second batch of slides I repeated probes SMC2, ABL1 and Surf and
included SPTAN1 and QSOX2. All test probes were closer to BCR than the neg-
ative control SMC2. ABL1 and Surf displayed the closes association, with median
separations ~ 0.5 μm less than SPTAN1 and QSOX2 (Fig 6.6.3).
6.7 Discussion
In this chapter I describe data from my CD34+ cell e4C with BCR bait showing
that the strongest trans association with BCR is in chromosome 9 band q34. I
demonstrate that this association is also present in Hi-C and TCC libraries generated
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Figure 6.6.3 – GM12878 DNA-FISH results. (A) Box plots showing target gene
separation with BCR in GM12878 cells. Nuclei with zero or greater than two signals
in either channel were ignored. Central line shows median, box edges show 10th and
90th percentiles, whiskers show 5th and 95th percentiles. Grey numbers below x axis
denote number of signals counted. (B) Representative DNA-FISH images in GM12878
nuclei. Scale bar is 2 µm.
from GM06990 and GM12878 cells and that this association is reciprocal. I discuss
analysis to identify a candidate region driving the association and experiments de-
signed to validate it using RT-qPCR 3Cand DNA-FISH.
This data shows a large scale enrichment of association between two regions
of chromosomes 9 and 22 containing the genes BCR and ABL1. This association
is specific and significant and validated by observations in both RT-qPCR 3C (em-
pirical gel band counting, Fig 6.5.3) and DNA-FISH. The data suggests that there
may be specific loci within these regions driving the association and causing BCR
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and ABL1 to associate through a “bystander effect”, however the identification
of specific loci with variations in association within chromosome 9 q34 was not
conclusive. This could be due to a number of reasons: the candidate loci chosen for
the validation may have not been the genes driving the association; the variations in
association between loci in this region may be too small to detect, or the variations
shown in the e4C data may not be accurate. Chromatin associations in trans are
significantly weaker than those in cis, making quantitative measurements difficult.
The observation that the most significant trans association of BCR is the region
of chromosome 9 containing ABL1 is an important finding. I discuss the implica-
tions of this in Chapter 7.
158
Chapter 7
Discussion
The three-dimensional organisation of the nucleus has a direct impact on the func-
tional regulation of mammalian genomes (discussed in Chapter 1). In this thesis
I describe how I have extended and further developed e4C, a technique based on
chromosome conformation capture. I have used e4C to investigate the genome-
wide association profiles of the proto-oncogenes BCR, ABL1 and MLL in human
CD34+ cells and the GM12878 cell line.
In this chapter I discuss the broader context and implications of the work presen-
ted in this thesis.
7.1 The e4C methodology
The technology behind many molecular biology techniques has undergone a radical
transformation in the past twenty years. The capacity of next generation sequencing
techniques has rapidly increased, in a trend that seems set to continue. As the
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quantity of data produced by experiments makes analysis through direct observation
impossible, the methods we use to process and digest data become increasingly
important.
The development of e4C sequencing described in this thesis acts as a paradigm
of this progression: the original 3C technique is analysed through the visualisation
of bands on a gel (Dekker et al., 2002); RT-qPCR 3C improves this by accurately
quantifying the amplification (Hagège et al., 2007); 4C scaled this technique to use
microarray technology (Simonis et al., 2006; Schoenfelder et al., 2010) and this
thesis describes the use of e4C sequencing to produce many millions of sequencing
reads across the genome.
With such large datasets, analysis methodologies must be systematic and as free
of bias as possible. It is interesting to note the convergent approaches in techniques
used to analyse association data found in the literature. In 2012 a methods paper
was written by the de Laat laboratory describing the 4C-seq protocol and analysis
(van de Werken et al., 2012a). They describe many of the same problems and sug-
gest some solutions that differ from those proposed in this thesis. For example, to
overcome problems with cluster calling due to bait region similarity in sequencing
they recommend spiking in phiX library, instead of Bareback processing. To norm-
alise restriction endonuclease site distribution they use running probes created over
multiple restriction fragments instead of calculating the proportion of fragments
observed in fixed window sizes. Future studies using similar techniques can review
a variety of analysis methodologies and choose those that suit their data best.
160
Chapter 7: Discussion
7.1.1 Future directions
The further development of e4C represents just one of many 3C derived techniques.
These methodologies have generally scaled up from the investigation of individual
loci to global all-to-all techniques such as HiC (Lieberman-Aiden et al., 2009)
and TCC (Kalhor et al., 2011), able to investigate all genomic associations within
a cell population in a single experiment. On initial inspection one might think
that these techniques supersede those before them, however they still suffer from
an Achilles’ heel: sequencing depth. Assuming a 3C library generated with a
restriction endonuclease recognising a six base-pair site such as HindIII, BglII or
AseI, there are approximately seven hundred and fifty thousand fragments in the
human genome (3.08×10
9
46 =752000). In order for a single association event to be
recorded between every fragment in the genome, over half a billion sequence reads
are needed (7520002 = 5.7×1011). Quantitative analysis of association frequencies
requires a great many more reads per fragment. For the level of complexity seen
in the BCR e4C datasets described in this thesis a HiC library would require over
seven thousand billion reads (5.7× 1011 × 12500 = 7.125× 1015), a number that
would require thousands of runs with today’s sequencing technology (the Illumina
HiSeq 2500 is capable of three billion single end reads per run).
Recent all-to-all association studies investigating smaller genomes such as the
yeast Saccharomyces cerevisiae and fruit fly Drosophila melanogaster give an in-
dication to the potential of these technologies when capable of reaching full se-
quencing depth (Duan et al., 2010; Sexton et al., 2012). However, until sequencing
technologies are able to reach similar depths of sequencing with the human genome,
there is a role for e4C and other techniques able to interrogate specific subsets of
3C libraries. As described in this thesis, e4C enriches 3C libraries for a specific
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bait, revealing an in-depth genome wide map of association for that fragment.
Other approaches exist such as ChIP-e4C (Schoenfelder et al., 2010) and ChIA-
PET (Fullwood et al., 2009) which use chromatin immunoprecipitation to enrich for
associations taking place in concert with proteins of interest. I believe that similar
techniques will continue to flourish to allowing the investigation of a myriad of
micro-environments within the nucleus.
A number of as yet unexplored avenues exist within comparative and dynamic
nuclear organisation. Comparative studies may yield new understanding of the
differences between different tissues, healthy and disease states, the evolution of
genome structure and heterogeneity between single cells and populations. Studying
the dynamics of genome organisation can give us new insights into cell cycle pro-
gression, tissue differentiation, the processes driving nuclear organisation and the
effect of pharmacological agents. As our understanding of the gross rules governing
these processes increases we will be able to better understand how differences in
nuclear organisation can affect biological function, and how biological function can
affect organisation. It is not unreasonable to expect diagnostic tests based on nuclear
organisations to reach the clinic in the future, along with drugs able to modify
organisation, especially as preventative measures.
7.2 An active nuclear compartment
The data discussed in chapter four suggests that the proto-oncogenes BCR, ABL1
and MLL reside within an active nuclear compartment, defined by the presence of
active epigenetic marks. The existence of such active and inactive nuclear com-
partments has been suggested by a number of recent studies. Lieberman-Aiden et
al. used HiC to investigate the nuclear organisation of GM06990 and K562 cells.
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They proposed that if two genomic loci are nearby in three-dimensional space, they
will have similar genome wide association profiles. They plotted intrachromosomal
heat maps of Pearson correlation matrices and observed a stark plaid pattern, which
was split into two genomic compartments using principal component analysis. The
authors characterised the active component as showing looser compaction and cor-
relating with gene density, mRNA expression, DNAse sensitivity and active histone
marks (Lieberman-Aiden et al., 2009). This observation has been replicated by
other groups (Yaffe and Tanay, 2011; Kalhor et al., 2011; Zhang et al., 2012) and
is supported by earlier studies showing associations between active loci (Simonis
et al., 2006; Schoenfelder et al., 2010) and domains of inactive chromatin (Guelen
et al., 2008).
The existence of active and inactive compartments within the genome is compat-
ible with the observation of transcription occurring at fixed transcription factories,
as well as models of chromatin loops described in Section 1.7. Clustering of act-
ive regions suggests a model of genomic organisation whereby the transcriptional
activity of genomic loci can be controlled by the adjustment of their position in the
nucleus. As inactive genes are stimulated by external factors, they can be epigen-
etically remodelled allowing escape from a repressive environment and recruitment
to a transcription factory (Chambeyron and Bickmore, 2004; Osborne et al., 2004).
Future studies into the dynamics and control of these compartments will surely
elucidate finer detail in the mechanisms by which mammalian gene expression is
controlled.
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7.3 Proto-oncogene associations
In chapter six I describe the co-association of BCR with chromosome 9 band q34,
the region containing the t(9;22)(q34;q11) translocation partner gene ABL1. The as-
sociation of these two loci has been studied before (Kozubek et al., 1997; Lukásová
et al., 1997; Neves et al., 1999; Kozubek et al., 1999; Schwarz-Finsterle et al., 2005),
as has the association of MLL with its translocation partner genes (Murmann et al.,
2005; Gué et al., 2006; Cowell et al., 2012). These studies differ from the work
described in this thesis by their use of FISH to measure association. While they are
able to show significantly enriched association in comparison to candidate control
loci, they cannot describe the association in the context of all genomic contacts. The
BCR bait e4C data in this thesis suggests that the BCR : chr9 q34 association is the
strongest trans association made by the BCR locus in the entire genome.
This data supports the hypothesis that chromosomal associations may play an
important role in the formation of chromosomal translocations (Section 1.10). Such
observations give greater weight to the need to understand the organisation of the
human genome in health and disease. Understanding the process of transloca-
tion formation is important for the continued development of cancer treatments.
For example, if therapy-related leukaemias involving the MLL gene are caused
by topoisomerase induced DSBs during transcription, in the future we may see
precautionary drugs able to modify the activity or localisation of the MLL gene.
The greater our understanding of biological processes, the greater our ability to
control them to prevent and cure disease.
My hypothesis at the start of this PhD was that chromosomal translocation
partner genes specifically associate at transcription factories. This was supported by
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evidence showing the recruitment of Myc to pre-existing transcription factories con-
taining transcribing Igh alleles (Osborne et al., 2007). There has been some dispute
to this finding since; Hakim et al. used 4C-seq to characterise the associations of
Myc and Igh in cultured B cells with and without AID, a protein involved in somatic
hypermutation (Hakim et al., 2012). They found the frequency of translocations
correlated with genomic association frequencies in the absence of AID, but that
AID translocation hotspots did not. Rocha et al. published a study using similar
methodologies that came to the opposite conclusion; that off target AID activity
does correlate with genomic association (Rocha et al., 2012). However, Rocha et
al. did not find Myc to be the most frequent association partner with Igh. It is of
note that both of these studies investigated cultured B cells undergoing steady state
transcription, whereas Osborne et al. used ex-vivo cells stimulated for five minutes
(Osborne et al., 2007). Myc is an immediate-early gene, meaning that it undergoes
rapid activation and transcription after activation. As such, the cells analysed by
Osborne et al. will have been undergoing a synchronised wave of transcriptional
activity and may exhibit different patterns of nuclear organisation to those studied
by Hakim and Rocha.
In my studies I investigated whether association between translocation partner
genes may be a general phenomenon. If so, e4C analysis would reveal association
between proto oncogenes in healthy cells. BCR and MLL have very different port-
folios of translocation partners, the former only found partnered with a handful
of genes and the latter more promiscuous with over 100 partners found to date
(discussed in Section 1.9). I expected the e4C trans association profiles to show
association with all of these genes, and for their association to correlate with trans-
location frequency. In general, the profiles that we discovered were not so simple.
BCR did show strong association with ABL1, but not in order of magnitude that
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we expected. Instead of the specific gene - gene associations, BCR was found to
associate with the entire telomeric arm of chromosome 9. These results suggest
that while association may affect the frequency of chromosomal translocations, it is
unlikely the be the sole cause for partner selection. Certainly, our view of nuclear
organisation is becoming increasingly complex.
An interesting observation described in this thesis is the presence of strong BCR
association in the vicinity of the ABL1 gene. Such a “bystander” effect has a number
of implications. For example, bystander genes may account for risk factors seen in
genome wide association studies (GWAS) which are not yet understood. To modify
deleterious gene associations, the behaviour of adjacent loci causing the contact
may need to be changed rather than the translocation partner genes themselves.
With the increasing capability of molecular biology techniques able to probe
nuclear structure, we will soon be able to investigate how the activity of other genes
can affect proto oncogenes on a more general scale.
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Appendices
A.1 Primers
A.1.1 RT-qPCR Primers
Table A.1.1 – RT-qPCR 3C Primers
Name Sequence
hSurf H1-1 ACCTCAGGGTTGTCCTCTGTTC
hSurf H1-2 GACCTTCAGACCCAGGGAAAG
hSurf H1-3 ATGCAATCATCATCCATTCTGG
hSurf H1-4 GAAGGAACTGGCCAGACTTTGT
hSurf H2-1 TCAGGTTTTGTTCCTGAGAACG
hSurf H2-2 AAGCCTTTGCGAAGCTAATGAC
hSurf H2-3 ACAGTGTGCATGGTTGAGAAGG
hSurf H2-4 TCAAAAGCCCGATACTTCCCTA
hSurf H3-1 CAGGAAGAGGCTGGAAGTCCT
hSurf H3-2 TCTGTCCATTTCCCTCCTTAGC
hSurf H3-3 TGCAACATCCTCTTCAGAACCT
hSurf H3-4 GGTTTGAGTAGACTTCTCTGGGTCT
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hSurf H4-3 GTAAACACGGCGAGCACATAAA
hSurf H4-4 TGAACCATATCCTGCTTGATGG
hBCR H1-3 TAGTGTGGTTCTTGCGATCTGG
hBCR H1-4 ACTCTCTGCCCTCCAACTTCTG
hABL H1-1 AGGTGCAGCTGTCTCTCTTCCT
hABL H1-2 GCAACCTCGTACAAGAAAAGCA
hABL H1-3 GAGATGCAGCGAATGTGAAATC
hABL H1-4 CACAAAAACATTGCAGTGTGGA
hABL H2-1 CCAGGGGCCTAATAAGGAAGAG
hABL H2-2 GCAGGCCACTCACTCTCTATGA
hABL H2-3 CAGTGTTTATTGACGCCCACTC
hABL H2-4 TTGCTTTGACAGCTAGGCTGAG
hSMC2 H1-1 CTCTCTGGCCCCAAGAAGTACA
hSMC2 H1-2 GCTGGCTGTGGCTTACTTTTCT
hSMC2 H1-3 GTCCGGCCATCTGTTTAGAAAT
hSMC2 H1-4 TGAGATGCTCCCATCGACTTTA
hZcchc6 H1-1 TGTGGCAGGAGATATACGCAGT
hZcchc6 H1-2 GGGGACCATATCGTAATTGCTC
hZcchc6 H2-1 CACATTGTTGAATAATACCCTTCC
hZcchc6 H2-2 CAAAAGTTTGCATGTTTTTGCT
hZcchc6 H2-3 GGGCACCGAGAAATTAGTTTTG
hZcchc6 H2-4 AAAGGGATCGTGACAAACAGGT
A.2 e4C Library Statistics
A.2.1 Numbers of e4C reads per Chromosome
Table A.2.1 – e4C reads by Chromosome.
BCR Run
1
BCR Run
2
MLL Run
1
MLL Run
2
MLL Run
3
MLL Run
3 PhiX
ABL1 MLL_1 MLL_2
1
Hits 886539 423842 1203 1228968 546017 2568 1265658 886650 931892
Hits
(dedup)
774 608 35 81 376 48 145 131 124
AseI
Frags
958
(0.90%)
833
(0.78%)
49
(0.05%)
88
(0.08%)
563
(0.53%)
71
(0.07%)
164
(0.15%)
141
(0.13%)
150
(0.14%)
2
Hits 702347 373986 2101 885876 593764 3120 865147 797590 735614
Hits
(dedup)
663 551 32 89 372 51 97 130 116
AseI
Frags
875
(0.70%)
755
(0.60%)
49
(0.04%)
109
(0.09%)
503
(0.40%)
71
(0.06%)
107
(0.09%)
140
(0.11%)
140
(0.11%)
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BCR Run
1
BCR Run
2
MLL Run
1
MLL Run
2
MLL Run
3
MLL Run
3 PhiX
ABL1 MLL_1 MLL_2
3
Hits 789199 338050 651 465938 519108 2837 748604 896418 832899
Hits
(dedup)
661 520 26 51 326 39 101 91 130
AseI
Frags
794
(0.75%)
686
(0.65%)
43
(0.04%)
61
(0.06%)
453
(0.43%)
58
(0.05%)
120
(0.11%)
92
(0.09%)
144
(0.14%)
4
Hits 671498 330078 2153 473346 443583 2299 685665 528751 581340
Hits
(dedup)
600 458 37 63 331 50 67 91 103
AseI
Frags
728
(0.63%)
623
(0.54%)
56
(0.05%)
69
(0.06%)
474
(0.41%)
75
(0.06%)
83
(0.07%)
111
(0.10%)
128
(0.11%)
5
Hits 501640 280020 898 951755 443227 2453 431719 481299 740173
Hits
(dedup)
528 394 22 78 273 41 72 77 105
AseI
Frags
658
(0.67%)
525
(0.53%)
29
(0.03%)
91
(0.09%)
374
(0.38%)
58
(0.06%)
70
(0.07%)
83
(0.08%)
137
(0.14%)
6
Hits 494300 319686 1332 727194 367236 1890 495133 727477 471205
Hits
(dedup)
505 443 38 40 279 34 70 102 84
AseI
Frags
632
(0.69%)
589
(0.64%)
59
(0.06%)
47
(0.05%)
383
(0.42%)
51
(0.06%)
79
(0.09%)
112
(0.12%)
103
(0.11%)
7
Hits 476244 212755 749 688327 280344 1331 453340 624651 486517
Hits
(dedup)
431 331 21 57 212 31 48 79 78
AseI
Frags
519
(0.66%)
452
(0.57%)
33
(0.04%)
55
(0.07%)
285
(0.36%)
40
(0.05%)
67
(0.09%)
94
(0.12%)
94
(0.12%)
8
Hits 416367 266614 724 533817 203668 1200 437464 229088 415457
Hits
(dedup)
439 346 20 47 210 22 41 63 71
AseI
Frags
528
(0.70%)
456
(0.61%)
29
(0.04%)
53
(0.07%)
295
(0.39%)
35
(0.05%)
44
(0.06%)
77
(0.10%)
79
(0.11%)
9
Hits 455003 227442 457 210815 377310 2214 14089114 310032 407339
Hits
(dedup)
395 310 16 22 209 32 834 60 61
AseI
Frags
477
(0.82%)
396
(0.68%)
22
(0.04%)
22
(0.04%)
285
(0.49%)
48
(0.08%)
672
(1.15%)
63
(0.11%)
75
(0.13%)
10
Hits 458043 204292 247 413720 205262 964 671827 203188 319160
Hits
(dedup)
409 317 17 35 171 19 66 42 72
AseI
Frags
480
(0.77%)
421
(0.68%)
24
(0.04%)
32
(0.05%)
237
(0.38%)
29
(0.05%)
74
(0.12%)
47
(0.08%)
86
(0.14%)
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BCR Run
1
BCR Run
2
MLL Run
1
MLL Run
2
MLL Run
3
MLL Run
3 PhiX
ABL1 MLL_1 MLL_2
11
Hits 422600 239318 6851 4307812 2510508 12945 892290 14981823 13145547
Hits
(dedup)
425 338 94 196 409 145 73 790 858
AseI
Frags
522
(0.83%)
462
(0.74%)
121
(0.19%)
185
(0.29%)
480
(0.76%)
186
(0.30%)
73
(0.12%)
623
(0.99%)
776
(1.24%)
12
Hits 587965 245711 713 930562 605475 2942 978019 480184 620858
Hits
(dedup)
452 355 20 43 211 29 74 66 84
AseI
Frags
558
(0.86%)
476
(0.73%)
29
(0.04%)
50
(0.08%)
283
(0.43%)
37
(0.06%)
77
(0.12%)
71
(0.11%)
105
(0.16%)
13
Hits 334196 175512 558 257937 169930 854 139197 505106 392592
Hits
(dedup)
326 268 20 39 189 21 34 64 64
AseI
Frags
411
(0.70%)
378
(0.65%)
31
(0.05%)
43
(0.07%)
270
(0.46%)
32
(0.05%)
39
(0.07%)
75
(0.13%)
78
(0.13%)
14
Hits 322578 187374 271 58770 36651 164 627703 191766 273517
Hits
(dedup)
310 282 10 22 165 11 51 47 43
AseI
Frags
380
(0.85%)
374
(0.83%)
17
(0.04%)
24
(0.05%)
230
(0.51%)
17
(0.04%)
60
(0.13%)
54
(0.12%)
49
(0.11%)
15
Hits 373427 188154 392 190630 130416 722 732461 277002 255223
Hits
(dedup)
322 272 9 20 148 21 67 55 49
AseI
Frags
389
(1.08%)
354
(0.98%)
12
(0.03%)
23
(0.06%)
208
(0.58%)
29
(0.08%)
82
(0.23%)
48
(0.13%)
61
(0.17%)
16
Hits 226640 168317 169 73883 296458 1645 533661 221188 169482
Hits
(dedup)
216 197 3 11 139 14 50 34 43
AseI
Frags
277
(0.97%)
272
(0.95%)
3 (0.01%) 14
(0.05%)
200
(0.70%)
18
(0.06%)
52
(0.18%)
45
(0.16%)
56
(0.20%)
17
Hits 512135 299241 586 367490 68173 344 1349407 264994 507019
Hits
(dedup)
417 336 13 16 202 13 86 54 64
AseI
Frags
503
(1.95%)
463
(1.79%)
16
(0.06%)
23
(0.09%)
303
(1.17%)
18
(0.07%)
90
(0.35%)
64
(0.25%)
74
(0.29%)
18
Hits 258583 134215 23 149524 158156 895 253479 116454 145111
Hits
(dedup)
250 180 6 24 132 22 38 33 32
AseI
Frags
306
(0.75%)
239
(0.58%)
9 (0.02%) 29
(0.07%)
190
(0.46%)
33
(0.08%)
44
(0.11%)
38
(0.09%)
35
(0.09%)
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BCR Run
1
BCR Run
2
MLL Run
1
MLL Run
2
MLL Run
3
MLL Run
3 PhiX
ABL1 MLL_1 MLL_2
19
Hits 255305 163418 34 82337 74237 305 287777 135796 353231
Hits
(dedup)
212 203 4 14 111 8 33 17 43
AseI
Frags
249
(1.84%)
272
(2.02%)
6 (0.04%) 15
(0.11%)
159
(1.18%)
11
(0.08%)
30
(0.22%)
17
(0.13%)
50
(0.37%)
20
Hits 201666 141846 706 191977 101117 642 298607 288105 346280
Hits
(dedup)
217 187 7 16 123 13 28 37 26
AseI
Frags
273
(1.22%)
263
(1.18%)
11
(0.05%)
20
(0.09%)
173
(0.77%)
22
(0.10%)
34
(0.15%)
39
(0.17%)
32
(0.14%)
21
Hits 211560 96444 473 213499 106146 516 354888 54673 143351
Hits
(dedup)
190 132 7 18 80 9 17 16 20
AseI
Frags
230
(1.24%)
185
(1.00%)
10
(0.05%)
23
(0.12%)
112
(0.60%)
15
(0.08%)
19
(0.10%)
18
(0.10%)
21
(0.11%)
22
Hits 5151402 4148254 71 24387 138754 585 280056 251658 142409
Hits
(dedup)
1727 1466 19 7 810 10 22 23 19
AseI
Frags
1625
(17.03%)
1531
(16.05%)
29
(0.30%)
7 (0.07%) 1019
(10.68%)
14
(0.15%)
23
(0.24%)
23
(0.24%)
27
(0.28%)
X
Hits 199693 90259 559 106708 105365 547 246552 234679 217705
Hits
(dedup)
220 152 12 33 96 13 39 63 57
AseI
Frags
252
(0.32%)
204
(0.26%)
15
(0.02%)
36
(0.05%)
131
(0.17%)
20
(0.03%)
51
(0.07%)
85
(0.11%)
66
(0.08%)
Y
Hits 19003 6048 1 6 17151 212 2 19 4959
Hits
(dedup)
23 11 1 1 15 4 2 1 5
AseI
Frags
32
(0.26%)
15
(0.12%)
2 (0.02%) 2 (0.02%) 16
(0.13%)
5 (0.04%) 2 (0.02%) 2 (0.02%) 7 (0.06%)
A.2.2 AseI Fragment Statistics
Near cis: within 2.5 megabases either side of bait gene. Far cis: beyond 2.5
megabases either side of bait gene.
Table A.2.2 – e4C library AseI fragment statistics.
All Fragments Hit Fragments % Hit
BCR Run1
trans 1425596 11,031 0.77%
near cis 1261 653 51.78%
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far cis 8279 972 11.74%
BCR Run2
trans 1425596 9,693 0.68%
near cis 1261 654 51.86%
far cis 8279 897 10.83%
MLL 1
trans 1372354 583 0.04%
near cis 1418 64 4.51%
far cis 61364 57 0.09%
MLL 2
trans 1372354 936 0.07%
near cis 1418 89 6.28%
far cis 61364 96 0.16%
MLL 3
trans 1372354 7146 0.52%
near cis 1418 126 8.89%
far cis 61364 354 0.58%
MLL 3 phiX
trans 1372354 807 0.06%
near cis 1418 95 6.70%
far cis 61364 91 0.15%
ABL
trans 1376812 1484 0.11%
near cis 1011 340 33.63%
far cis 57313 332 0.58%
MLL p1
trans 1372354 1539 0.11%
near cis 1418 314 22.14%
far cis 61364 309 0.50%
MLL p2
trans 1372354 1879 0.14%
near cis 1418 340 23.98%
far cis 61364 437 0.71%
A.2.3 Datasets used for active mark correlations
Accession codes for publicly available datasets:
Table A.2.3 – Accession codes.
Name NCBI GEO Accession Code
CD34+ Cell Datasets
RNA-Seq GSM651554
DNase GSM595917
H3K27ac GSM772870, GSM772885, GSM772894
H3K36me3 GSM486705, GSM486714
H3K4me1 GSM486707, GSM486708
H3K4me3 GSM486709, GSM486711
H3K9me3 GSM537663
H3K27me3 GSM537649
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ChIP-Seq Input GSM822292
Other Cell Types
GM12878 RNAP II GSE19550
K562 RNAP II GSM325933
HeLa RNAP II GSM320734
NB4 RNAP II GSM325935
A.2.4 Library trimming statistics
Percentage of possible sequences that were successfully aligned are shown in italics.
Table A.2.4 – Library trimming statistics.
Reads
starting
with
correct
barcode
Reads with
second
AseI site
(dis-
carded)
Reads with
NlaIII site
(too short
to be
mapped)
Reads with
NlaIII site
(long
enough to
be
mapped)
Reads with
no NlaIII
site (long
enough to
be
mapped)
Aligned
reads
BCR Run 1 22390498
85448
(0.4%)
3823824
(17.1%)
2860849
(12.8%)
18203128
(81.3%)
14931033
(66.7%)
(82.0%)
BCR Run 2 12616122
41823
(0.3%)
1493641
(11.8%)
1146963
(9.1%)
10932276
(86.7%)
9260876
(73.4%)
(84.7%)
MLL Run 1 55868 15 (0.03%)
29279
(52.4%)
1819
(3.3%)
26129
(46.8%)
21923
(39.2%)
(83.9%)
MLL Run 2 16442664
45012
(0.03%)
1388307
(8.4%)
662684
(4.0%)
14950490
(90.9%)
13535278
(82.3%)
(90.5%)
MLL Run 3 9960249
1535
(0.02%)
557742
(5.6%)
450422
(4.5%)
9368936
(94.1%)
8498056
(85.3%)
(90.7%)
MLL Run 3
phiX
56994 321 (0.6%)
1974
(3.5%)
1983
(3.5%)
48952
(85.9%)
44194
(77.5%)
(90.3%)
ABL Run 1 32140483
434554
(1.4%)
201658
(0.6%)
988675
(3.1%)
31082375
(96.7%)
27117770
(84.4%)
(87.2%)
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MLL Promoter
1
27548835
243399
(0.9%)
485996
(1.8%)
1124315
(4.1%)
26290533
(95.4%)
23688930
(86.0%)
(90.1%)
MLL Promoter
2
30333263
232741
(0.8%)
1917547
(6.3%)
1875757
(6.2%)
27748869
(91.5%)
22638880
(74.6%)
(81.6%)
A.2.5 e4C library read counts
Percentages in brackets show proportion of total number of reads. Italicised num-
bers in brackets show the duplicates normalised to the total number of reads in that
region for easier comparison between libraries.
Table A.2.5 – e4C library read counts.
Total reads Near cis (≤ 5
megabases)
Far cis (> 5
megabases)
trans
BCR Run 1
Raw 14931033 3986287
(26.7%)
1165115 (7.8%) 9779631
(65.5%)
De-duplicated 10714 1007 (9.4%) 873 (8.1%) 8834 (82.5%)
Av. dups / read
(per 106 reads)
1394 (93) 3959 (265) 1335 (89) 1107 (74)
BCR Run 2
Raw 9260876 3542934
(38.3%)
605320 (6.5%) 5112622
(55.2%)
De-duplicated 8657 935 (10.8%) 767 (8.9%) 6955 (80.3%)
Av. dups / read
(per 106 reads)
1070 (116) 3789 (409) 789 (85) 735 (79)
MLL Run 1
Raw 21923 5030 (22.9%) 1821 (8.3%) 15072 (68.7%)
De-duplicated 489 54 (11.0%) 40 (8.2%) 395 (80.8%)
Av. dups / read
(per 106 reads)
45 (2045) 93 (4249) 46 (2077) 38 (1740)
MLL Run 2
Raw 13535278 3236378
(23.9%)
1071434 (7.9%) 9227466
(68.2%)
De-duplicated 1023 107 (10.5%) 89 (8.7%) 827 (80.8%)
Av. dups / read
(per 106 reads)
13231 (978) 30247 (2235) 12039 (889) 11158 (824)
MLL Run 3
Raw 8498056 1701901
(20.0%)
808607 (9.5%) 5987548
(70.5%)
De-duplicated 5589 140 (2.5%) 269 (4.8%) 5180 (92.7%)
Av. dups / read
(per 106 reads)
1520 (179) 12156 (1430) 3006 (354) 1156 (136)
MLL Run 3 phiX
Raw 44194 9054 (20.5%) 3891 (8.8%) 31249 (70.7%)
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De-duplicated 700 83 (11.9%) 62 (8.9%) 555 (79.3%)
Av. dups / read
(per 106 reads)
63 (1429) 109 (2468) 63 (1420) 56 (1274)
ABL Run 1
Raw 27304920 10005936
(36.6%)
4121827
(15.1%)
13177157
(43.8%)
De-duplicated 2170 512 (23.6%) 331 (15.3%) 1327 (61.2%)
Av. dups / read
(per 106 reads)
12583 (461) 19543 (1953) 12453 (3021) 9930 (754)
MLL Promoter 1
Raw 23693130 11118007
(46.9%)
3868012
(16.3%)
8707111
(36.7%)
De-duplicated 2171 467 (21.5%) 324 (14,.9%) 1380 (63.6%%)
Av. dups / read
(per 106 reads)
10913 (461) 23807 (2141) 11938 (3086) 6310 (725)
MLL Promoter 2
Raw 22727268 8803028
(38.7%)
4359567
(19.2%)
9564673
(42.1%)
De-duplicated 2439 470 (19.3%) 397 (16.3%) 1572 (64.5%)
Av. dups / read
(per 106 reads)
9318 (410) 18730 (2128) 10981 (2519) 6084 (636)
A.2.6 Genome wide association withBCR in GM12878 Cells
Hi-C other ends were extracted for the region surrounding the BCR gene in the pub-
licly available Hi-C data from Kalhor et al. (2011), SRA accession code SRA025848.
These reads were then processed as described in Section 4.
175
Chapter A: Appendices
A.3 e4C analysis scripts
A.3.1 In-silico restriction fragment libraries
,
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1 #!/usr/bin/perl
2 use warnings;
3 use strict;
4 #############################################################
5 # Name: Potential Hits (4C) #
6 # Authors: Phil Ewels #
7 # Version 1.0 - 08/04/2011 #
8 # --------------------------------------------------------- #
9 #############################################################
10
11 ###########################
12 ## CONFIGURATION OPTIONS ##
13 ###########################
14
15 # Path to chromosome fasta files. Replace chromosome number with %s
16 my $fn_base = ’D:\Genome Sequences\Human\chromFa\chr%s.fa’;
17 #my $fn_base = ’D:\Genome Sequences\Human\GRCh37\Homo_sapiens.GRCh37.55.dna.
chromosome.%s.fa’;
18
19 # Path to output file
20 my $output = ’AseI_NlaIII_fragments.txt’;
21
22 # Chromosomes to use. Default is (1..22,’X’,’Y’) - other options are ’MT’ etc.
23 my @chromosomes = (1..22,’X’,’Y’);
24
25 # First restriction site to use (3C digestion - assumes palindromic 6 cutter)
26 my $re_search1 = ’ATTAAT’;
27
28 # Second restriction site to use (4C digestion)
29 my $re_search2 = ’CATG’;
30
31 # Size selection parameters (in base pairs)
32 my $minsize = 10;
33 my $maxsize = 700;
34
35 ##################################
36 ## END OF CONFIGURATION OPTIONS ##
37 ##################################
38
39 open (OUT,’>’,$output) or die $!;
40
41 # go through each chromosome
42 foreach my $chromosome (@chromosomes) {
43 my $filename = sprintf($fn_base, $chromosome);
44 open (IN,$filename) or die "Can’t read file: $!";
45 warn "Starting Chromosome $chromosome ($filename)\n";
46 my $sequence = ’’;
47 $_ = <IN>; # Remove fasta header
48 while (my $line = <IN>) {
49 chomp ($line);
50 $sequence .= $line;
51 }
52
53 # Search for restriction enzyme sites (greedy regex)
54 while ($sequence =~ /$re_search1(.*?)$re_search1/g) {
55 # Kick out fragments with lots of N’s (centromeres and telomeres)
56 next if (index ($1,’NNNNN’) >=0);
57 # Add fragment to array, with half of restriction site added back on either
end
58 # Not using real site so we can revcomp and join without modifying (if AseI =
AT^TAAT, fragment is AAT...ATT)
59 my $fragment = substr($re_search1,2,4).$1.substr($re_search1,0,2);
60
61 # Only proceed if we have a NlaIII site (otherwise ignore fragment)
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62 if ($fragment =~ /CATG/i) {
63
64 # Get sequence from start of string to first NlaIII site
65 $fragment =~ /(^.+CATG?).*$/i;
66 #print OUT "$chromosome_name\t$start\t$end\t$length_fragment\t$string\n";
67 #warn "$chromosome\t".pos($sequence)."\t".(pos($sequence)+length("${1}CATG")
)."\t+\t".length("${1}CATG")."\t${1}CATG\n";
68 if(length($fragment) > $minsize && length($fragment) < $maxsize) {
69 print OUT "$chromosome\t".pos($sequence)."\t".(pos($sequence)+length("${1}
CATG"))."\t+\t".length("${1}CATG")."\t${1}CATG\n";
70 }
71
72 # Get sequence from last NlaIII site to end of string
73 $fragment =~ /^.+CATG(.+$)/i;
74 #warn "$chromosome\t".pos($sequence)."\t".(pos($sequence)+length("${1}CATG")
)."\t-\t".length("${1}CATG")."\t${1}CATG\n";
75 #sleep(1);
76 if(length($fragment) > $minsize && length($fragment) < $maxsize) {
77 print OUT "$chromosome\t".pos($sequence)."\t".(pos($sequence)+length("${1}
CATG"))."\t-\t".length("${1}CATG")."\t${1}CATG\n";
78 }
79 }
80 # Move array pointer back six so that we don’t skip a fragment
81 pos($sequence) -= 6;
82 }
83 close IN;
84 }
A.3.2 Systematic bias correction
,
1 #!/usr/bin/perl
2 use warnings;
3 use strict;
4 use Math::Round;
5 #############################################################
6 # Name: GC Bias #
7 # Author: Phil Ewels #
8 # Version 1.0 - 04/11/2011 #
9 #############################################################
10
11 ####################
12 #### SETUP ####
13 ####################
14 my $GC_binsize = 5/100;
15 my $AN_fraglength_binsize = 10;
16
17
18
19 # Set input file by command line
20 my ($input) = @ARGV;
21 if (!defined $input) {
22 die "Usage is GC_bias.pl [input file]\n";
23 }
24
25 # Get genome into a hash
26 warn "Loading Genome...\n";
27 my $fn_base = ’D:\Genome Sequences\Human\chr%s.fa’;
28 my @chromosomes = (1..21,’X’,’Y’);
29 my %chrom;
30 foreach my $chromosome (@chromosomes) {
31 my $filename = sprintf($fn_base, $chromosome);
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32 open (CHROMOSOMES,$filename) or die "Can’t read file: $!";
33 $_ = <CHROMOSOMES>; # Remove fasta header
34 while (my $line = <CHROMOSOMES>) {
35 chomp ($line);
36 $chrom{$chromosome} .= uc($line); # Make everything upper case
37 }
38 warn "Chromosome $chromosome loaded...\n";
39 }
40
41 # Load annotated report
42 open (IN,$input) or die "Can’t read file: $!";
43 $_ = <IN>; # File Header
44 my %all_frags_percent;
45 my %hit_frags_percent;
46 my %all_frags_length;
47 my %hit_frags_length;
48
49 ##########################################
50 #### WORK OUT CORRECTION FACTORS ####
51 ##########################################
52 warn "\nCalculating statistics";
53 my $counter = 0;
54 while (my $line = <IN>) {
55 $counter++;
56 chomp ($line);
57 my @field = split(/\t/, $line);
58 my $chr = $field[1]; # Chromosome
59 my $start = $field[2]; # Start
60 my $end = $field[3]; # End
61 my $hit = ($field[11] eq ’1.0’) ? 1 : 0;
62 if (exists $chrom{$chr}) { # Check that we have the chromosome for this fragment
63 ########### GC CONTENT
64 my $seq = substr($chrom{$chr},$start,($end - $start + 1));
65 my $at = ($seq =~ tr/AaTt//);
66 my $gc = ($seq =~ tr/GgCc//);
67 $at = (int($at)) ? $at : 0; # make sure that vars are numeric
68 $gc = (int($gc)) ? $gc : 0;
69 if(($gc + $at) > 0){ # kick out empty strings
70 my $ratio = $gc / ($gc + $at);
71 $ratio = nearest($GC_binsize, $ratio);
72 $all_frags_percent{$ratio} += 1; # count for all fragments
73 if($hit) { # count only for hit hits
74 $hit_frags_percent{$ratio} += 1;
75 }
76 }
77
78 ######### FRAGMENT LENGTH
79 my $length = $end - $start + 1; # +1 because of genomic co-ordinates, eg. pos
4 to 5 is 2 bases, 5-4 = 1
80 $length = nearest($AN_fraglength_binsize, $length);
81 $all_frags_length{$length} += 1; # count for all fragments
82 if($hit) { # count only for hit hits
83 $hit_frags_length{$length} += 1;
84 }
85 }
86 if($counter % 200000 == 0) { warn "$counter lines analysed\n"; }
87 }
88 warn "\nStatistics calculated.";
89
90 ##### Total number of fragments processed
91 my $all_num_frags = 0;
92 my $hit_num_frags = 0;
93 while ((my $key, my $value) = each(%all_frags_percent)){
94 $all_num_frags += $value;
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95 }
96 while ((my $key, my $value) = each(%hit_frags_percent)){
97 $hit_num_frags += $value;
98 }
99 warn "\n\nNumber of Fragments Processed\nTotal: $all_num_frags\tHit:
$hit_num_frags\n\n";
100
101 ##### Calculate GC correction values
102 warn "Caculating GC correction values\n";
103 my %GC_correction;
104 foreach my $key (sort keys %all_frags_percent) {
105 my $percent_all = 0;
106 my $percent_hit = 0;
107 $GC_correction{$key} = 1;
108 if (exists $hit_frags_percent{$key}) {
109 $percent_all = $all_frags_percent{$key} / $all_num_frags;
110 $percent_hit = $hit_frags_percent{$key} / $hit_num_frags;
111 $GC_correction{$key} = $percent_hit / $percent_all;
112 }
113 }
114 ##### Optional - print output GC correction values
115 warn "Printing GC correction values\n";
116 open (GC_OUT, ’>’,$input."_GC_correction_factors.txt") or die "Can’t read file: $!
";
117 foreach my $key (sort keys %GC_correction) {
118 print GC_OUT ($key*100)."%\t".$GC_correction{$key}."\n";
119 }
120
121 ##### Calculate AseI - NlaIII fragment length correction values
122 warn "Caculating AseI - NlaIII fragment length correction values\n";
123 my %ANlength_correction;
124 foreach my $key (sort {$a<=>$b} keys %all_frags_length) {
125 my $percent_all = 0;
126 my $percent_hit = 0;
127 $ANlength_correction{$key} = 1;
128 if (exists $hit_frags_length{$key}) {
129 $percent_all = $all_frags_length{$key} / $all_num_frags;
130 $percent_hit = $hit_frags_length{$key} / $hit_num_frags;
131 $ANlength_correction{$key} = $percent_hit / $percent_all;
132 }
133 }
134
135 ##### Optional - print output frag length correction values
136 warn "Printing AseI - NlaIII fragment length correction values\n";
137 open (FL_OUT, ’>’,$input."_fragLength_correction_factors.txt") or die "Can’t read
file: $!";
138 foreach my $key (sort {$a<=>$b} keys %ANlength_correction) {
139 print FL_OUT "$key\t".$ANlength_correction{$key}."\n";
140 }
141
142 #########################################
143 ##### OUTPUT
144 #########################################
145 ##### Print final correction value for each fragment
146 warn "\nPrinting final correction value file\n\n";
147 my $starting_chance = $hit_num_frags / $all_num_frags;
148 open (OUT, ’>’,$input."_correction_values.txt") or die "Can’t read file: $!";
149 # reset input file pointer
150 seek(IN, 0, 0);
151 # loop through input file again
152 $counter = 0;
153 while (my $line = <IN>) {
154 $counter++;
155 chomp ($line);
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156 my @field = split(/\t/, $line);
157 my $chr = $field[1]; # Chromosome
158 my $start = $field[2]; # Start
159 my $end = $field[3]; # End
160 my $chance = $starting_chance;
161 if (exists $chrom{$chr}) { # Check that we have the chromosome for this fragment
162 ########### GC CONTENT
163 my $seq = substr($chrom{$chr},$start,($end - $start + 1));
164 my $at = ($seq =~ tr/AaTt//);
165 my $gc = ($seq =~ tr/GgCc//);
166 $at = (int($at)) ? $at : 0; # make sure that vars are numeric
167 $gc = (int($gc)) ? $gc : 0;
168 if(($gc + $at) > 0){ # kick out empty strings
169 my $ratio = $gc / ($gc + $at);
170 $ratio = nearest($GC_binsize, $ratio);
171 # Multiple the chance by the correction value for this ratio
172 $chance = $chance * $GC_correction{$ratio}
173 }
174
175 ######### FRAGMENT LENGTH
176 my $length = $end - $start + 1; # +1 because of genomic co-ordinates, eg. pos
4 to 5 is 2 bases, 5-4 = 1
177 $length = nearest($AN_fraglength_binsize, $length);
178 # Multiple the chance by the correction value for
A.3.3 Mock in-silico e4C library generation
,
1 #!/usr/bin/perl
2 use warnings;
3 use strict;
4 use Math::Random::MT::Perl qw(srand rand);
5 use IO::File;
6 #############################################################
7 # Name: Single Window p Value #
8 # Author: Phil Ewels #
9 # Version 1.0 - 04/11/2011 #
10 #############################################################
11
12 ####################
13 #### SETUP ####
14 ####################
15 my $repeats = 5;
16
17 # Set input file by command line
18 my ($corrections_file) = @ARGV;
19 if (!defined $corrections_file) {
20 die "Usage is single_window.pl [corrections file]\n";
21 }
22
23 # Open output filehandles
24 my @output;
25 for my $i (0 .. ($repeats-1)) {
26 push(@output, IO::File->new(’> library_’.($i+1).’.txt’));
27 }
28
29 # Load corrections
30 warn "Loading correction factors..\n\n";
31 my $counter = 0;
32 open (CORRECTIONS, $corrections_file) or die "Can’t read file: $!";
33 while (my $line = <CORRECTIONS>) {
34 $counter++;
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35 chomp ($line);
36 my @field = split(/\t/, $line)
A.3.4 Restriction site search
,
1 #!/usr/bin/perl
2 use warnings;
3 use strict;
4 #############################################################
5 # Name: Single RE Fragments #
6 # Author: Phil Ewels #
7 # Version 1.0 - 05/05/2011 #
8 # --------------------------------------------------------- #
9 #############################################################
10
11 #===============================
12 #==== CONFIGURATION OPTIONS ====
13 #===============================
14
15 # Set by command line (optional)
16 my ($output,$re_search) = @ARGV;
17 if (defined $output && !defined $re_search) {
18 die "Usage is single_RE_fragments.pl [output file] [search string]\nLeave blank
to use defaults\n";
19 } elsif(!defined $output) {
20 # Path to output file
21 $output = ’AseI_fragments.txt’;
22 # Restriction site to use
23 $re_search = ’ATTAAT’;
24 warn "Using file defaults: search string = $re_search, output = $output\n";
25 } else {
26 warn "Using command line variables: search string = $re_search, output = $output
\n";
27 }
28
29 # Path to chromosome fasta files. Replace chromosome number with %s
30 my $fn_base = ’D:\Genome Sequences\Human\chr%s.fa’;
31 #$fn_base = ’D:\Genome Sequences\Human\GRCh37\Homo_sapiens.GRCh37.55.dna.
chromosome.%s.fa’;
32 warn "Looking for Genome Sequences in $fn_base\n\n";
33
34 # Chromosomes to use. Default is (1..22,’X’,’Y’) - other options are ’MT’ etc.
35 my @chromosomes = (1..22,’X’,’Y’);
36
37
38 #==================================
39 #== END OF CONFIGURATION OPTIONS ==
40 #==================================
41
42 open (OUT,’>’,$output) or die $!;
43
44 # go through each chromosome
45 foreach my $chromosome (@chromosomes) {
46 my $filename = sprintf($fn_base, $chromosome);
47 open (IN,$filename) or die "Can’t read file: $!";
48 warn "Starting Chromosome $chromosome ($filename)\n";
49 my $sequence = ’’;
50 $_ = <IN>; # Remove fasta header
51 while (my $line = <IN>) {
52 chomp ($line);
53 $sequence .= uc($line); # Make everything upper case
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54 }
55
56 my ($offset, $lastpos, $pm) = (0, 1, "+");
57 my $pos = index($sequence, $re_search, $offset);
58 while ($pos != -1) {
59 # Kick out fragments with lots of N’s (centromeres and telomeres)
60 #next if ( index( substr($sequence,$lastpos,($pos-$lastpos)),’NNNNN’) >=0);
61 # Too slow...
62
63 print OUT $chromosome."\t". # Chromosome Name
64 $lastpos."\t". # Position Start
65 $pos."\t". # Position Finish
66 $pm."\n"; # Arbitrary orientation to help visulaisation
67 if ($pm eq "+") { $pm = "-"; } else { $pm = "+"; }
68 $lastpos = $pos + length($re_search);
69 $offset = $pos + length($re_search);
70 $pos = index($sequence, $re_search, $offset);
71 }
72
73 close IN;
74 }
A.4 Web Tools
I am a keen advocate in the publication and sharing of bioinformatics tools. Some
of the scripts that I wrote during my thesis could be useful for others, so I published
them on my personal blog, at http://www.tallphil.co.uk/bioinformatics
These scripts are not printed here due to their length.
A.4.1 Sequences
Frustrated by the lack of a quick and simple tool to get reverse compliment se-
quences during primer design, I created a web page which uses JavaScript to gen-
erate common derivations of short genomic sequences. The tool can be seen online
at http://www.tallphil.co.uk/bioinformatics/sequences
A.4.2 Genome RE Sites
I found myself frequently running a script I wrote to generate lists of restriction
endonuclease recognition site co-ordinates. To make this tool generally available I
adapted it to work through a web page with Human and Mouse genomes, plus all lis-
ted New England Biolabs restriction endonucleases. The tool can be seen at http:
//www.tallphil.co.uk/bioinformatics/genome_re_sites
A.4.3 Cytobands
To batch convert cytogenetic bands (eg. 9q34) into chromosomal co-ordinates (eg.
chr:130,300,000-141,213,431) I wrote a script that uses data from the UCSC table
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browser. The script automatically recognises the format of the input and returns
both cytogenetic band and chromosomal co-ordinates. The tool can be seen at
http://www.tallphil.co.uk/bioinformatics/cytobands
A.4.4 FastQC
FastQC is a tool written by Dr Simon Andrews of the Babraham bioinformatics
department. It analyses fastQ sequence files and produces a report describing a
number of metrics that can be used to assess sequence quality. The reports are
given as a HTML web page, divided into sections. I re-wrote the CSS (cascading
style sheet) styles for the report to produce a static navigation bar on the side of
the page which aided use of the report. The styles respond to the size of the device
being used and are moved for small screens. FastQC can be found at http://
www.bioinformatics.babraham.ac.uk/projects/fastqc/
A.5 Publications
Meet the neighbours: tools to dissect nuclear structure and function
Osborne CS, Ewels PA, Young AN
Briefings in Functional Genomics (2011) 10(1), 11-7
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